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Abstract 
 
  
 Enzymes that utilize nonheme diiron centers to activate dioxygen and carry out 
various chemical transformations are of great fundamental and practical interest. The 
mechanisms of these enzymes can be studied using various spectroscopic and 
biochemical methods, which are greatly aided by parallel studies on relevant model 
complexes. This thesis work employs this approach to investigate three non-cannonical 
diiron enzymes, human deoxyhypusine hydroxylase (hDOHH), as well as CmlA and 
CmlI, a pair of oxygenases on the biosynthesis pathway of the antibiotic 
chloramphenicol. 
 We first provide a summary of recent studies on enzymes that employ the 
canonical 4-helix-bundle motif to house a diiron cluster with a 2-His-4-carboxylate 
ligand set, as well as those that use a whole new range of structural motifs and/or exibit 
non-canonical reactivities (Chapter 1). We have successfully characterized an unusually 
stable, yet functional, peroxo intermediate of hDOHH (hDOHHperoxo), an enzyme 
which possesses a superhelical HEAT-repeat fold (Chapter 2). Detailed spectroscopic 
analysis of hDOHHperoxo and related model complexes reveals that hDOHHperoxo 
contains a (cis-μ-1,2-peroxo)diiron(III) unit (Chapter 2) with an additional μ-hydroxo 
ligand (Chapter 3). This μ-hydroxo ligand is proposed to contribute to the remarkable 
stability of hDOHHperoxo and its reactivity. The formation of hDOHHperoxo and its 
reaction with substrate are detailed in Chapter 4. hDOHH adopts various conformations 
in different forms, that significantly affect the formation and activation of 
 v
hDOHHperoxo. Notably, we have observed the epoxidation of one of the unsaturated 
analogues of the native deoxyhypusine-containing eIF5A substrate. 
 In line with the studies on the unusual hDOHHperoxo intermediate, we have also 
studied another unique and relatively stable peroxo intermediate of CmlI (CmlIperoxo). 
Resonance Raman spectroscopy suggests that CmlIperoxo possibly contains a (μ-η1:η2-
peroxo)diiron(III) cluster instead of the more common (μ-1,2-peroxo)diiron(III) cluster 
found in canonical diiron enzymes and model complexes (Chapter 5). EXAFS analysis of 
as-isolated CmlI reveals that it contains about 3 His ligands, which is consistent with 
sequence homology analysis. The third His ligand in CmlI could be responsible for the 
shift in the peroxo binding geometry of CmlIperoxo. Finally, resonance Raman and 
EXAFS analysis of CmlA, a β-hydroxylase, shows that this enzyme contains a (μ-
oxo)(μ-1,3-carboxylato)diiron(III) cluster with about 4 His ligands, a feature similar to 
diiron reductases and hydrolases. As found for CmlI, the extra His ligands in CmlA may 
lead to alternative reactive oxygen species as opposed to those found for methane 
monooxygenase and other canonical diiron enzymes.  
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Chapter 1                                                                            
The versatility of diiron clusters in biology: structures, reactivities, 
mechanisms, and biological roles of oxygen-activating diiron enzymes 
that turnover organic substrates 
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In the past three decades, the number of proteins containing non-heme non-sulfur 
carboxylate-bridged diiron active sites, so-called nonheme diiron enzymes, has increased 
rapidly.1-23 These enzymes catalyze a wide range of chemical reactions, mainly 
oxidoreductive and some hydrolytic. They play various important roles in biology, 
including: (i) oxygen transport and/or sensing,1, 24-26 (ii) O2 and NO scavenging,10 (iii) 
oxidative stress responses,7, 27 (iv) iron storage and transport,28 (v) biosynthesis of 
important biomolecules (DNAs,8 lipids,6 and proteins16) and bioactive products 
(antibiotics,12, 14, 15, 18, 22 ubiquinone,17 etc.), and (vi) metabolisms of hydrocarbons4, 5 and 
other organic compounds.11, 13, 20, 21 Of great fundamental and practical interest are the 
diiron enzymes that activate dioxygen to selectively oxidize organic substrates (roles v 
and vi). These enzymes are linked to a number of diseases including cancer, malaria, 
HIV, diabetes, obesity and aging.6, 11, 17, 29-31 The conversion of organic substrates such as 
the selective functionalization of C-H bonds or small alkane synthesis would be relevant 
to chemical, pharmaceutical and energy industries. Understanding the molecular details 
of how these enzymes work would augment our knowledge of how Nature works that can 
potentially lead to practical applications.  While recent reviews for specific types of 
diiron enzymes are available,6, 8, 9, 32 the last excellent reviews on the entire class of diiron 
enzymes in general were published about 15 years ago.2, 3 This chapter is devoted to a 
review of recent studies of both well characterized and recently found diiron enzymes 
that convert organic substrates. The first section will summarize the past and recent 
studies of canonical substrate-converting diiron enzymes. The subsequent sections will 
describe studies that expand the reactivities of the canonical enzymes as well as those 
 3
with new structural motifs catalyzing both old and new chemistries, including those that 
are included in this thesis. 
1.1. The canonical oxygen-activating diiron enzymes that oxidize organic substrates 
1.1.1. The conserved 4-helix bundle and 2-His-4-carboxylate structural motifs 
 
Table 1.1. Diiron enzymes 
 
Enzymes Fold Ligands Function Ref. 
Canonical enzymes 
BMMs α4 2 H, 4 E/D Hydrocarbon hydroxylation 
Alkene epoxidation 
4, 5, 9 
Desaturases α4 2 H, 4 E/D Hydrocarbon desaturation 6 
R2  α4 2 H, 4 E/D Tyrosine oxidation 8 
Ferritin H-chain α4 1-2 H, 4 E/D Ferroxidase 28 
Rubrerythrin family α4 1-2 H, 5-6 D/E Peroxidase 7, 27 
Hemerythrin family  α4 5 H, 2 D/E O2 carrier or sensor 1, 24-26 
Fe-Urease -- 4H, 1D, 1K, ?  Urea hydrolysis 40 
Uterroferin αββα 3 H, 1 Y, 2 D, 1 N Phosphoric acid ester hydrolysis 41-43 
Flavo-diiron proteins αββα 3-4 H, 3 D/E NO and O2 reduction 10 
Recently found enzymes 
BoxB and PaaA α4 2 H, 4 E/D Aromatic ring epoxidation 44-47 
AD α4 2 H, 4 E/D Aldehyde decarbonylation 19-21, 23 
AurF α4 3 H, 4 E/D Arylamine N-oxygenation 12, 14, 15 
MIOX -- 4H, 2 D 4-electron oxidation of MI to DG 11, 13, 48-55 
DOHH HEAT 4H, 2E ? C-H bond hydroxylation 16, 56-58 
CmlA αββα 3-4 H, 3-4 E/D C-H bond hydroxylation 18 
 
 
The canonical organic substrate-oxidizing diiron enzymes belong to the 
multicomponent bacterial monooxygenase (BMMs) family, fatty acid desaturases family, 
and class Ia ribonucleotide reductase subunit R2 (R2). As found for most of other diiron 
enzymes, BMMs, desaturases, and R2 utilize a 4-helix-bundle protein fold to house their 
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diiron active sites.3 A ligand set consisting of two His and four carboxylate (Glu and/or 
Asp) residues in the conserved sequence motif (E/D)XnEX2H (n = 29 – 37) is found to be 
unique for BMMs, desaturases, and R2s (Figure 1).2, 3, 9, 33-39 Diiron enzymes that deviate 
from having either the 4-helix-bundle motif or a 2-His-4-carboxylate ligand set were not 
previously known to oxidize organic substrates (Table 1.1). 
 
 
 
Figure 1.1. Overall protein scaffold of MMOH with the 4-helix bundle highlighted 
(1FYZ). 
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A (1FYZ)                    B (1MHY) 
 
 
                    
   C (1XIK)            D (1RIB) 
 
 
        
  E (1AFR) 
                     
     F (1PIM)              G(1PIU) 
 
Figure 1.1. (Cont.). The diiron active sites with 2-His-4-carboxylate ligand sets of 
reduced MMOH (A), oxidized MMOH (B), reduced R2 (C), oxidized R2 (D), reduced 
Δ9D (E), reduced D84E R2 (F), and oxidized D84E R2 (G). 
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Among organic substrate oxidizing diiron enzymes, the structures of BMMs 
appear to be further conserved.9, 39 The active site ligand arrangement of methane 
monooxygenase,33-36 toluene/o-xylene monooxygenase,37,38 and toluene 4-
monooxygense39  are homologous in both  reduced and oxidized states (Fig. 1A and B, 
respectively), which are distinct from those of R2 (Fig. 1C and D), desaturases (Fig. 1E), 
and other diiron enzymes that do not exhibit oxygen atom transfer chemistry. 
Interestingly, having similar structures to those of BMMs in both oxidized and reduced 
forms (Fig. 1F and G), the mutant W48F/D84E R2 also exhibits monooxygenase 
chemistry instead of tyrosine oxidation as observed in wild type R2.59, 60 
 
 
1.1.2. General mechanism 
 
 The general mechanism of diiron enzymes is shown in Scheme 1.1 based on the 
extensive studies of R2, MMO, and Δ9D. In addition to the diiron-containing subunits, 
reductases are required for these enzymes in multiple turnover reaction. Furthermore, a 
small and cofactorless protein component that plays important regulatory role is found for 
BMMs.  Of great interest are the oxygen activation steps, which involve the binding of 
O2 to the diiron(II) center to form a peroxo intermediate that then undergoes O-O bond 
cleavage to form oxygenated high valent iron species. A mixed valent diiron(III/IV) (X) 
and a diiron(IV) (Q) intermediates have been trapped and characterized for R2 and 
MMO, respectively. A 2.5 Å Fe---Fe distance is found by EXAFS analysis for both of 
these intermediates.61, 62 This distance could only be achieved in diamond core structures, 
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bis(μ-oxo)diiron(IV) for Q or (μ-1,1-carboxylato)(μ-oxo)diiron(III/IV) for X (Scheme 
1.1), as observed in several model complexes.63, 64 
  
 
Scheme 1.1. Simplified generally accepted mechanisms for canonical oxygen-activating 
diiron enzymes 
 
 
 
Q hydroxylates methane and other aliphatic hydrocarbons in a radical pathway 
involving the rate-determining homolytic cleavage of strong C-H bonds as evidenced by 
a very large substrate H/D KIE.65, 66 On the other hand, X performs 1-electron oxidation 
of a nearby tyrosine residue (Y120) in R2 to form a diiron(III)-tyrosyl radical species67-69 
that is involved in a long range proton coupled electron transfer (PCET) to the catalytic 
subunit of RNR (R1). Oxygenated high valent species like Q and X are implicated in 
other diiron enzymes and observed in some synthetic model systems as the species 
responsible for substrate oxidation. Analogously, an iron(IV)-manganese(IV) has been 
observed in the  O2 activation by class Ic RNR from Chlamydia trachomatis, which is 
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then converted to a mixed valent iron(III)-manganese(IV) species functionally equivalent 
to the diiron(III)-tyrosyl radical system in class Ia R2.70-72 
1.1.3. The peroxo intermediates 
The peroxo intermediates of several canonical organic substrate-oxidizing diiron 
enzymes have been characterized by UV/Vis-detected stopped-flow techniques and 
rapid-freeze quench Mossbauer spectroscopy.2, 73-80 Vibrational data of the O-O and Fe-O 
bonds have only been obtained for the peroxo intermediates of Δ9D and D84E-R2, which 
unambiguously reveal a Fe-O-O-Fe (μ-1,2-peroxo) binding goemetry.77, 78 A similar μ-
1,2-peroxo intermediate has also been observed for the diiron ferroxidase site of frog 
ferritin.81 While Δ9Dperoxo is off pathway as it decays to a diferric state without 
desaturating its bound substrate,6 the formation of X is the dominant decay pathway of 
D84E-R2peroxo, making it the only catalytically relevant peroxo intermediate of orgainic 
substrate oxidizing diiron enzymes that bears direct evidence for the peroxo moiety. Most 
of other peroxo intermediates of diiron enzymes have UV/Vis and Mössbauer 
spectroscopic properties similar to those of Δ9Dperoxo, D84E-R2peroxo, and their model 
complexes and are thus believed to also have the μ-1,2-peroxo geometry. Furthermore, 
the Mössbauer parameters of these peroxo species differ from those of (μ-1,2-
peroxo)diiron(III) complexes with an additional oxo/hydroxo/alkoxo ligand. 82, 83 
R2peroxo converts to X upon injection of an exogeneous electron via an electron 
transfer pathway involving the W48 residue near the surface of the protein. Blocking this 
electron transfer pathway to the diiron active site by replacing the W48 residue with an 
Ala or Phe residue of D84E-R2 allows the accumulation of the peroxo intermediate to a 
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yield suitable for structural analysis with EXAFS. A 2.5 Å Fe---Fe distance was derived 
by EXAFS for W48A/D82E-R2peroxo, leading to a proposed diamond core structure 
with two μ-1,1-carboxylato ligands in additional to the μ-1,2-peroxo moiety.84 The same 
structure is also proposed for the peroxo intermediate of the ferroxidase subunit of frog 
ferritin that decays to a diferric cluster and H2O2 without O-O bond cleavage.85 A closely 
related structure has been found only observed for a synthetic dimanganese peroxo 
complex,86 but not yet found for any peroxo diiron model compound. The significantly 
large disorder parameter (10×10-3 Å2) required by the EXAFS analysis for the 2.5 Å Fe---
Fe path of W48A/D84E-R2peroxo at a small coordination number (0.6) 84 contradicts the 
proposed rigid structure consisting of two monoatomic and one diatomic bridging 
ligands. Indeed, in a later combined spectroscopic and computational study, the authors 
of this work proposed a ~ 3.6 Å Fe---Fe distance for W48F/D84E-R2peroxo, which is 
presumably identical to W48A/D84E-R2peroxo.87 These contradicting results cast doubt 
on the precise structures of the peroxo intermediates of oxygen-activating diiron enzymes 
remains ambiguous. 
The formation and activation of MMOperoxo has been extensively studied. The 
reaction of reduced hydroxylase subunit MMOH with O2 is enhanced by 1000-fold in the 
presence of  1 – 2 equivalents of the regulatory subunit MMOB, allowing the 
accumulation of transient intermediates that are not observed in the absence of MMOB.  
Lipscomb and coworkers found evidence for two intermediates, designated as O and P*, 
prior to the formation of MMOperoxo  from Methylosinus trichosporium.88 O is an 
oxygen adduct forming upon the addition of O2 to reduced MMOH, in which the diiron 
center remains in the reduced state as evidenced by the characteristic g = 16 signal. P* 
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forms after O with the lost of the g = 16 signal and decays to MMOperoxo. Subsequent 
conversion of MMOperoxo to Q is a single exponential step. Both the formation of 
MMOperoxo from P* and its conversion to Q are pH-dependent with KSIE of 1.3 and 
1.4, respectively.88 Proton inventory measurements reveal that one proton is delivered in 
each of these steps.88 Lippard and coworkers later also found KSIE of 2.0 and 1.8 for the 
formation and activation, respectively, of MMOperoxo from Methylococcus capsulatus.89 
They also proposed that proton transfer to an active site carboxylate residue in P* leads to 
the isomerization of this intermediate to MMOperoxo.  
Interestingly, Lippard and co-worker observed a “colorless” peroxodiiron(III) 
intermediate in ToMO (ToMOperoxo) with Mössbauer parameters distinct from the 
usually colored μ-1,2-peroxo intermediate (Table 1.2).90 When the T201 residue, which is 
critical for the active site hydrogen bonding network, is mutated to several other residues, 
a colored peroxo species (T201Xperoxo) with UV/Vis and Mössbauer parameters typical 
of (μ-1,2-peroxo)diiron(III) species is observed in addition to ToMOperoxo (Table 
1.2).73, 91 Detailed kinetic analysis reveals that T201Xperoxo rapidly and reversibly 
isomerizes to ToMOperoxo involving a proton transfer event.92 ToMOperoxo is then 
proposed to proceed on the reaction pathway as the aromatic ring attacking species. 
Whether ToMOperoxo is truly the substrate-oxidizing intermediate requires further 
investigation, both on the enzymatic and model systems. Nevertheless, the observation of 
multiple inter-converting peroxo species for ToMO, in line with that observed earlier for 
MMO, is an important insight toward understanding the oxygen activation mechanism by 
diiron enzymes. 
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Table 1.2. Properties of diiron(III)-peroxo units in enzymes and related model complexes 
 
Peroxo Species 
λ (nm) 
 (ε (M-1cm-1)) 
δ 
(mm/s) 
ΔEQ 
(mm/s) 
J 
(cm-1) 
ν(O-O)
(cm-1) 
r(Fe⋅⋅⋅Fe)
(Å) 
t1/2 (T (oC)) 
formation  
t1/2  (T (oC)) 
decay  Ref. 
hDOHH 630 (2800) 
0.55, 0.58 
(0.49, 0.63) 
1.16, 0.88 
(1.05, 0.99)
50-70 855 3.44 ~ 1 min (4) Stable 16, Chapters 3 
and 4 
Mt MMOH 725 (2500) 0.67 1.51 - - - 77 ms (4) 270 ms (4) 88 
Mc MMOH 720 (1350) 0.66 1.51 - - - 1 s (4) 2 s (4) 89 
R2 mutants 700 (1500) 0.63 1.58 50 868 2.50 <130 ms (5) <120 ms (5) 77, 79, 93 
Mouse R2 700 (1500) 0.63 1.73 - - - <1 ms (10) 11 ms (10) 74 
Δ9D 700 (1200) 0.68, 0.64 1.90, 1.06 - 898 - 15 ms (6) 30 min (25) 76, 78 
Frog M Ferritin 650 (1000) 0.62 1.08 70 851 2.53 < 70 ms < 1 s  85, 93, 94 
ToMOH T201S 675 (1500) 0.67 1.51 - - - 8 ms (4) 0.23 s (4) 73 
ToMOH † 0.54 0.66 - - - 26 ms (4) 15 s (4) 90 
OxyHr 500 (2000) 0.51, 0.54 1.09, 1.92 154 844 3.23 < 3 ms (6) - 1, 95-102 
AurF 500 (500) 0.54 (49%) 
0.61 (33%) 
0.66 
0.35 
- - - <10 ms (20) 7 min (20) 103 
CmlI 500 (500) - - - 791 - - 30 min (25)
3 hrs (4) 
104, Chapter 5 
OxyHr models 470 (2600) 
484 (2350) 
0.53, 0.53 
0.53, 0.49 
0.99, 1.57 
1.76, 1.15 
- 
- 
843 
841 
- 
- 
- 
- 
- 
- 
105 
 
Models type 1a 
682 (3450) 
694 (2650) 
- 
0.66 
- 
1.40 
- 
- 
876 
888 
3.65 
4.00 
- 
- 
- 
- 
106 
107 
Models type 2b 
560-750 
(1200-3200) 
0.53-0.56 0.52-1.26 57-60 845-908 3.05-3.47 - - 83, 108, 109 
† No chromophore observed. a bis( µ-1,3-carboxylato)(µ-1,2-peroxo)diiron(III) cores.b(µ-1,2-peroxo)diiron(III) cores with an additional µ-alkoxo, µ-hydroxo, or 
µ-oxo ligand. 
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1.2. New reactivities of the canonical motif: regioselective aromatic ring epoxidation 
of CoA-tethered substrates by PaaA and BoxB 
 
Scheme 1.2. Phenylacetyl-CoA and benzoyl-CoA metabolism.46, 47 
 
 
Aromatic compounds are among the major environmental pollutants110 as well as 
the second most abundant class of organic growth substrate, next to carbohydrates, for 
microorganisms. Microorganisms overcome the stabilizing aromatic resonance energy 
with several strategies depending on the availability of oxygen. In aerobic pathways, the 
aromatic compounds are hydroxylated and ring cleaved by oxygenases using oxygen as 
the oxidant.111, 112 In the absence of oxygen, aromatic compounds are usually converted to 
benzoyl-CoA that undergoes reductive dearomatization and ring cleavage.113 A hybrid 
pathway occurs under semi-aerobic conditions, where CoA-tethered benzoate and 
phenylacetate have recently been shown to be first epoxidized by a monooxygenase and 
subsequently undergo oxygen-independent ring rearrangement and cleavage (Scheme 
1.2).46, 47 Among the enzymes involved in the epoxidation step, PaaA and BoxB are 
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identified as the monooxygenase subunits, whereas other components are reductase 
(PaaE and BoxA) or regulatory and structural subunits.  
 
      
   A (3Q1G)        B (3PM5)  
 
Figure 1.2. Crystal structures of BoxB.44 A: oxidized form at 2.5 Å resolution. B: 
NADPH-reduced form with bound substrate at 2.3 Å resolution from views perperdicular 
to or along the Fe---Fe vector. The benzoyl substrate moiety is shown in grey. Glu 150 
residue shifts away from bridging mode (shown in light blue-green). Sequence motif: 
E120X30E150X2H153 and D211X29E240X2H243 
 
Recent studies show that PaaA and BoxB belong to a new branch of BMMs.44, 45 
Sequences of both enzymes contain the conserved diiron binding motifs (D/E)X29-
30EX2H found for the canonical oxygen activating diiron enzymes.3 The 2-His-4-
carboxylate ligand set of BoxB has been confirmed by the crystal structure of its oxidized 
form. Although none of the iron-loaded forms of PaaA has been crystallized, 
superimposing the crystal structures of apo PaaA and oxidized ToMO reveals that 2 His 
and 4 carboxylate residues are located in a putative diiron binding site of PaaA in a 
similar fashion as in ToMO.45  
In the oxidized form of BoxB, the 2-His-4-carboxylate ligand set arranges around 
the diiron active site in a way closely resembling that found for previously known BMMs 
(Fig. 2A). There is a well defined water-derived bridging ligand with Fe-O distances of 
2.00 and 2.04 Å, an ∠Fe-O-Fe bond angle of 119.3o, and an Fe---Fe distance of ~ 3.5 Å. 
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Mössbauer spectroscopy shows that the oxidized form of BoxB contains a diiron(III) 
cluster with a quadruple splitting of 0.69 mm/s. This small ΔEQ value is indicative of 
octahedral electronic geometry, which is smaller than values of 0.9 – 2.4 mm/s found for 
oxo-bridged diiron clusters with distorted electronic geometry.114-116 The ΔEQ value and 
structural parameters of the Fe-O-Fe unit are consistent with a μ-hydroxo bridged 
structure rather than a μ-oxo-bridged core as found in desaturases and R2 (Fig. 1.1), 
consistent with the 3.5 Å Fe---Fe distance. A second water molecule is found near a 
bridging position, which possibly leads to a bis(μ-hydroxo)diiron(III) core for oxidized 
BoxB, which is simlar to those in BMMs. 
The crystal structure of a complex of BoxB with benzoyl-CoA has been obtained 
under anaerobic conditions in the presence of both BoxA and NADPH. The identity of 
the reduced diiron cluster is unclear although EPR shows that in vitro reduction of 
oxidized BoxB in solution yielded a mixed valent diiron(II/III) form. In the absence of 
NADPH, benzoyl-CoA did not co-crystallize with BoxB. Complexes of apo PaaA-PaaC 
with several CoA derivatives have also been obtained. There is a significant active site 
rearrangement in the crystal structure of reduced BoxB with benzoyl-CoA compared to 
the structure of oxidized BoxB. One iron center is displaced by 0.7 Å and the μ-1,3 Glu 
residue switches away from the diiron site. The two iron centers of reduced 
BoxB:benzoyl-CoA complex are thus not bridged (Fig. 2B), a feature also observed for 
the mixed valent state of phenol hydroxylase.117 It is likely that oxidized BoxB and PaaA 
have low affinity for their substrates and that the reduction of the diferric state is 
necessary for the conformational change to occur upon substrate binding.  
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Complexes of PaaA and the NADPH-reduced form of BoxB with their substrates 
are the first examples of monooxygenase-substrate complexes that are co-crystallized. 
There are hydrophilic substrate channels with narrow entrances, which resemble that of 
stearoyl-ACP Δ9D.118 The benzoyl moiety is positioned near the active site with one side 
of the benzene ring facing the diiron cluster. A dioxygen molecule can be modeled as a 
μ-1,2-peroxo ligand of the diiron cluster and pointing toward the C2 and C3 atoms of the 
benzoyl moiety. The crystal structure data thus provides the rationale for the exclusive 
observation of 2,3-epoxide product of BoxB (Scheme 1.2).47 Likewise, 1,2-epoxide is the 
sole product of the reaction of PaaA (Scheme 1.2), which is likely a result of precise 
positioning of carrier-tethered substrate. Such strict regioselectivity is observed for 
desaturases that act on carrier protein-bound fatty acids118, 119 but not for BMMs. 
 
1.3. New reactivity of the canonical motif: alkane synthesis by aldehyde 
decarbonylase 
 
 
Figure 1.3. Crystal structure of fatty acid decarbonylase from from P. marinus MIT9313 
(2OC5). Fe-μO = 1.940, 2.007 Å, ∠Fe-O-Fe = 109.9o, Fe---Fe = 3.232 Å. Sequence 
motif: E45X28E73X2H75 and E128X29E157X2H160 
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Scheme 1.3. Synthesis pathway of alkane or alkene from fatty acids with possible C1 co-
products.19-22 N/F/FR = NADPH, ferredoxin, and ferredoxin reductase system. N/P = 
NADH and 5-methylphenazinium methylsulfate system.  
 
 
 
The biosythensis of alkanes is one of the newest approaches toward renewable 
fuel. A two-step pathway in cyanobacteria was discovered recently in which ACP-bound 
fatty acids are reduced to corresponding aldhydes that in turn undergo C1-C2 bond 
scission to produce alkane (Scheme 1.3).19 The removal of the carbonyl group is carried 
out by the enzyme aldehyde decarbonylase (AD) as first reported by Schirmer et al in 
2010. A 1.68 Å crystal structure of AD from Prochlorococcus marinus MIT9313 
(PmAD) was deposited in 2006 by the Joint Center for Structural Genomics before its 
function was found (pdb code 2OC5). The overall protein fold of PmAD and its apparent 
diiron active site, which is yet to be confirmed, closely resemble that of class Ia R2, 
except that there is an unidentified μ-1,3 ligand, possibly a fatty acid molecule, 
displacing a Glu ligand (Fig. 1.3). A detailed review by Krebs, Bollinger, and Booker on 
ADs has been recently published (ref. 120). Summarized here are the most important 
details on AD reaction, some of which are not included in ref. 120. 
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The original study by Shirmer et al. focused on elucidating the role of AD in the 
synthesis of alkane and alkene; they only tentatively assigned the C1 co-product as CO, 
which makes it a self-redox reaction (Reaction 1, Scheme 1.3). The in vitro assay of ADs 
from various sources required a reducing system such as NADPH, ferredoxin, and 
ferredoxin reductase (N/F/FR).19 The requirement for reducing reagents by ADs, and the 
fact that ADs bear the structure motif of O2-activating dinuclear metal enzymes, 
prompted Krebs, Bollinger, Booker and co-workers to further investigate the identity of 
the C1 co-product. They obtained three important results for the reaction of AD from 
Nostoc punctiforme (NpAD): 1) the C1 co-product is formate, not CO; 2) the aldehyde H 
atom remains on the formate co-product; and 3) O2 is required for the reaction and one 
oxygen atom from O2 is incorporated into the formate co-product. Based on this 
observation, Krebs, Bollinger, Booker and co-workers proposed a “cryptic” reaction for 
NpAD (Reaction 2, Scheme 1.3).21, 23 Several O2-activation mechanisms of AD using 
different types of dinuclear active sites were also hypothesized although supporting 
experimental data have yet to be obtained.23, 120 
Shortly after the work by Krebs, Bollinger, Bookers and co-workers, Das et al. 
reported their study on PmAD, in which for the first time AD is shown unequivocally to 
be an iron-dependent enzyme.20 In vitro reconstitution of apo AD with Mn(II), Fe(II), 
Co(II), Ni(II), Cu(II) and Zn(II) revealed that only Fe(II) supports alkane formation. 
More importantly, in the presence of the NADH:PMS reducing system (N/P), PmAD  is 
only active under strict anaerobic conditions, but inactive under aerobic conditions.  
Formate was also found as the C1 co-product in the anaerobic reaction of PmAD. 
Labeling experiments using D2O or deuterated substrate unequivocally indicated that 
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aldehyde H atom remained on the formate co-product, which is also observed for the 
reaction of NpAD under aerobic condition, while a hydrogen atom from water is 
incorporated to the alkane product (Reaction 3, Scheme 1.3). In the absence of a reducing 
system and under anaerobic conditions, Das et al. observed the formation of a high spin 
iron(III) species at g = 4.3 when adding heptadecanal to PmAD. Using the spin trapping 
reagent phenyl-N-tert-butylnitrone (PBN), they was also able to probe another radical 
species that formed together with the high spin iron(III) species. These observations led 
to a proposed mechanism involving electron transfer from iron to aldehyde to initiate C1-
C2 bond cleavage with the reducing system serves as an “electron buffer”. 
 Notably, PmAD turns over about 0.4 times per minute under anaerobic 
conditions with N/P, which is about 100 to 1000-fold more active than NpAD under 
aerobic conditions with N/F/FR (~ 3 turnovers in 20 hours).21, 23 It is unclear why PmAD 
is more reactive than NpAD, although there are differences in the sequences of PmAD 
and NpAD (60% sequence identity) and the reaction conditions are likely among the 
causes. More importantly, why one AD requires O2 to function while the other is only 
active in the absence of O2 is intriguing and should draw immediate attention. 
 
1.4. An additional His ligand and a new reactive species: Substrate oxidizing peroxo 
intermediates in AurF and CmlI 
 
A considerable number of natural products exhibiting remarkable biological 
activities contain nitroaryl groups, which are often synthesized via the oxygenation of the 
corresponding aminoaryl groups.121, 122 AurF from Streptomyces thioluteus was the first 
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binuclear metalloenzyme reported to catalyze N-oxygenation of p-aminobenzoic acid 
(PABA) to p-nitrobenzoic acid (PNBA), a step involved in the biosynthesis of the 
polyketide antibiotic aureothin (Scheme 1.4).12, 123 Homologs of AurF are found in a 
number of non-ribosomal peptide synthetase (NRPS) or polyketide synthase (PKS) 
pathways,124, 125 including CmlI from Streptomyces venezuelae that is involved in the 
biosynthesis of chloramphenicol.104  
 
Scheme 1.4. Oxygenation of p-aminobenzoic acid (PABA) by AurF as a step in the 
aureothin PKS synthesis pathway (left) and its proposed mechanisms. 
 
           
 
 
Figure 1.4. Active site structure of AurF from Streptomyces thioluteus (3CHU). 
Sequence motif: E101X34E136 X2H139, E196X26H223X3E227 X2H230 
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The sequence of AurF contains the conserved diiron binding motif E101X34E136 
X2H139, E196X30E227 X2H230 with an additional His at position 223. The crystal structure 
of AurF shows that a binuclear active site is indeed supported by a 4-helix bundle protein 
fold.15 Furthermore, there is an electron transfer pathway similar to that found in class Ia 
R2.126 The active site of AurF was at times proposed to be a diiron,12 dimanganese,14 and 
iron/manganese127 cluster based on crystallographic and spectroscopic studies. Choi et al. 
later showed in reconstitution experiments of apo AurF with mixtures of Fe and Mn that 
the N-oxygenase activity of AurF is optimal with Fe:Mn ratio of 1:0 and decreases as the 
Fe:Mn ratio decreases.15 The pure manganese form showed only nominal activity 
compared to the iron form. The ligand arrangement in the oxidized AurF crystal structure 
is similar to that found in R2 and MMOH, except that H233 replaces a labile coordinating 
water molecule (Fig. 1.4).15 In pH 7.5 solution, the diiron(III) cluster of AurF exists 
mainly in a μ-oxo bridged form (~ 78 % by Mössbauer spectroscopy), but a μ-OH 
bridged form is also observed (~ 22 %), indicating that the μ-oxo ligand of AurF is 
reversibly protonatable under physiological conditions.103 Sequence comparison and 
Mössbauer studies104 together with EXAFS analysis (Chapter 5) of CmlI showed that this 
enzyme also contains a diiron cluster with 3 His ligands that exists in a mixture of µ-oxo-
bridged and µ-hydroxo-bridged forms. Having an additional His ligand and a reversibly 
protonatable μ-oxo ligand, AurF and CmlI are clearly different from the canonical diiron 
enzymes.  
In the reaction of reduced AurF with O2, a broad chromophore at 500 nm (ε = 500 
M-1cm-1) is observed, which differs from both the reduced form and the oxidized form of 
AurF.103 This chromophore is associated with two sets of Mössbauer parameters, δ1 = 
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0.54 mm/s, ΔEQ,1 = 0.66 mm/s and δ2 = 0.61 mm/s, ΔEQ,2 = 0.35 mm/s at a ratio of ~ 
1.5:1. These parameters are typical of high-spin iron(III) species128 but different from the 
parameters of oxidized AurF. This species is thus assigned as a peroxo intermediate 
(AurFperoxo) that is perhaps present as an equilibrium mixture of two or more isomers. 
A peroxo intermediate with similar spectroscopic parameters has also been observed for 
CmlI (CmlIperoxo).104 Unlike in AurFperoxo, the Mössbauer spectrum of CmlIperoxo 
exhibits two doublets with equivalent intensities, which more likely arise from one 
diiron(III) species.104 The UV/Vis and Mössbauer parameters of AurFperoxo and CmlI 
are different from those of μ-1,2-peroxo intermediates of the canonical diiron enzymes, 
82, 83, 106, 109, 129-131  but their Mössbauer parameters resemble those of the optically inactive 
ToMOperoxo.90  
AurFperoxo, which forms with t1/2 ~ 5 ms, and is relatively stable (t1/2 ~ 7 min at 
pH 7.5 and 20 oC) but decays rapidly upon the addition of 1 equivalent of PABA (t1/2 = 5 
ms). No intermediate is observed in the reaction of AurFperoxo with PABA, suggesting 
that this intermediate is the substrate-oxygenating species. It is proposed that the peroxo 
moiety is nucleophilically attacked by the electron rich arylamine and subsequently 
undergoes O-O bond cleavage, which may also be the case for the reaction of 
ToMOperoxo with its nonnative substrate phenol.90 More interestingly, Li et al. found 
that AurFperoxo is capable of 4-electron oxidation of the p-hydroxyaminobenzoic acid 
(PHABA) intermediate in vitro to form PNBA and the active diferrous AurF (Scheme 
1.4C).132 An alternative stepwise reaction is proposed for AurF (Scheme 1.4B), in which 
the enzyme uses only two equivalents of O2 and two equivalents of reducing reagent. 
This mechanism is much more chemically economical than the generally accepted 
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mechanism involving 3 equivalents of O2 and 6 equivalents of reducing reagent (Scheme 
1.4A). While it is unclear whether 4-electron oxidation of PHABA truly occurs in vivo, 
there is also a discrepancy with the study reported by Li et al. The incubation of 450 μM 
PHABA with reduced AurF and 900 μM O2 generates 50 – 70 μM PABA based on  the 
reported HPLC traces in ref.132 This formation of PABA cannot be assigned to the auto-
decomposition of PHABA as the incubation of PHABA with O2 in the absence of 
reduced AurF did not produce PABA. The production of PABA from PHABA in the 
presence of reduced AurF clearly complicates the kinetics of the reaction. Nevertheless, 
the in vitro 4-electron oxidation is an unique reactivity of a (peroxo)diiron(III) species. 
 CmlIperoxo decays much more slowly than AurFperoxo (t1/2 = 0.5 and 3 hours at 
25 and 4 oC, respectively),104 which allowed us to characterize this species in solution 
with resonance Raman spectroscopy (Chapter 5). Surprisingly, our resonance Raman 
study revealed an unusually low ν(O-O) frequency (791 cm-1) for CmlIperoxo, which 
was attributed to a (µ-η1:η2-peroxo)diiron(III) cluster instead of the more common (µ-
1,2-peroxo)diiron(III) species (Table 1.2). The additional His ligand in CmlI perhaps 
contributes to the shift in peroxo binding geometry of CmlIperoxo. Although this peroxo 
binding geometry has been found in heterobinuclear Fe-heme copper peroxo 
intermediates,133 it has not been previously observed for any (peroxo)diiron(III) species. 
A similar peroxo binding geometry is also expected for AurFperoxo given the 
spectroscopic similarity of AurFperoxo and CmlIperoxo. It could be possible that the µ-
η1:η2-peroxo is a common geometry in the peroxo intermediates of the diiron N-
oxygenase family of enzymes, which significantly expands our current knowledge of 
oxygen activation by nonheme diiron enzymes.  
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1.5. A new reactive species: Substrate oxidizing superoxo intermediate in MIOX 
 
Scheme 1.5. Reaction of MIOX and formation of the proposed C-H bond cleaving 
superoxo intermediate G. 
 
 
 
 
 
 
 
    
Figure 1.5. Crystal structure of mouse MIOX with bound substrate (2HUO). 
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myo-Inositol (MI) and its various biochemical derivatives play various cellular 
roles including membrane structure, signal transduction, and osmoregulation.48, 49 MI is 
converted by myo-inositol oxygenase (MIOX) to D-glucuronate (DG) (Scheme 1.5), 
which is subsequently transformed to xylitol. Aberrant homeostasis of MI, i.e. depletion 
of MI and overproduction of xylitol, are sometime linked to diabetes, suggesting MIOX 
as a target for treatment of this disease.48, 49 
Despite being found in 1950’s, MIOX has only been well studied recently. The 
sequence of MIOX is conserved among many species.51 The crystal structures of 
substrate-bound MIOX from mouse and humans are almost identical.11, 55 Although it is a 
diiron enzyme that oxidizes an organic subtrate, MIOX is different from the canonical 
enzymes in several ways. First, MIOX carries out the 4-electron oxidation of its substrate 
using one equivalent of O2, as opposed to 2-electron oxidation by the canonical enzymes. 
Thus, MIOX does not formally require a reducing system as found for the canonical 
enzymes. Second, MIOX does not bear the 4-helix bundle motif (Fig. 1.5). Third, the 
ligand set of MIOX contains 4 His and 2 Asp residues supported by 5 helices (Fig. 1.5). 
Fourth, MIOX is active in a mixed valent diiron(II/III) form in contrast to the diiron(II) 
state in the canonical enzymes. Finally, and most interestingly, the substrate-oxidizing 
intermediate in MIOX is found to be a terminal superoxo-diiron(III) species, not a high-
valent species. The crystal structures of MIOX from mouse and humans both reveal that 
MI binds to the iron(III) center in a bidentate mode using the hydroxy groups at positions 
1 and 6, the oxidation target. A labile terminal water molecule is found on the iron(II) 
center that is syn to the MI molecule (Fig. 1.5). This structure suggests that O2 could 
replace this water ligand and get activated to the form of a superoxide that points toward 
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the C1-H bond of MI (Scheme 1.5). As the reaction goes on, the oxidation state of the 
substrate-binding iron center remains unchanged. Based on the structure and proposed 
mechanism of MIOX, the O2-binding iron center of MIOX can be considered as a 
monoiron enzyme with 2-His-1-carboxylate facial triad. The function of the iron(III) 
center, which occupies to coordination sites of the facial triad through the μ-hydroxo and 
μ-1,3-carboxylato ligands, is to arrange the substrate to an optimal position for C1-H 
bond activation. Additional details can be found in a recent excellent review of MIOX 
structure and chemistry (ref. 54). 
 
1.6. A new structural motif for hydroxylase: DOHH, the first human diiron 
hydroxylase 
 
Scheme 1.6. Post-translational (+)-hypusine biosynthesis. DHS = deoxyhypusine synthase.  
 
 
 
(+)-Hypusine, (+)-N-4-amino-(2-hydroxybutyl)lysine, is an unusual amino acid 
found only in the sequence of the eukaryotic initiation factor 5A (eIF5A),56, 57 which is 
synthesized posttranslationally in a two-step pathway involving deoxyhypusine synthase 
(DHS) and deoxyhypusine hydroxylase (DOHH). eIF5A is highly conserved among 
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eukaryotes and is required for cell proliferation. Based on the crystallographic study of 
EF-P, a homolog of eIF5A in Thermus thermophilus, it is proposed that eIF5A(Hpu) 
binds to the complexes of ribosome and fMet-tRNAifMet and properly positions them for 
the formation of the first peptide bond.134 eIF5A(Hpu), but not the other forms of eIF5A, 
has been shown to promote translation elongation.135  Inhibition of DHS and/or DOHH 
leads to a decreased amount of cellular eIF5A(Hpu), resulting in the inhibition of cell 
growth. Thus, DOHH is an attractive target for interfering with cell proliferation in 
antitumor, antimalaria, and anti-HIV-1 therapy.29, 30, 56, 57 Indeed, two potential drugs 
have been reported to inhibit HIV-1 gene expression in cells at clinically relevant 
concentrations by preventing the maturation of eIF5A.29  
 
       
Figure 1.6. Hypothetical structure of hDOHH and a proposed structure of its (μ-1,2-
peroxo)diiron(III) intermediate. 
 
 
Although DOHH was found twenty years ago, its structure and mechanism have 
not been well understood. DOHH has been shown to be an oxygen- and iron-dependent 
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enzyme.58, 136, 137 Although it carries out C-H bond hydroxylation, DOHH has an amino 
acid sequence that does not resemble those of BMMs or monoiron hydroxylases. Instead 
DOHH has a superhelical structure consisting of 8 HEAT motifs, with four strictly 
conserved pairs of adjacent His-Glu residues.58 Based on mutagenesis experiments and 
metal analysis of holoprotein, DOHH is proposed to have a 4-His, 2-Glu ligand 
combination to bind two iron atoms.136 Later spectroscopic analysis showed that DOHH 
indeed contains a diiron active site, making it the first diiron enzyme found to 
stereospecifically hydroxylates protein-bound substrate.16 
Interestingly, human DOHH (hDOHH) expressed in E. coli has a blue color (λmax 
~ 630 nm),136 which has been shown by our recent spectroscopic study (reported in 
Chapter 2) to arise from a (μ-1,2-peroxo)diiron(III) species (hDOHHperoxo) by various 
spectroscopic techniques.16 A ~ 3.4 Å Fe---Fe distance was unequivocally derived by 
EXAFS analysis for hDOHHperoxo. The spectroscopic properties of this species suggest 
that it is similar to (peroxo)diiron(III) model compounds with an additional single-atom 
bridge, but differs substantially from those in the canonical enzymes and their relevant 
model compound (Table 1.2). Notably, although hDOHH is stable (t1/2 = weeks at 4 oC at 
pH 8.2), it is on the eIF5A(Dhp) hydroxylation pathway16 and one of its peroxo oxygen 
atom is incorporated in the product (our unpublished result). hDOHHperoxo is thus the 
only extensively characterized functional peroxo intermediate of diiron enzymes thus far. 
The activation of hDOHHperoxo may involve protein conformational change upon 
protein substrate binding, as well as the removal of this single-atom bridge that allows the 
peroxo moiety to isomerize to a more activated geometry. A regulatory analogous to 
those of BMMs may also be required for peroxo activation. Further studies on activation 
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of hDOHHperoxo would bring significant insight into the oxygen activation mechanism 
by diiron enzymes. 
1.7. A new structural motif for hydroxylase: CmlA, a hydroxylase with a β-
lactamase fold 
 
Many natural products, including pharmaceutically important antibiotic and 
chemotherapeutic drugs, are synthesized in nonribosomal peptide synthetase (NRPS)-
based pathways and contain β-hydroxy amino acid moieties. 138-140 The hydroxyl group is 
the target of many tailoring reactions required for pharmacological activity, including 
glycosylation, oxidation, and macrocycle formation.141 The β-hydroxy group is typically 
introduced stereospecifically by cytochrome P450s and alpha-ketoglutarate-dependent 
nonheme iron-containing enzymes. 
 
Scheme 1.7. The biosynthetic pathway of chloramphenicol 
 
 
 
 
 
Recently, a large new family of tailoring enzymes that contain a nonheme oxo-
bridged diiron active site has been identified.18 These enzymes catalyze β-hydroxylation 
in the biosynthesis of a wide range of antibiotic and cytostatic agents, including 
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bleomycin and the planin family of antibiotics. The first isolated member of this family is 
CmlA that catalyzes β-hydroxylation of p-aminophenylalanine (L-PAPA) linked by a 
thioester bond to the thiolation domain of the NRPS CmlP (Scheme 1.7). CmlA is the 
second example of a diiron monooxygenase that hydroxylates protein-bound substrate. 
 
       
Figure 1.7. A dinuclear metalloprotein with αββα (β-lactamase fold) and a proposed 
core structure of CmlA 
 
 
Interestingly, CmlA and its family have sequences that are distinct from those of 
the BMMs. They infact belong to a superfamily of metalloenzymes bearing the αββα fold 
(β-lactamase). β-lactamase enzymes are often known to carry out hydrolysis chemistry, 
but iron-dependent β-lactamase enzymes, FprA and ROO, function as NO and O2 
reductase. CmlA is the first example of a β-lactamase fold enzyme  shown to catalyze C-
H bond hydroxylation. While the X-ray crystal structure of an enzyme from CmlA and its 
family has not been reported, XAS and other spectroscopic analysis of CmlA suggested 
that it contain a (μ-oxo)(μ-1,3-carboxylato)diiron cluster with 3 or 4 His ligands, a 
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structure similar to that found in AurF or FprA and ROO (Chapter 6). The CmlA 
structure indicates that the conserved active-site structure motif of BMMs may only valid 
for that family, and different active site structure could also catalyze oxygen atom 
transfer to hydrocarbon. 
 
1.8. Summary 
New reactivities have been found for enzymes with canonical 4-helix bundle and 
2-His-4-carboxylate motifs, including fatty aldehyde decarbonylation to form alkanes 
with one less carbon atom (aldehyde decarbonylase) and aromatic ring epoxidation (PaaA 
and BoxB). AurF and CmlI with the 4-helix bundle protein fold and a 3-His-4-
carboxylate ligand set oxidize arylamines to nitro compounds with a new type of peroxo 
intermediate. Surprisingly, a µ-η1:η2-peroxo geometry, instead of the more common µ-
1,2-peroxo configuration, has been found for CmlIperoxo. Equally exciting are the 
discoveries of enzymes with different protein folds and ligand sets, even one with 
structural motif typical of hydrolases, that could catalyze oxygenase chemistry (myo-
inositol oxygenase (MIOX), deoxyhypusine hydroxylase (DOHH), and CmlA). A 
substrate-oxidizing superoxo intermediate has been characterized for MIOX. A stable 
peroxo intermediate of DOHH has been isolated and thoroughly studied. The new 
structural motifs and reactive intermediates have brought significant insight into the 
oxygen activation mechanisms by diiron enzymes.  
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Figure 1.8. The diverse functions, structural motifs, reactivities, and mechanisms of diiron enzymes
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1.9. Scope and aims of thesis 
 The ultimate goal of this thesis work is to elucidate how substrate-oxidizing and 
oxygen-activating diiron enzymes work at the molecular level. Thus, both structural and 
mechanistic aspects of diiron enzymes and their key intermediates will be targeted. As 
the canonical enzymes have been well studied, the mechanistic picture of oxygen 
activation by diiron enzymes remains incomplete; especially the structure of the 
peroxodiiron(III) intermediate and how this intermediate is activated to form substrate-
oxidizing high-valent species are not well understood. Hence, novel enzymes with 
different structural motifs and new intermediates will provide important pieces of 
information to the oxygen activation picture. As the three-dimensional structures of the 
enzymes studied in this work, hDOHH, CmlA, and CmlI, are not available, spectroscopic 
methods play instrumental roles to gain insight into their active sites at different states 
along their reaction cycles. The spectroscopic interpretations for these enzymes are aided 
with parallel studies of relevant model complexes and related enzymes. In addition to 
structural and mechanistic aspects, the biochemistry of DOHH at a more physiologically 
relevant level are also investigated as it is of therapeutic and pharmaceutical interests. 
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Chapter 2                                                                            
Human deoxyhypusine hydroxylase, an enzyme involved in regulating 
cell growth, is an oxygen-activating nonheme diiron enzyme 
 
 
 
 
 
 
 
This work has been published in its entirety as:  
Vu, V. V.; Emerson, J. P.; Martinho, M.; Kim, Y. S.; Munck, E.; Park, M. H.; Que, L., 
Jr., Human deoxyhypusine hydroxylase, an enzyme involved in regulating cell growth, 
activates O2 with a nonheme diiron center. Proc. Nat. Acad. Sci. U. S. A. 2009, 106, 
14814-14819. 
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2.1. Introduction 
Hypusine is an unusual, but highly conserved, amino acid that is found only in the 
eukaryotic translational initiation factor 5A (eIF5A), a protein that regulates cell 
proliferation.56, 57  The biosynthesis of eIF5A involves a post-translational modification of 
the eIF5A precursor, where a lysine residue is first modified to deoxyhypusine (Dhp) by 
deoxyhypusine synthase (DHS) and then the nascent Dhp is hydroxylated by 
deoxyhypusine hydroxylase (DOHH) to form hypusine (Hpu) (Scheme 2.1).56, 57 The 
importance of hypusine and these two enzymes has been shown by several studies where 
depletion of spermidine142 or inhibition of either DHS or DOHH143, 144 leads to a decrease 
of hypusine-containing eIF5A (eIF5A(Hpu)) and inhibition of eukaryotic cell growth. 
Consequently, these results suggest that eIF5A and DOHH could be promising targets for 
antitumor145 and anti-HIV-1 therapies.146 
 
Scheme 2.1. Biosynthesis of hypusine on eIF5A 
 
 
 
The hydroxylase activity of recombinant human DOHH (hDOHH) has been 
shown to depend on Fe(II), and not on any other physiologically relevant divalent metal 
ion. An estimated iron-to-holoprotein stoichiometry of 2 is observed.136 Sequence 
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examination, homology modeling and mutagenesis experiments suggest two possible iron 
binding sites consisting of histidine and carboxylate ligands.58, 136 Thus at first glance, 
hDOHH appears to resemble members of the superfamily of bacterial diiron 
multicomponent monooxygenases, like methane or toluene monooxygenase, that utilize 
nonheme diiron centers to activate dioxygen for the hydroxylation of hydrocarbons.2, 4, 5 
However there is little sequence similarity between the latter enzymes and DOHH.  
hDOHH can be overexpressed in E. coli, and the enzyme isolated from such cells 
is blue in color. This chromophore gives rise to two absorption features at 320 nm and 
630 nm with molar extinction coefficients indicative of ligand-to-metal charge transfer 
transitions.136 These features resemble those associated with diiron(III)-peroxo 
intermediates of the hydroxylase component of methane monooxygenase (MMOH),2 
stearoyl-acyl carrier protein Δ9 desaturase (Δ9D),76, 78 the R2 proteins of class I 
ribonucleotide reductases (R2),74, 77, 79, 84, 87 and the ferroxidase site of frog M ferritin.71, 73 
Some of these intermediates have been characterized by resonance Raman spectroscopy 
and found to exhibit vibrational features typical of a (μ-1,2-peroxo)diiron(III) unit.77, 78, 81 
Here we report direct spectroscopic evidence for a diiron cluster in hDOHH. 
Interestingly, as-isolated hDOHH is blue in color, and the blue chromophore derives from 
a peroxo-bridged diiron(III) center that is generated by reaction of the reduced enzyme 
with oxygen. Comparisons with related diiron(III)-peroxo enzyme intermediates and 
synthetic complexes shed light on the nature of this active site and augment our 
understanding of the mechanism of oxygen activation by diiron enzymes. 
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2.2. Experimental 
2.2.1. Protein expression and purification 
 hDOHH plasmid was generously provided by Dr. Myung Hee Park at National 
Intitutes of Health (NIH). Dr. Park and her coworker, Dr. Yeon Sook Kim provided 
hDOHH for initial studies. Protein expression and purification was carried out as 
described previously by Park et al.58, 136 To prepare 57Fe-hDOHH, ~10 mg of 57Fe 
(Cambridge Isotope Laboratories INC) metal was dissolved in ~ 3 mL concentrated HCl 
and added to the culture (5 L) at induction. Typical enzyme sample purified by one-step 
GSH affinity chromatography is a mixture of ~ 30 – 50 % holoenzyme and 50-70% 
apoenzyme, designated as as-isolated sample. Unless otherwise noted, the final enzyme 
solutions were in thrombin cleavage buffer (20 mM Tris-HCl, 150 mM NaCl, 2.5 mM 
CaCl2, pH 8.4).  
2.2.2. Reduction and Re-oxidation of hDOHH 
 Sodium dithionite (Sigma-Aldrich) was dissolved in anaerobic buffer, and the 
concentration was determined using ε316 = 8000 M-1cm-1.147 Protein solutions were made 
anaerobic in conical vials or in cuvettes sealed with septa by equilibrating under argon 
atmosphere for 2 hours in an ice bath. For tandem reduction-oxidation study, approximate 
2.2 equiv. (with respect to diiron cluster) of dithionite was added to the protein solution 
in a sealed cuvette and the cuvette was opened to introduce oxygen after A630 reached a 
minimum value. For resonance Raman studies, 10 equiv. of dithionite was used, and after 
complete reduction (judged by UV/Vis spectroscopy) protein samples were equilibrated 
with anaerobic buffer using 10K cut-off spin-filters (Pall Corp.) in an anaerobic glove 
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box until no dithionite was detected in the flow through solution prior to exposure to 
dioxygen sources. 
2.2.3. Activity assay 
 ~800 μL solution of ~50 μM hDOHHperoxo and ~50 μM deoxyhypusine-
containing eIF5A in Tris.HCl buffer pH 7.5 was incubated at room temperature for 24 
hours. At each incubation time a UV/Vis spectrum was collected and 100 μL reaction 
solution was mixed with 100 μL 20% trichloroacetic acid solution. Self-decay of 
hDOHHperoxo was monitored under the same conditions but without protein substrate. 
Hypusine and deoxyhypusine quantification was then carried out by Dr. Myung Hee Park 
as described else where.137 
2.2.4. Spectroscopic Studies 
Electron paramagnetic resonance spectroscopy (EPR) spectra were recorded in 
both perpendicular and parallel modes at X-band and Bruker E500 spectrometer equipped 
with an Oxford ESR-910 cryostat. Mössbauer analysis was carried out by Dr. Marlene 
Martinho and Prof. Eckard Münck at Carnegie Mellon University. Mössbauer spectra 
were collected with constant acceleration spectrometers, using two cryostats that allowed 
studies at 4.2 K in applied fields up to 8.0 T. Isomer shifts are reported with respect to 
iron metal at 298 K. The WMOSS software package (WEB Research, Edina, MN) was 
used to analyze the data. Resonance Raman experiments were performed on an Acton 
AM-506 spectrophotometer (1,200-groove grating) with a Princeton Instruments 
LN_CCD-1100-PB_UVAR detector cooled to -120oC with liquid nitrogen. The 647.1 nm 
excitation line at 100-mW power was provided by a Spectra-Physics BeamLok 2060-KR-
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RS krypton ion laser, which is filtered out by a Kaiser Optical holographic super notch 
filter. Samples were contained in flat-bottomed NMR quartz tubes and maintained at a 
temperature range of -10oC to 10oC, and spectra were collected in 90o scattering 
geometry at resolution of 4 cm-1, and referenced to indene. Typically, 256 accumulations 
of 30 second exposures were collected for each sample. UV/Vis spectra of sample show 
no change after laser exposure. GRAMS/AI (Thermo Galactic, Salem, NH) was utilized 
for baseline correction and curve fitting.  
 
Analysis of the exchange coupling in as-isolated hDOHH. Analysis of the exchange 
coupling of diferric complexes has been described by Kauffmann and Münck148 and by 
Krebs and coworkers.93 The variable temperature spectra were analyzed with a spin 
Hamiltonian appropriate for an exchange coupled dinuclear complex comprising two 
high-spin (S1 = S2 = 5/2) FeIII ions, 
{ }∑
=
⋅−⋅+⋅+⋅=
2,1
21
ˆˆˆˆˆˆ2ˆˆJˆ
i
inniioi gAH IBISBSSS ββ  (1) 
 
where i = 1,2 sums over the two iron sites. The zero-field splittings of the high-spin ferric 
sites with octahedral N/O coordination of the type encountered in non-heme proteins are 
generally small, |Di| < 2 cm-1, and can be neglected. Under conditions where the 
electronic spin fluctuates fast among the thermally populated spin levels (in the present 
case, essentially the S= 0 ground state and the S = 1 excited state of the spin-coupled 
system) the 57Fe nuclei experience an internal field Bint, which opposes the applied field 
B.  
Bint = -<Si>th Ao/gnβn       (2) 
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 In eq 2, <S>th is the thermally averaged electronic spin 
<S>th = v/ Σn exp(-En/kT)  (3) 
 
where En = E(S, M) = JS(S+1)/2 + 2βBM labels the energy levels of the coupled system. 
For the FeIII sites under consideration, Ao/gnβn ≈ -21 T.  
 
According to eq. 1 the system is magnetically isotropic, so the effect of J on the 
spectra is felt by a reduction of the splitting at higher temperature (as if the applied field 
had been reduced) relative to the splitting at 4.2 K. We have evaluated the data by using 
eq. 1 and the 2Spin option of WMOSS. We should mention that Mössbauer spectroscopy 
is very suitable for the determination of J in hDOHH, mainly because the technique 
“recognizes” impurities such as the 18% FeIII contaminant which would difficult to deal 
with in magnetic susceptibility studies. 
 
X-ray absorption spectroscopy (XAS). XAS data were collected in fluorescence mode 
on beamline 9-3 at Stanford Synchrotron Radiation Lightsource (SSRL) of the SLAC 
National Accelerator Laboratory and on beamline X3B at the National Synchrotron Light 
Source of Brookhaven National Laboratory. At SSRL, the synchrotron ring SPEAR was 
operated at 3.0 GeV and 80-100 mA. Energy resolution of the focused incoming X-rays 
was achieved using a Si(220) double crystal monochromator. At NSLS, the synchrotron 
ring was operated at 2.8 GeV and 100-300 mA and a Si(111) double crystal 
monochromator. Fluorescence data were collected over the energy range of 6.8 - 8.0 keV 
using a 30-element Ge detector (SSRL) for as-isolated hDOHH and 13-element Ge 
detector (NSLS) for chemically reduced hDOHH. The sample temperature was 
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maintained at ~ 10 – 15 K (SSRL) or 20 – 25 K (NSLS). All protein samples contained 
25% glycerol and were frozen using liquid isopentane at 113K. 130 μL of 56Fe-hDOHH 
solution containing 4mM Fe was frozen in an EXAFS solution cell for data collection at 
SSRL, while 250 μL  chemically reduced hDOHH sample (1mM in Fe) frozen in a 
tandem Mössbauer/XAS cup was used for XANES scans at NSLS. The beam spot size 
was 13 mm (horizontal) x 1 mm (vertical) for the SSRL samples and 4 mm (horizontal) x 
1 mm (vertical) for the NSLS sample. All spectra were referenced again Fe foil, and 
energy was calibrated to 7112 eV.  
At SSRL, the edge energy gradually decreased upon continuous scans at the same 
spot.  Thus, first scans on five different spots of two samples were collected and assigned 
to as-isolated sample. At one spot, the sample was exposed to the X-ray beam at 8000 eV 
for 20 min, and then 16 scans were collected, for which no further edge energy shift was 
observed.  
Standard procedures were used to reduce, average and process the raw data using 
EXAFSPAK,149 which was also used for EXAFS analysis. Theoretical EXAFS amplitude 
and phase functions were calculated using FEFF 8.40.150 The model for FEFF calculation 
that is shown in Fig. 2.1 unbiasedly leads to reasonably good fits with only single 
scattering paths. The parameters r and σ2 were floated, while N was kept fixed for each 
fit and systematically varied between fits. The scale factor was fixed at 0.9 and threshold 
energy (E0) was varied but maintained at a common value for all shells. The goodness of 
fit was reported as 2626 /)(       kχkF expcalexp χχ ∑∑ −= .149 Pre-edge quantification was 
carried out with SSExafs using a standard procedure.151 
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Figure 2.1. Models for FEFF calculation, generated by ChemBioDraw Ultra 11.0, which 
differs in the Fe-O and Fe⋅⋅⋅Fe distances. The Fe-O distance and Fe⋅⋅⋅Fe distance vary 0.1 
Å steps from 1.9 to 2.1 Å and from 3.0 to 3.8 Å, respectively.  
 
 
Estimation of the photoreduction yield (PY). PY, or the percentage of the 
photoreduced form present in a sample spot of an XAS sample, can be considered 
roughly proportional to the amount of time it is exposed to the beam. Fig. 2.2 shows the 
exposure time profile for the first and second scan on the same sample spot. XANES 
comparison provides a mean to estimated the PY at the edge jump of the second scan 
Linear combination fitting of the XANES spectrum of the second scan using those of the 
first and fully photoreduced scans as standards results in the percentage of the 
photoreduced form present in the sample spot at the edge jump of the second scan.  From 
this value, PY at different exposure time, k-range, and energy can be calculated (Table 
2.1). Fig. 2.4 shows that 100% photoreduction results in a significant change in the inner 
shell peak but no evident change in the outer shell peak. There is no clear effect of 
photoreduction on the first scan data at 10, 11, and 12 Å-1. 
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Figure 2.2.  Energy-dependence of exposure time. Exposure time after 1st scan (15 Å-1) is 
1200 s, at 0 Å-1 (edge) is 140 s. Total exposure time at the edge of 2nd scan is 1340 s.  
 
 
 
 
 
 
 
Figure 2.3.  XANES linear combination fitting using Athena program.152 A linear 
combination fit (linear combo) to a second scan was obtained using a 1st scan and fully 
photoreduced data as standards. E0 values, determined as the first inflection points of the 
edges using derivative plots, are ~ 7126.3, 7125.5, and 7124.5 eV for 1st scan, 2nd scan 
and photoreduced data, respectively. Fit range = E0-20 – E0+30 eV. The weight of 
photoreduced data in the linear combination is ~ 49 %, which is assigned as 
photoreduction yield at 1340 seconds exposure.  
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Table 2.1. Photoreduction yields (PY) at different k values of first scan data, assuming 
photoreduction rate is proportional to exposure time (t).153 PY = 49×t/1340 (%). 
 
kmax (Å-1) Energy (eV) Exposure time (s) PY (%) 
13.0 7768 880 32 
12.5 7720 815 30 
12.0 7673 750 27 
11.5 7627 690 25 
11.0 7586 630 23 
10.5 7545 578 21 
10.0 7506 535 20 
9.5 7469 493 18 
9.0 7433 455 17 
 
 
 
 
 
 
Figure 2.4. EXAFS data (k3χ(k)) photoreduced sample (hDOHHphr) and the average data 
of first scans on 5 different fresh sample spots are shown in the top panel, while Fourier 
transforms at different k ranges are presented in the bottom panel. The k range of first 
scans data reflects the exposure time, which in turn reflects the photoreduction yield (see 
Table 2.1). Upon photoreduction, the inner shell r’ ~ 1.5 – 1.6 Å clearly shifts to a longer 
distance, but there is no apparent change in the position of the r’ = 3 Å peak. The first 
scans data in the k range = 2 – 12 Å-1 is then assigned to hDOHHperoxo. 
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2.3. Results 
2.3.1. Evidence for an O2-activating diiron cluster in hDOHH 
As-isolated hDOHH is blue in color, with characteristic UV-Vis absorption 
features at 320 nm and 630 nm (Fig. 2.5). The features are apparently due to enzyme-
bound iron, as they are absent in the iron-free apoenzyme.136 Upon addition of dithionite, 
these absorption features decrease slowly over approximately 3 hours, but rapidly 
reappear upon exposure of the colorless solution to air, regaining ca. 80% of their initial 
intensities (Fig. 2.5 inset). The blue chromophore of hDOHH thus appears to undergo 
reduction by dithionite and regeneration by exposure to O2. Reduced hDOHH therefore 
resembles many oxygen activating nonheme diiron enzymes like RNR R2, MMO, and 
Δ9D2 in its ability to react readily with O2. 
 
 
Figure 2.5.  The UV-Visible spectra of hDOHH at room temparature. Conversion of as-
isolated hDOHH (⎯) by 2.2 equiv. dithionite to reduced hDOHH (⋅⋅⋅) and its 
regeneration upon exposure to air after 180 minutes of anaerobic incubation (---). Inset:  
Change of A630 with time. 
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As-isolated hDOHH is EPR silent. Its 4.2 K zero-field Mössbauer spectrum, 
shown in Fig. 2.6A, consists of a broadened doublet (representing 82% of total Fe) that 
can be simulated as a superposition of two doublets with sharp absorption lines of width 
0.27 mm/s (FWHM). The four lines can either be assigned to a nested pair, with  ΔEQ(1) 
= 1.16(2) mm/s, δ(1) = 0.55(1) mm/s and ΔEQ(2) = 0.88(2) mm/s, δ(2) = 0.58(1) mm/s, 
or to a non-nested pair with ΔEQ(1) = 1.05(2) mm/s, δ(1) = 0.49(1) mm/s and ΔEQ(2) = 
0.99(2) mm/s, δ(2) = 0.63(1) mm/s. Spectra recorded at 4.2, 20, 50 and 80 K in an  8.0 T 
applied field show that these doublets belong to an antiferromagnetically coupled pair of 
high-spin Fe(III) ions , with 50 cm-1 < J < 70 cm-1 (with the convention H  = J⋅S1⋅S2 , S1 = 
S2 = 5/2). The solid lines in Fig. 2.6 are spectral simulations obtained with WMOSS 
option 2Spin.  The 8.0 T spectra can be simulated equally well for the nested or the non-
nested pair. The sample also contained a high-spin Fe3+ contaminant representing ∼18% 
of the Fe in the sample; a spectrum of this contaminant and comments on the fits of Figs. 
2.6C and D are presented in the Mössbauer spectroscopy section in Supporting 
Information. 
Protein and Fe concentrations of the sample of Figure 2.6A were 0.85 mM and 
0.56 mM, respectively. Given that ∼18% of the Fe belongs to the Fe(III) contaminant, 
these concentrations suggest that only 27% of the active sites are occupied by a 
diiron(III) cluster. Assuming that all absorption at 630 nm can be attributed to the 
diiron(III) cluster then yields for this sample ε(630 nm) = 2800 M-1cm-1. 
Upon treatment with dithionite, the diiron(III) cluster is reduced into the diiron(II) 
state, hDOHHred. This state exhibits two doublets characteristic of high-spin Fe(II), with 
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ΔEQ(1) = 3.26 mm/s, δ(1) = 1.29  mm/s and ΔEQ(2) = 2.90 mm/s, δ(2) = 1.29  mm/s (Fig. 
2.6B). The sample also contained ~ 5 % of the original diiron(III) cluster and a high-spin 
Fe(II) species with ΔEQ = 2.4 mm/s (∼ 20 %). The percentage of the latter suggests that it 
represents the reduced form of the Fe(III) contaminant present in the as-isolated sample. 
We have subtracted the remaining diiron(III) and the Fe(II) contaminant from the raw 
data to obtain the spectrum of Fig. 2.6B. 
 
 
Figure 2.6. Mössbauer studies of hDOHH.  4.2 K zero field Mössbauer spectra of as-
isolated hDOHH (A) and reduced with dithionite (B). The solid line in (A) is a simulation 
assuming two nested doublets as described in the text. (B) The solid line is a simulation 
of hDOHHred assuming two equally intense doublets representing ~ 75% of Fe. Details of 
data reduction and analyses are given in Supporting Information. 8.0 T Mössbauer 
spectra of as-isolated hDOHH recorded at 4.2 K (C) and 50 K (D). The solid lines are 
spectral simulations for an antiferromagnetically coupled diiron(III) center containing 
two high-spin (S = 5/2) Fe(III) sites. For the simulation of the 50 K spectrum we used J = 
70 cm-1.  At 50 K the central features of the 8.0 T spectrum contain contributions from 
the mononuclear Fe(III) contaminant (see Mössbauer spectroscopy section in Supporting 
Information). 
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2.3.2. Evidence for a (μ-peroxo)diiron(III) unit in hDOHH  
 
 
          
 
Figure 2.7.  Resonance Raman spectra of hDOHH samples. A: as-isolated hDOHH. B-D: 
reduced hDOHH exposed to 16O2, 18O2, and mixed-labeled O2 (16O2, 18O2 and 16O18O). 
Background features due to the protein itself have been subtracted using the spectrum of 
fully-reduced hDOHH collected under the same conditions. Experimental data are 
presented with thick lines and fits are presented with thin lines.  
 
 
Figure 2.7 shows resonance Raman spectra of different hDOHH samples obtained 
with 647.1 nm excitation. The spectra of as-isolated and 16O2-reoxidized hDOHH 
(hDOHH16) overlay perfectly, indicating that the reoxidized blue species is identical to 
the as-isolated form (Figs. 2.7A and B). Three features are observed in these spectra at 
855 (observed as a Fermi doublet), 493 and 473 cm-1. The combination of these features 
suggests an iron(III)-peroxo chromophore, with observed features corresponding to 
ν(O−O) and ν(Fe−O2) modes.77, 78, 81 In confirmation, 18O2-labeled hDOHH (hDOHH18), 
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obtained by exposing hDOHHred to 18O2, exhibits features downshifted to 811, 476, and 
457 cm-1 (Fig. 2.7C), with Δν values of 44, 17, and 16 cm-1, respectively, that are 
consistent with those expected for the mass change in the diatomic O−O and Fe−O 
oscillators (~50 cm-1 and ~20 cm-1, respectively). From this point on, we designate the 
blue form of hDOHH as hDOHHperoxo. 
 
Table 2.2. Properties of diiron(III)-peroxo units in enzymes and related model complexes 
Species 
λ 
(nm) 
δ 
(mm/s) 
ΔEQ 
(mm/s) 
J 
(cm-1)
ν(O-O) 
(cm-1) 
r(Fe⋅⋅⋅Fe) 
(Å) Ref. 
hDOHHperoxo 630 
0.55,0.58 
(0.49,0.63)* 
1.16,0.88 
(1.05,0.99)*
50-70 855 3.44 
This work 
MMOH 725 0.66 1.51    154 
D84E R2  700 0.63 1.58 50 868 2.50 77, 79, 84, 
87, 93 
Δ9D 700 0.68,0.64 1.90,1.06  898  76, 78, 93 
Frog M Ferritin 650 0.62 1.08 70 851 2.53 85, 93, 155
ToMOH † 0.54 0.66    75 
OxyHr 500 0.51,0.54 1.09,1.92 154 844  101, 102 
1 694 0.66 1.40 66 885 4.01 106, 107 
2 600 0.51 0.80 85 900 3.46 109, 130 
3 644 0.50 1.31  908 3.40 131 
4 700(br) 0.58,0.65 0.74,1.70   3.33 82 
* Mössbauer data can be assigned either to a nested pair of doublets with parameters shown in plain text or 
to an overlapping pair of doublets with parameters shown in italics.  
† No chromophore observed. 
1 = [Fe2(HB(3,5-iPr2pz)3)2(μ-O2)(μ-O2CCH2C6H5)2] (pz = pyrazole). 
2 = [Fe2(N-Et-HPTB)(μ-O2)(OPPh3)2]3+ (N-Et-HPTB = anion of N,N,N′,N′-tetrakis(1′-ethylbenzimidazolyl-
2′-methyl)-2-hydroxy-1,3-diaminopropane).  
3 = [Fe2(6-Me2-BPP)2(μ-O2) (μ-OH)]+ (6-Me2-BPP = N,N-bis(6-methyl-2-pyridylmethyl)-3-
aminopropionate). 
4 = [Fe2(Ph-bimp)(μ-O2)(μ-O2CC6H5)]2+ (Ph-bimp = 2.6-bis[bis{2-(1-methyl-4,5-
diphenylimidazolyl)methyl}-aminomethyl]-4-methylphenolate). 
 
 
For the sample prepared by exposing reduced hDOHH to a mixture of 25% 16O2, 
50% 16O18O and 25% 18O2 (hDOHHM), a band appears at 833 cm-1, halfway between the 
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ν(O−O) bands in the hDOHH16 and hDOHH18 spectra, and is assigned to the 16O18O 
isotopomer (Fig. 2.7D). The three components of the ν(O−O) band at 856, 833, and 811 
cm-1 exhibit an intensity ratio consistent with the isotopomer ratio of the mixed-labeled 
O2 used. Due to the relative large (~20-25 cm-1) width of the individual features, the 
central component does not show evidence for the presence of distinct 16O18O and 18O16O 
isotopomers, as found for oxyhemerythrin100 but resembles that observed for the mixed-
labeled Δ9D peroxo intermediate,78 which has been assigned as having a symmetric 1,2-
O−O bridge. The observations that hDOHHperoxo has a peroxo-to-iron(III) charge 
transfer band with λmax of 630 nm and exhibits Raman spectra resembling those of other 
(μ-1,2-peroxo)diiron(III) centers in proteins and model complexes (Table 2.2) lead us to 
propose that the O−O moiety in hDOHHperoxo also bridges the two iron atoms in a μ-
1,2 mode. 
Figure 2.8A shows X-ray absorption near edge spectra (XANES) of hDOHH. For 
the as-isolated enzyme, the K-edge energy was observed to downshift by ~ 2 eV in the 
first scan with increasing exposure to the synchrotron beam, suggesting photoreduction of 
the sample. This downshift of the photoreduced sample (hDOHHphr) can be compared to 
the further downshift of 2.0 eV observed in a sample of the dithionite-reduced enzyme. 
This progression suggests that roughly half of the Fe(III) sites in the frozen as-isolated 
sample in the layer exposed to X-ray beam were reduced to Fe(II), resulting in an edge 
energy that is the average of the diiron(III) and diiron(II) species. The same stepwise 
progression has been observed for MMOH as the diiron(III) form was reduced to the 
diiron(II) form one electron at a time.156 
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Figure 2.8.  X-ray absorption spectroscopic analysis of hDOHH. A: XANES spectra of 
hDOHHperoxo first scans (⎯), hDOHHphr (---), and hDOHHred (⋅⋅⋅). B and C: Fe K-edge 
EXAFS data k3χ(k) of hDOHHphr and hDOHHperoxo and their Fourier transforms (thin 
lines) in k range = 2 – 14 Å-1 and 2 – 11.8 Å-1, respectively. Best fits are represented by 
the thick lines.  Details of the fitting protocols are provided in Table 2.3. 
 
 
Information about the iron coordination number can be deduced from the intensity 
of the pre-edge feature that is attributed to 1s → 3d transitions.157 The pre-edge areas of 
12.0 units for hDOHHperoxo and 13.8 units for hDOHHphr are similar to those of the 
diiron(III) forms of Δ9D (~ 11 – 11.5 units),158 metHrN3 (~10.4 units), and RNR R2met 
(10.1 units) but larger than those for the diiron(II,III) form of uteroferrin (4.8 units).159 
The larger pre-edge areas associated with hDOHH suggest that its iron centers deviate 
significantly from centrosymmetry with likely coordination numbers of 5. 
Because of its superior signal-to-noise ratio we have focused on the analysis of 
the extended X-ray absorption fine structure (EXAFS) data of hDOHHphr with maximum 
usable data extending to 14 Å-1 (Fig. 2.8B). The Fourier transform of the k3-weighted 
EXAFS data exhibits prominent peaks at 1.6 and 3 Å. The r’ = 1.6 Å feature of the 
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hDOHHphr data is best fit with 5 O/N scatterers at 2.08 Å, consistent with the pre-edge 
analysis. The average iron-ligand bond distance of 2.08 Å is close to those associated 
with the principal shell of scatterers in the iron(II)iron(III) forms of MMOH (2.06 – 2.09) 
(2 histidine/4 carboxylate ligand set)156 but shorter than the 2.13 Å average distance found 
in semimetHrN3 (5 histidine/2 carboxylate ligand set),150 suggesting a ligand set with 
more carboxylate ligands than histidines. The r’ = 3 Å feature corresponds to an Fe 
scatterer at 3.44 Å, the addition of which significantly improves the fit quality (compare 
Fits in bold text in Table 2.3). This 3.44-Å distance is close to the Fe⋅⋅⋅Fe distances found 
in the iron(II)iron(III) sites of photoreduced MMOH,156 uteroferrin,159 and 
semimetHrN3.96 EXAFS analysis thus further corroborates the diiron nature of the active 
site of hDOHHphr. 
We have collected first scans on five different fresh spots of an as-isolated 
hDOHH sample, during which photoreduction yield is estimated to be at most ~ 25% at k 
= 12 Å-1 based on the edge position of the second scans. The summation of these first 
scans enables us to carry out a preliminary structural analysis of hDOHHperoxo. The best 
fit to the k3-weighted EXAFS data of hDOHHperoxo (Table 2.3) also gives an Fe⋅⋅⋅Fe 
distance of 3.44 Å, suggesting that the iron atoms do not move from their original 
positions upon photoreduction at ~ 20 K. Interestingly, the average Fe-O/N distance in 
the first shell is 2.05 Å, which is 0.03 Å shorter than that for DOHHphr, consistent with 
the change in the diiron oxidation state. The lengthening of the average first-shell 
distance upon photoreduction without changing the Fe⋅⋅⋅Fe distance has also been 
observed in a similar study of MMOH.146 
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Table 2.3. Parameters for fits to unfiltered k3-weighted EXAFS data of photoreduced 
hDOHHphr and hDOHHperoxo. 
  
  Fe-O/N   Fe-N/O   Fe-Fe   Fe-C   
Fit# N* R† σ2‡ N R σ2 N R σ2 N R σ2 F(%)§ 
hDOHHphr 
O3 3 2.06 8.0          53.53 
O4 4 2.06 10.8          49.87 
O5 5 2.05 13.8          50.85 
O6 6 2.05 17.1          53.81 
N3    3 2.08 6.5       55.15 
N4    4 2.08 8.7       50.36 
N5    5 2.08 10.9       49.16 
N6    6 2.08 13.3       50.56 
O3N1 3 2.03 7.8 1 2.18 3.5       49.48 
O2N2 2 2.01 5.3 2 2.16 4.8       49.30 
O1N3 1 1.98 3.0 3 2.13 4.9       49.23 
O4N1 4 2.06 10.8 1 2.34 30.3       49.70 
O3N2 3 2.05 9.5 2 2.13 22.6       49.85 
O2N3 2 2.03 9.5 3 2.11 13.6       49.50 
O1N4 1 1.99 6.6 4 2.12 10.5       49.13 
O4-F1 4 2.05 10.8    1 3.44 4.6    43.82 
N5-F1    5 2.08 11.0 1 3.44 4.6    42.96 
O4-C4 4  2.05 10.9       4 3.46 2.5 49.37 
N5-C4    5 2.08 10.9    4 3.46 2.3 47.80 
hDOHHperoxo 
O3 3 2.02 7.13          56.74 
O4 4 2.03 9.59          51.60 
O5 5 2.02 11.93          49.42 
O6 6 2.02 14.31          49.55 
N3    3 2.05 5.8       60.27 
N4    4 2.05 7.8       53.97 
N5    5 2.05 9.7       50.11 
N6    6 2.05 11.6       48.43 
O4N1 4 2.00 8.2 1 2.17 0.9       48.33 
O3N2 3 1.98 5.6 2 2.15 2.8       48.11 
O2N3 2 1.96 3.4 3 2.13 4.0       47.96 
O1N4 1 1.93 0.5 4 2.07 5.7       48.00 
O5N1 5 2.00 11.4 1 2.17 3.7       48.94 
O4N2 4 1.98 9.3 2 2.15 5.3       48.51 
O3N3 3 1.97 7.1 3 2.13 6.1       48.06 
O2N4 2 1.95 5.1 4 2.11 7.1       47.67 
O1N5 1 1.93 2.6 5 2.07 8.4       47.42 
O5-F1 5 2.02 12.1    1 3.44 3.6    41.47 
N6-F1    6 2.05 11.7 1 3.44 3.5    40.39 
O5-C4 5 2.02 12.0       4 3.47 0.9 46.04 
N6-C4    6 2.05 11.7    4 3.47 0.9 44.26 
              
k range = 2-14 Å-1 for hDOHHphr and 2-11.8 Å-1 for hDOHHperoxo.  Resolution ~0.13 Å for  hDOHHphr  
and 0.17 Å for hDOHHperoxo. * Coordination number. † Distance in Å. ‡ σ2 in units of 10-3 Å2. § 
2626 /)(       kχkF expcalexp χχ ∑∑ −=  
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2.3.3. Long-lived hDOHHperoxo can hydroxylate the deoxyhypusine residue in 
eIF5A 
 
       
 
Figure 2.9.  Reaction of hDOHHperoxo with ~ 1 equiv. of substrate, deoxyhypusine-
containing eIF5A. Left: The decay of hDOHHperoxo was monitored by following the 
change in A630 at different incubation times in the absence of eIF5A(Dhp) (?) and in the 
presence of eIF5A(Dhp) (?).Yields of hypusine (?) are calculated based on the 
observed amounts of hypusine (Hpu) and deoxyhypusine (Dhp); % Hpu  = 
(Hpu×100)/(Hpu+Dhp). Right:  UV/Vis spectra of hDOHHperoxo (blue) incubated with 
substrate for 24 hours at room temperature (yellow). After 24 hour incubation, the 
reaction mixture was cloudy and the precipitate was removed using centrifugation before 
the yellow spectrum was recorded. 
 
 
Fig. 2.9 shows the fate of hDOHHperoxo upon treatment of one equiv. of its 
protein substrate, deoxyhypusine-containing eIF5A (eIF5A(Dhp)). At room temperature, 
the absorption at 630 nm of hDOHHperoxo, shown above to result from peroxo-to-iron 
charge transfer transition, slowly decreases with time. Upon addition of eIF5A(Dhp), the 
decay rate of A630 increases and is comparable to the rate of hypusine formation. After 24 
hours incubation, deoxyhypusine is almost completely converted to hypusine (~ 96 %) 
and hDOHHperoxo turns yellow (Fig. 2.9). This result indicates that long-lived 
hDOHHperoxo is activated by substrate binding and carries out the hydroxylation of 
deoxyhypusine in eIF5A. 
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2.4. Discussion 
Our spectroscopic studies have shown that recombinant human DOHH has a 
nonheme diiron active site, the reduced form of which can react readily with oxygen. 
This finding extends the family of oxygen activating nonheme diiron enzymes2-5 to 
include for the first time a hydroxylase that is not of bacterial origin and of vital 
importance for human metabolism. These nonheme diiron enzymes are capable of 
carrying out a variety of dioxygen-dependent chemical transformations under mild 
physiological conditions, including methane hydroxylation by MMO, desaturation of 
fatty acids by Δ9D and related desaturases, and the generation of a catalytically essential 
tyrosyl radical by R2 in DNA biosynthesis.2 
Despite their functional diversity, the diiron enzymes characterized thus far share 
a common structural motif. They all have a pair of conserved (D/E)X29-37EX2H ligand 
sequence motifs that provide the ligands to a common diiron active site formed within a 
four-α-helix bundle.3 hDOHH appears not to follow this pattern. Instead, hDOHH has a 
pair of conserved HEX31HE sequences that are symmetrically located near the C- and N-
termini, which possibly provide the metal binding ligands.58 On the basis of homology 
modeling and circular dichroism experiments, the overall structure of hDOHH has been 
proposed to contain a dyad of four consecutive α-hairpins (called a HEAT repeat motif) 
surrounding the active site.58 Mutagenesis experiments show that both iron binding and 
activity are lost upon single mutations of the Hn, Hn+33 and En+34 residues of each 
HEX31HE sequence to A, but mutation of the En+1 residues to A results in loss of activity 
but with no loss in iron content.136 These results suggest a 4-His-2-carboxylate ligand set 
for hDOHH, which is different from the 2-His-4-carboxylate ligand set found in many 
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oxygen-activating diiron enzymes.3 However, EXAFS analysis of hDOHH shows that the 
average Fe-O/N bond length from the principal shell of ligands to the iron is in fact 
comparable to those found for diiron enzymes with 2-His-4-carboxylate ligand sets, but 
shorter than that of the histidine-rich diiron site in hemerythrin (Table 2.4). Additional 
experiments are needed to determine which ligands are bound to the diiron site of 
hDOHH. 
 
 
Table 2.4. Representative best fits to k3-weighted EXAFS data of hDOHH and related 
diiron enzymes 
 
  Fe-O/N  Fe-Fe   
Species Protein Ligands N* R† σ2‡ N R σ2 Ref. 
hDOHHphr  5 2.08 11.0 1 3.44 4.6 This  
hDOHHperoxo  6 2.05 11.7 1 3.44 3.5 work 
       
Fe(II)Fe(III)       
MMOH§ 2H-4(E/D) 2.07  1 3.42  156 
Uteroferrin 3H-3(E/D)-1Y 2.08  1 3.52  159 
SemimetHr¶ 5H-2(E/D) 2.13  1 3.46  96 
       
Peroxo       
R2¶ 2H-4(E/D) 2.06  0.7 2.50  84 
Ferritin 1H-4(E/D) 2.00  0.6 2.53  85 
OxyHr¶ 5H-2(E/D) 2.17  1 3.24  95 
* Coordination number. 
† Distance in Å. 
‡ σ2 in units of 10-3 Å2.  
§ Average values for several samples. 
¶Average Fe-O/N distance not including Fe-μ-O bond. 
 
 
In contrast, the accumulated spectroscopic information on hDOHH does shed 
some light on the nature of its non-protein-derived ligands. Clearly established is a 
dioxygen-derived ligand that is identified by resonance Raman experiments to be a 
peroxide (Fig. 2.8); this result shows that dioxygen binding to hDOHHred results in the 
2e-reduction of O2. Concomitant oxidation of the diiron(II) center to the diiron(III) 
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oxidation state is demonstrated by Mössbauer spectroscopy. The peroxide ligand most 
likely binds to the diiron(III) center in a 1,2-bridging mode and acts as the principal 
conduit for the antiferromagnetic interaction (J = 50 – 70 cm-1) deduced from the analysis 
of Mössbauer spectra recorded in strong applied magnetic fields. This J value is too small 
for an oxo bridge (150 < J < 300 cm-1) but too large for a hydroxo bridge (10 < J < 35 cm-
1) (Table II of ref. 160). It is in fact comparable to J values found for the (μ-1,2-
peroxo)diiron(III) intermediates of RNR W48F/D84E R2 and frog M ferritin93 and 
related model (μ-1,2-peroxo)diiron(III) complexes (Table 2.4).  
The Fourier-transformed EXAFS data for hDOHHperoxo and hDOHHphr (Fig. 
2.8) show a strong feature at r’ ~ 3 Å that corresponds to an Fe scatterer at ~ 3.44 Å. The 
intensity of this peak and the small Debye-Waller factor associated with the Fe scatterer 
implicate a relatively rigid diiron core structure, which could probably not derive from 
the presence of the peroxide bridge alone and requires an additional single atom bridge. 
A perusal of the few synthetic (cis-μ-1,2-peroxo)diiron(III) complexes that have been 
characterized by X-ray crystallography shows that an Fe-Fe distance of 3.4 ± 0.1 Å is 
associated with those peroxo complexes with an additional hydroxo or alkoxo bridge82, 
130, 131 (but not an oxo bridge, because it gives rise to shorter Fe-Fe distances of 3.1 ± 0.1 
Å86, 161). Based on these results, we propose the dibridged diiron(III) core structure of 
hDOHHperoxo shown in Fig. 2.10. 
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Figure 2.10. Proposed core structure of hDOHHperoxo 
 
 
The 3.44-Å Fe⋅⋅⋅Fe distance found in hDOHHperoxo stands in distinct contrast to 
the much shorter 2.5-Å Fe-Fe distances determined by EXAFS for the peroxo 
intermediates of W48A/D84E R2123 and the ferroxidase site of frog M ferritin.85 Such 
very short metal-metal separations are found only for synthetic complexes that have 2 or 
3 single-atom bridges.86, 161 Despite this apparent difference, these three diiron(III)-
peroxo intermediates exhibit ν(O-O) Raman features of comparable frequency, at 855, 
868 (observed for the peroxo intermediate of W48F/D84E R2 and assumed to resemble 
that of W48A/D84E R2 in structure), and 851 cm-1, respectively.85, 87 The similarity of 
the ν(O-O) values suggests that the diiron-peroxo core structures may not be as different 
as suggested by the EXAFS results. This notion derives from a model developed by 
Brunold and Solomon to rationalize the vibrations of (μ-1,2-peroxo)diiron(III) 
complexes.162 In this model, the observed ν(O-O) frequency is modulated by mechanical 
coupling of the O-O and the Fe-O stretching modes, the extent of which is governed by 
the Fe-O-O angle. As the Fe-O-O angle is related to the Fe⋅⋅⋅Fe distance, the ν(O-O) can 
reflect the Fe⋅⋅⋅Fe distance. This mechanical coupling model is supported by a recent 
study of a series of synthetic (cis-μ-1,2-peroxo)diiron(III) complexes.109 Indeed, a 
detailed spectroscopic and DFT analysis of the W48F/D84E R2 peroxo intermediate also 
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questions the 2.5-Å Fe⋅⋅⋅Fe distance deduced by EXAFS and favors an Fe⋅⋅⋅Fe distance of 
3.68 Å87 that is closer to the 3.44 Å distance we have determined for hDOHHperoxo by 
EXAFS analysis. Based on the calculations, it is proposed that the R2 peroxo 
intermediate has a (cis-μ-1,2-peroxo)diiron(III) center supported by two bidentate 
carboxylate bridges. The absence of a single-atom bridge may rationalize why the 
predicted Fe scatterer is not observed at 3.7 Å in the EXAFS analysis. There thus appears 
to be a discrepancy between the Raman and EXAFS results for the peroxo intermediates 
of D84E R2 and frog M ferritin, which will need to be resolved. For hDOHHperoxo, 
however, the Raman and EXAFS results are in good agreement with respect to the Fe⋅⋅⋅Fe 
distance.  
Lastly, it is interesting that it is the hDOHHperoxo form that is isolated directly 
from the expression strain. Its blue chromophore persists for at least several days at room 
temperature, so its stability surpasses even that of peroxo Δ9D, the peroxo intermediate 
obtained from chemically reduced Δ9D, which has a half-life of ~30 minutes at room 
temperature.76 Thus the lifetimes of diiron-peroxo intermediates of these enzymes vary 
significantly and can range from milliseconds to days.74, 76, 77, 79, 81, 84, 87, 154 Interestingly, 
the decay of hDOHHperoxo is accelerated by the addition of its substrate, the 
deoxyhypusine containing eIF5A. But more remarkable is the observation that the 
deoxyhypusine residue is in fact hydroxylated to hypusine (Fig. 2.9).  This result 
implicates hDOHHperoxo as an intermediate on the catalytic pathway of hDOHH. 
The extended stability of active hDOHHperoxo raises the questions of what 
makes it stable and how it is activated. From their studies of W48F/D84E R2, Skulan et 
al. conclude that a cis-μ-1,2-peroxo form is the most stable structure for the diiron(III)-
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peroxo intermediate and must undergo a structural change prior to O-O bond cleavage to 
generate the high valent iron species required for substrate oxidation.87 The additional 
single-atom bridge deduced to be present in the diiron(III)-peroxo unit in hDOHHperoxo 
(Fig. 2.10) is likely to further stabilize the cis-μ-1,2-peroxo structure, raising the barrier 
for O-O bond cleavage to form the high-valent iron oxidant. Indeed a number of 
metastable synthetic complexes are characterized to have core structures like that shown 
in Fig. 2.10; some in fact are stable enough to have been crystallized.82, 109, 130, 131 As the 
target hydroxylation site of hDOHH resides on a protein substrate, it seems plausible that 
substrate binding triggers a conformation change that activates the (μ-1,2-
peroxo)diiron(III) intermediate to carry out eIF5A(Dhp) hydroxylation (Scheme 2.1). The 
important role of such protein-protein interactions in modulating enzyme activity has 
been demonstrated for several diiron enzymes.6, 39, 163 As the in vitro reaction of 
hDOHHperoxo with its protein substrate is very slow, additional protein factors yet to be 
identified may be required to further accelerate this reaction in the cell. 
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2.5. Supporting information 
 
 
 
 
Figure S.2.1. 4.2 K spectrum of hDOHH as isolated recorded in an external field of 8.0 T 
applied parallel to the observed γ-radiation; same conditions as in Fig. 2.6C but wider 
velocity scan. The red line is a spectral simulation, using Ao = -21.7 T for the magnetic 
hyperfine constant, of the mononuclear high-spin ferric contaminant. 
 
 
 
Fig. S.2.1 shows a 4.2 K spectrum of as-isolated hDOHH, recorded in a parallel 
field of 8.0 T. The spectrum shown contains the contribution of a mononuclear high-spin 
ferric contaminant. Matching the simulated spectrum (red line) to the data suggests that 
this contaminant represents about 18% of the iron in the sample. The two (weak) 
innermost lines of the contaminant superimpose with the features of the dinuclear center 
of hDOHH which dominates the central part of the spectrum. At 4.2 K, the presence of 
the contaminant interferes only minimally with the data analysis. At 50 K, however, the 
electronic spin system of the contaminant was found to be in the intermediate relaxation 
regime, yielding featureless absorption underneath the DOHH spectrum. Fortunately, the 
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positions of the main hDOHH bands at – 1 mm/s and + 2.1 mm/s are little affected by the 
presence of the contaminant; the position of these two bands convey the main 
information about the exchange coupling constant J. For the manipulation of the data 
yielding Fig. 2.6B, see caption of Fig. S.2.2. 
 
 
 
 
 
 
Figure S.2.2.   (A) 4.2 K zero field spectrum of DOHHred (raw data). The red curve 
outlines the remnant (5% of Fe) oxidized hDOHH. Subtraction of the oxidized fraction 
from (A) yields the “data” in (B). The red line in (B) indicates a high-spin ferrous 
species; as this species accounts for ∼20% of  the Fe,  it  is  reasonable to assume that  it 
represents the ferrous form of the mononuclear ferric contaminant (18%) of Fig. S.2.1. 
Subtraction of this contaminant yields (C) which is the spectrum shown in Fig. 2.6B. 
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Chapter 3                                                                            
The bridging structure of hDOHHperoxo 
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3.1. Introduction 
 The core structures of diiron(III) peroxo intermediates can play an important role 
in how these intermediates are activated. Spectroscopic and computational studies have 
proposed that the cis-μ-1,2 geometry is the most stable conformation of a diiron(III)-
peroxo species.87, 162 Isomerization to a more activated geometry is thus necessary for O-
O bond cleavage. Indeed, the cis-μ-1,2 geometry is the sole conformation of diiron(III) 
peroxo intermediates characterized spectroscopically and/or crystallographically thus 
far.82, 83, 106, 109, 129-131 In well studied model complexes, additional ligands are shown to 
support this geometry. In most cases, a single atom bridge ligand (μ-oxo, μ-hydroxo, or 
μ-alkoxo) is present (see complexes 1 – 7 in Fig. 3.1 for examples),82, 83, 109, 129-131 but two 
complexes containing two μ-1,3-carboxylato ligands and no single atom bridge have also 
been reported (complexes 8 and 9, Fig. 3.1).106, 107  
 We previously tentatively proposed that hDOHHperoxo contains at least a single 
atom bridging ligand in addition to the μ-1,2 peroxo ligand on the basis of its 
spectroscopic analysis. The Mössbauer isomer shifts of hDOHHperoxo (δ = 0.55 and 
0.58 mm/s) are somewhat smaller than those of MMOHperoxo, D84E-R2peroxo, 
Ferittinperoxo, Δ9Dperoxo and model complex 9 (δ ≥ 0.63 mm/s). The crystal structure 
of 9 shows that it does not contain any single atom bridge, which is also proposed for the 
peroxo intermediates of diiron enzymes. Instead, the δ values of hDOHHperoxo are 
rather similar to those of (μ-O(R))(μ-1,2-peroxo)diiron(III) clusters (δ ≤ 0.58 mm/s), 
suggesting that hDOHHperoxo contains a μ-O(R) ligand. However, this argument is 
undermined by the observation of large isomer shifts (δ = 0.58 and 0.65 mm/s) in 
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[Fe2(Ph-bimp)(O2CPh)(O2)]2+ (11) in which the diiron cluster is triply bridged by μ-OR, 
μ-1,2-O2 and μ-1,3-O2CPh ligands with Ph-bimp = 2.6-bis[bis{2-(1-methyl-4,5-
diphenylimidazolyl) methyl}aminomethyl]-4-methylphenolate).82  
 
 
 
Figure 3.1. (μ-1,2-Peroxo)diiron(III) complexes for XAS study or discussed in this 
chapter. 
 
The unequivocal observation of the ~3.4 Å Fe---Fe distance in the photoreduced 
form of hDOHHperoxo by EXAFS provides another hint for the μ-O(R) ligand in 
hDOHHperoxo. Preliminary EXAFS analysis of hDOHHperoxo reported earlier suggest 
that the Fe---Fe distance did not change upon photoreduction and data collection at 
temperature < 20 K.16  The single atom bridging ligand could make the diiron cluster of 
hDOHHperoxo more rigid such that both the thermal and statistic disorders of the ~3.4 Å 
Fe---Fe path are small enough to enable its observation by EXAFS. Here we report a 
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systematic XAS study of hDOHHperoxo and model complexes that provides more 
compelling evidence for the (μ-O(R))(μ-1,2-peroxo)diiron(III) core in hDOHHperoxo. In 
addition, an EPR study of cryo-reduced hDOHHperoxo shows that the single atom 
bridging ligand of hDOHHperoxo is a μ-OH ligand. 
 
3.2. Experimental 
3.2.1. Sample preparation 
hDOHHperoxo was prepared using GSH-Sepharose affinity resin as previously 
described58 except that O2-saturated buffer was used. hDOHH is purified as a mixture of 
apo and holo peroxo form. Using O2-saturated buffer significantly improves the yield of 
the peroxo form.  The protein was then further purified with size exclusion 
chromatography (SEC) using a S200 HR 26×60 column (GE Healthcare) and mobile 
phase (25 mM Tris buffer containing 125 mM NaCl at pH 8.25) flow rate at 0.5 or 1.0 
ml/min. 2 ml fractions were collected. Fractions that contain holo hDOHHperoxo 
(A280/A630 ~ 15) were pooled and concentrated. All steps were performed at 0 – 4 oC.  
To prepare 17O2-hDOHHperoxo, ~ 3 ml of hDOHH mixture (A630 ~ 0.5) 
(obtained from the first affinity purification step) was reduced with slightly excess 
dithionite. The reduced hDOHH solution was exposed to 70 % enriched 17O2 gas 
(Cambridge Isotopes), which was kindly provided by Michael Mbughuni and Professor 
John D. Lipscomb. The re-oxidized hDOHH mixture was purified with SEC as described 
above. The incorporation of 70 % 17O2 in to hDOHHperoxo was verified by resonance 
Raman spectroscopy (see Supporting Information) using our reported procedure.16 
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Oxyhemerythrin (oxyHr) was generously provided by Dr. Thomas M. Makris in 
Professor Lipscomb’s group. 17O2-oxyHr was prepared by reducing oxyHr with a 
stoichimetry amount of dithionite and exposing the reduced sample to 60 % enriched 17O2 
(Cambridge Isotopes). The resulting 17O2-oxyHr was then transferred to standard X-band 
EPR and Raman sample tubes in a glove box maintained at 0 ppm O2 for further studies. 
Resonance Raman spectroscopy confirmed the incorporation of ~ 60% 17O2 into oxyHr 
(see Supporting Information).  
3.2.2. X-ray absorption spectroscopy 
 Two concentrated samples of hDOHH (~ 3 mM in [Fe]T) were prepared in pH 
6.5 (200 mM MES) or pH 9.5 (200 mM CHES). 20% glycerol was added to prevent the 
formation of ice crystals in the samples.  The samples were frozen in tandem 
Mössbauer/XAS cups with large sample windows allowing data to be collected on 11 
sample spots on each sample. One scan was collected on each sample spot. 9 scans were 
collected for each sample. Sample preparation and data collection of a chemically 
reduced hDOHH sample and a photoreduced hDOHHperoxo sample at pH 8.2 are 
described in ref. 16 and Chapter 2.   
We noted from previous experiments (Chapter 2) that hDOHHperoxo is 
photoreduced rapidly upon exposure to the X-ray beam. To minimize photoreduction 
during the sample aligment process, the beam flux was reduced by placing aluminum 
foils between the samples and the incident beam and the monochromator was set at 7130 
eV instead of ~ 8000 eV as usually carried out for stable samples. As a result, the 
XANES spectra of hDOHHperoxo at pH 9.5 and 6.5 are almost identical with the edges 
at slightly higher energy than that of hDOHHperoxo at pH 8.2 collected earlier (Fig. 3.3). 
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A photoreduction yield of ~ 20 – 25 % is estimated when the first scans of the pH 8.2 
samples were collected to energy of the edge jump. 
 The model complexes 1, 2, 6, 7, 8, and 10 ([Fe2(N-Et-HPTB)(μ-
OH)(NO3)2](NO3)2) were prepared according to previously published methods. 
Complexes 3, 4, and 5 were originally synthesized by Dr. Jonathan R. Frisch and reported 
in ref. 83. All samples were prepared in tandem Mössbauer/XAS cups or solution cells 
with sample spot sizes typical of 1 mm × 5 mm.  
 
 
Table 3.1. Model complexes used in this study 
 
Complex Concentration (mM) Prepared by Ref. Scans Beamline 
1 5 Dr. Xiaopeng Shan 131 16 SSRL 7-3 
2 6 Dr. Xiaopeng Shan 131 15 SSRL 7-3 
3 5 Dr. Jonathan R. Frisch 83 12 SSRL 9-3 
4 5 Dr. Jonathan R. Frisch 83 12 NSLS X3B 
5 5 Dr. Jonathan R. Frisch 83 8 SSRL 9-3 
6 5 Dr. Jonathan R. Frisch 129 16 SSRL 7-3 
7 3.6 Dr. Jonathan R. Frisch 130 16 SSRL 9-3 
8 3 Dr. Anusree Mukherjee 106 16 SSRL 7-3 
10 Solid sample* Dr. Feifei Li 164 4 NSLS X3B 
*Sample was mixed with dry BN at ~1:20 sample:BN ratio. 
 
XAS data were collected on beamlines 7-3 and 9-3 at Stanford Synchrotron 
Radiation Lightsource (SSRL) of the SLAC National Accelerator Laboratory and on 
beamline X3B at the National Synchrotron Lightsource of Brookhaven National 
Laboratory (NSLS).  At SSRL, the synchrotron ring SPEAR was operated at 3.0eV and 
50-100 mA beam current. Energy resolution of the focused incoming X-rays was 
achieved using a Si(220) double crystal monochromator.  At NSLS, the synchrotron ring 
was operated at 2.8 GeV and 100-300 mA beam current and a Si(111) double crystal 
monochromator was used.  Fluorescence data were collected over the energy range of 6.8 
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- 8.0 keV using a 30-element Ge detector at 25 minutes/scan (SSRL) or 13-element Ge 
detector at 55 minutes/scan (NSLS). XAS spectra of an iron foil were collected 
concomitantly with that of the samples, the first inflection points of which were set at 
7112 eV, to calibrate the energy of the sample spectra. 
Standard procedures were used to reduce, average and process the raw data using 
the EXAFSPAK package,149 which was also used for pre-edge quantification following a 
standard method165 and EXAFS fitting. The XAS data was normalized using the 
MBACK method.166 Theoretical EXAFS amplitude and phase functions were calculated 
using the FEFF package (version 8.4).  The input models for FEFF calculations are built 
based on the crystal structures of 1, 7, and 9.  The parameters r and σ2 were floated, while 
N was kept fixed for each fit and systematically varied in integer steps between fits. The 
scale factor was fixed at 0.9 and threshold energy (E0) was varied but maintained at a 
common value for all paths. All fits with E0 outside of the  ± 10 eV range were not 
considered. The goodness of fit was calculated as 
26 )( calexp χχkF −= ∑ . To judge the 
effect of the addition of a shell to the fit, a normalized goodness of fit, F', was used. F' = 
F2/nν, where ν = nidp – nvar, n is the number of data point, nidp is the number of 
independent points, and nvar is the number of variables used in each optimization step.  
3.2.3. Cryo-reduction of hDOHHperoxo using X-ray beam or 60Co γ rays 
 hDOHHperoxo and oxyHr (~ 0.5 mM peroxo, 50% glycerol) were frozen in X-
band quartz EPR tubes. These samples were irradiated with ~ 5 Mrad of 60Co γ rays at 77 
K and a dose rate 0.95 Mrad/hour. Cryo-reduction with 60Co  γ rays was carried out at the 
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Nuclear Radiation Laboraotry at University of Illinois-Urbana Champaign with a great 
help from Dr. Stoyan A Toshkov, as well as Dr. Ilia Denisov in Prof. Steve Sligar’s group 
at UIUC and Dr. Thomas M. Makris. EPR spectra of the samples were collected before 
annealing, after annealing at 77K with 120 W white light, and after annealing at 150 – 
170 K for 5, 10, and 15 minutes. An hDOHHperoxo sample was prepared in a tube made 
from kapton tape and exposed to the X-ray beam on beamline X-3B at NSLS for about 
one hour at ~ 20 K. The kapton tube was then put in to a regular X-band EPR tube and 
maintained at 77 K for later EPR measurement. 
 
3.3. Results 
3.3.1. XANES analysis 
It has been established that the nature of the coordination sphere of a diiron 
cluster can be deduced from the pre-edge features in their Fe-K edge XAS spectra.157, 165 
Fig. 3.2 shows the pre-edge features of hDOHHperoxo at pH 6.5 and model complexes. 
The XAS spectra of hDOHHperoxo at pH 6.5, and 9.5 are almost identical (Fig 3.3). The 
features can be fitted with two Gaussian peaks (Table 3.2), which is typical for octahedral 
high-spin iron(III) species. These two peaks are assigned to 1s → 3d(t2g) and 1s → 3d(eg) 
transitions, the ratio between which reflects the magnitude of 3d-4p mixing and thus the 
order of distortion of the electronic geometry around the iron center.165  
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Figure 3.2. Fe K-edge XAS pre-edge features of hDOHHperoxo at pH 6.5 and model 
complexes. Index: 0: hDOHHperoxo; 1: 8; 2: 1; 3: 2;4: 3; 5: 4; 6: 5; 7: 6; 8: 7; 9: 10.  
 
 
The pre-edge feature of hDOHHperoxo changes significantly upon 
photoreduction (Fig. 3.3).  The photoreduction of hDOHH peroxo yields a mixtures of 
iron(III) and iron(II) oxidation states as evidenced by the position of the Fe-K edge of the 
photoreduced sample compared to that of the non-photoreduced and fully reduced 
samples. The pre-edge intensity between 7113-7115 eV of reduced hDOHH (2.8 units) is 
significantly smaller than that of the hDOHHperoxo (~ 7 units), suggesting that the 
photoreduction would yield a much less intense pre-edge feature. Unexpectedly, the pre-
edge feature of the photoreduced sample increases to 8.7(2) units. More importantly, the 
pre-edge peak ratio increases from 1:1 to 1:1.5 (Fig. 3.4), indicating that there is a 
considerable distortion of the electronic geometry around the iron center upon 
photoreduction.  
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Figure 3.3. XANES spectra of hDOHHperoxo at pH 6.5 (──), 9.5 (──), 8.2 (─ ─) 
(partially photoreduced,  photoreduced hDOHHperoxo at pH 8.2 (─ • ─), and chemically 
reduced hDOHH at pH 8.2 (••••).  
 
 
 
 
Figure 3.4. Fitting of the pre-edge feature of hDOHH. A: hDOHHperoxo at pH 9.5; B: 
reduced hDOHH at pH 8.2; C: hDOHHperoxo at pH 8.2, partially photoreduced (see Fig. 
3.3); D: photoreduced hDOHHperoxo at pH 8.2. Legend: data (ooo), fit (───), 
background (••••), pre-edge peaks (─ ─ ─). 
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Table 3.2. XANES parameters for various hDOHH forms and model complexes 
 
Complex μ-O(R) Peak 1  
(eV) 
Int. 1 Peak 2  
(eV) 
Int. 2 Total  
Int. 
Int.  
ratio 
FWHM 
hDOHH 
pH 6.5$  7113.5(0) 3.3(2) 7115.1(1) 3.5(2) 6.8(4) 1:1.1 1.84(10) 
pH 9.5$  7113.5(0) 3.2(1) 7115.0(0) 3.6(1) 6.8(2) 1:1.1 1.76(6) 
pH 8.2$  7113.5(0) 3.1(1) 7115.1(0) 3.9(1) 7.0(3) 1:1.3 1.98(10) 
Photored.&  7113.5(1) 3.5(3) 7114.9(0) 5.1(1) 8.7(2) 1:1.5 2.14(16) 
Reduced#  7112.2(0) 1.7(2) 7114.4(1) 1.4(2) 4.5(6)  1.24(2) 
    7113.2(3) 1.4(1)    
Model complexes 
1 OH 7113.8(0) 3.4(2) 7115.3(0) 3.1(3) 6.5(5) 1:0.9 1.84(8) 
2 O/OH ? 7113.7(0) 5.1(2) 7115.2(1) 5.8(1) 10.9(3) 1:1.1 2.14(2) 
3 OR 7113.5(0) 4.1(1) 7115.0(0) 4.3(1) 8.4(2) 1:1.0 1.80(2) 
4 OR 7113.3(1) 4.1(3) 7114.8(1) 4.4(3) 8.5(6) 1:1.1 1.96(8) 
5 OR 7113.6(1) 3.4(1) 7115.0(0) 6.0(3) 9.4(4) 1:1.8 1.82(4) 
6 OR 7113.3(0) 3.4(0) 7114.7(0) 6.2(1) 9.6(1) 1:1.8 1.68(2) 
7 OR 7113.4(1) 3.1(1) 7114.9(0) 6.3(4) 9.4(5) 1:2.0 1.64(4) 
8 None 7113.3(0) 3.1(1) 7115.0(0) 3.5(1) 6.6(2) 1:1.1 1.96(6) 
10* OR/OH   7114.1(0)  14(1)  2.96(12) 
FWHM = Full width at half maximum. *Symmetric pre-edge feature that can best fitted with one Gaussian 
peak. $hDOHHperoxo. & Photoreduced hDOHHperoxo at pH 8.2. # Chemically reduced hDOHH at pH 8.2 
 
 
 
The total pre-edge area of 1, 3 – 8 are all smaller than 10 units, which are 
consistent with 6-coordinate diiron clusters without a μ-oxo ligand. The pre-edge areas of 
3 – 7 are on the higher end of the range found for non-oxo bridged 6-coordinate 
diiron(III) species, while those of 1, 8, and hDOHHperoxo are on the lower end.157, 165 
Complex 10 with the same ligand framework as that of 3 – 7 exhibits an unusually 
intense pre-edge feature (14 units) for a non-oxo-bridged 6-coordinate diiron(III) 
compound. Thus, the higher intensities of the pre-edge features in 3 – 7 can be attributed 
to the alkoxo ligand, which is very unlikely to be present in hDOHHperoxo. The peak 
ratios (Table 3.2) of 5 – 7 (~ 1:2) indicate that these compounds have distorted 
geometries, while hDOHHperoxo, 1, 3, 4, and 8 with peak ratios of ~ 1:1 have more 
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symmetric geometries. The total pre-edge area of 2 is ~ 11 units, which is relatively small 
for a μ-oxo bridged 6-coordinate diiron(III) cluster.157, 165 The peak ratio of 2 is close to 
1:1, which is not expected for a (μ-oxo)diiron(III) cluster. A duplicate sample of 2 gave 
the same data. EXAFS analysis (vide infra) of these data indicates that the sample is an ~ 
1:1 mixture of 1 and 2, consistent with the report that 2 gradually converts to 1 even in 
crystal form.131  
 
3.3.3. EXAFS analysis 
 
Fig. 3.5 shows the EXAFS spectra of hDOHHperoxo at pH 6.5 and 9.5. These 
two spectra are almost identical  and similar to that of the sample at pH 8.2 reported 
earlier (Chapter 2). The FT spectra exhibit an intense inner shell features between r’ = 1 – 
2 Å, a second shell feature between r’ = 2 – 2.8 Å, and a third shell peak at r’ ~ 3.0 Å. 
These features are typical of diiron clusters with the inner-shell feature arise from the first 
coordination sphere, the second shell from C/N atoms of the ligands, and the symmetric 
third shell peak from an iron scatterer. The outer shell peaks of the hDOHHperoxo data 
are symmetric and intense as observed in the model complexes (vide infra) but not in 
diiron enzyme peroxo intermediates. 
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Figure 3.5. Fourier transforms (left) and unfiltered Fe K-edge k3-weighted EXAFS data 
(right) of hDOHHperoxo at pH 6.5 (top traces) and pH 9.5 (bottom traces). 
 
 
Table 3.3. EXAFS fitting results for hDOHHperoxo 
 
Fe-O/N Fe-N.O Fe---C Fe---Fe/C   Fit 
# N R σ2 N R σ2 N R σ2 N R σ2 F F’ 
hDOHHperoxo at pH 9.5 
1 6 2.01 14.6          114 0.0655
2 5 2.01 12.5          115 0.0658
3 3 1.95 5.3 3 2.12 3.0       86 0.0572
4 2 1.93 3.0 4 2.11 4.4       85 0.0561
5 1 1.91 0.5 5 2.08 6.7       85 0.0565
6 2 1.94 3.4 4 2.11 4.6 3 3.13 2.3    70 0.0550
7 2 1.93 3.0 4 2.11 4.4 3 3.10 7.9 1Fe 3.43 3.1 25 0.0239
8 2 1.93 2.9 4 2.11 4.2 3 3.11 3.6 4C 3.47 0.7 33 0.0320
hDOHHperoxo at pH 6.5 
1 6 2.03 14.4          131 0.0769
2 5 2.03 12.4          133 0.0781
3 1 1.91 0.2 5 2.09 6.0       94 0.0636
4 2 1.94 2.7 4 2.12 3.7       92 0.0622
5 3 1.96 5.1 3 2.13 2.3       93 0.0629
6 2 1.95 3.2 4 2.12 3.9 3 3.15 0.9    73 0.0586
7 2 1.93 2.7 4 2.11 3.6 2 3.12 4.4 1Fe 3.43 2.5 17 0.0173
8 2 1.94 2.7 4 2.12 3.5 2 3.13 1.1 4C 3.47 0.1 25 0.0248
N = coordination number. R = distance (Å). σ2 = respective Debye-Waller factor (10-3×Å2). Scale factor S02 
= 0.9. For both hDOHHperoxo data: k range = 2 – 13.5 Å-1, resolution ~ 0.14 Å, back transform range 0.85-
3.3 Å, n = 116, nidp = 18.  
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The fitting results to Fourier-filtered data of hDOHHperoxo at pH 6.5 and pH 9.5 
are identical and shown in Table 3.3 and Fig. 3.6. The inner shell features data are fitted 
with two subshells of Fe-O/N paths at 1.93 Å and 2.11 Å. The weak second shells are 
fitted with several Fe---C paths at ~ 3.1 Å. The intense outer shell peak is well simulated 
with an Fe---Fe path at 3.43 Å. Replacing this path with several Fe---C paths at the same 
distance does not reproduce the outer shell feature (compare Fits 7 and 8). Thus, EXAFS 
analysis clearly shows that the Fe---Fe distance is 3.43 Å for hDOHHperoxo at both pH’s 
6.5 and 9.5. This distance is also derived from preliminary EXAFS analysis for of 
hDOHHperoxo at pH 8.2.16  
Fig. 3.6 shows Fourier-filtered EXAFS spectra and best fit results of model 
complexes 1-8 in comparison with the hDOHHperoxo spectra. The spectra of 2 are 
significantly different from those of 1, indicating that there is significant structural 
change upon deprotonation of 1. The fitting results of 1 and 2 are provided in Table 3.4. 
The progressive fit of 1 is essentially similar to that of hDOHHperoxo. The best fit 
parameters of 1 (Fit 7, Table 3.4) is consistent with its crystal structure, with an Fe---Fe 
distance of 3.42 Å.131 As suggested by pre-edge quantification, the sample of 2 is indeed 
a mixture of 1 and 2. An Fe-O distance at 1.84 Å is derived from the fit, which is slightly 
longer than the 1.80 Å distances normally observed for the Fe-μO bond by both XRD and 
EXAFS. More importantly, the outer shell feature can be well simulated with ~ 0.6 Fe---
Fe path at 3.17 Å and ~ 0.4 Fe---Fe path at ~ 3.46 Å, but not with only one Fe---Fe path 
at either distance (compare fit 11 to fits 7-9, Table 3.4). These distances are similar to 
those observed in the crystal structure of 1 and 2, respectively.131 Unlike the spectra of 
hDOHHperoxo and other model complexes, the Fourier transform of 8 does not exhibit 
 76
any peak at ~ 3.0 Å (Fig. 3.5). Instead, its outer shell feature is near 3.3 Å. The best fit of 
8  required two subshells of Fe-O/N paths at 1.98 Å and 2.14 Å, several Fe---C paths at 
3.13 Å, and one Fe---Fe path at 3.61 Å. Replacing the Fe---Fe path with several Fe---C 
path at ~ 3.6 Å significantly decreases the fit quality (compare Fit 7 and 8, Table 3.4). In 
addition, the presence of light atoms at ~ 3.6 Å with disorder small enough to contribute 
to the EXAFS signal of 8 is difficult to justify. Thus, it is clear that the outer shell feature 
of 8 arises from an Fe---Fe path at 3.61 Å. Furthermore, introducing an Fe---Fe path at 
shorter distances (Fits 9 and 10, Table 3.4) only results in very large σ2 value for this path 
and significantly lower fit quality.  EXAFS analysis of 8 thus clearly shows that its Fe---
Fe distances is 3.61 Å. 
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Table 3.4. EXAFS fitting result for 1, 2, and 8 
 
Fe-O/N Fe-N.O Fe---C Fe---Fe/C   Fit 
# N R σ2 N R σ2 N R σ2 N R σ2 F F’ 
Complex 1 
1 6 1.97 24.6          319 0.1608
2 5 1.95 19.4         314 0.1583
3 2 1.95 2.1 4 2.19 6.9       189 0.1087
4 3 1.96 5.0 3 2.19 3.2       186 0.1067
5 4 1.96 8.8 2 2.20 0.6       193 0.1110
6 3 1.95 4.9 3 2.19 3.3 4 2.99 2.8    113 0.0754
7 3 1.95 4.9 3 2.19 3.4 4 3.00 2.0 1Fe 3.42 1.6 18 0.0140
8 3 1.95 4.8 3 2.19 3.2 4 3.00 2.7 4C 3.45  -0.7 31 0.0243
Complex 2 
1    6 2.21 48.5       318 0.1378
2 1 1.85 1.3 5 2.16 19.5       215 0.1053
3 1 1.95 0.7 2 2.06 8.0       202 0.1134
    3 2.25 4.5         
4 1 1.84 0.6 2 2.02 8.5 5 2.95 1.0    108 0.0711
    3 2.22 4.6         
5 1 1.84 1.1 2 2.02 9.6 5 2.97 1.2 1Fe 3.16 2.4 44 0.0353
    3 2.22 4.9        
6 1 1.84 0.4 2 2.02 7.8 5 2.94 1.1 1Fe 3.46 3.1 76 0.0607
    3 2.22 4.4        
7 1 1.84 1.0 2 2.02 9.4 5 2.97 1.6 1Fe 3.17 2.5 30 0.0302
    3 2.22 4.8    4C 3.48 3.7   
8 1 1.84 0.8 2 2.02 8.9 5 2.96 1.6 4C 3.20 1.1 29 0.0291
    3 2.22 4.8    1Fe 3.45 6.3   
9 1 1.84 0.8 2 2.02 8.9 5 2.96 2.0 4C 3.19 0.3 47 0.0470
    3 2.22 4.8    4C 3.51 5.1   
10 1 1.84 0.9 2 2.02 9.0 5 2.97 2.3 0.6Fe 3.17 0.8 28 0.0284
    3 2.22 4.7    0.4Fe 3.46 1.6   
Complex 8 
1 6 2.06 15.7          104 0.0607
2 5 2.07 12.7          95 0.0555
3 3 2.01 9.6 2 2.15 1.8       67 0.0445
4 2 1.98 6.5 3 2.14 2.9       65 0.0434
5 1 1.94 3.2 4 2.13 4.6       67 0.0445
6 2 1.98 6.7 3 2.14 3.0 4C 3.14 7.8    
7 2 1.98 6.4 3 2.14 2.8 4C 3.13 7.3 1Fe 3.61 5.4 19 0.0177
8 2 1.98 6.5 3 2.12 2.9 4C 3.14 7.7 4C 3.64 3.1 32 0.0302
9 2 1.97 6.3 3 2.14 2.8 1Fe 3.10 11.7 4Fe 3.64 3.4 50 0.0464
10 2 1.98 7.2 3 2.14 3.3 1Fe 2.58 21.2 4C 3.64 3.2 28 0.0331
     4C 3.12 9.5     
N = coordination number. R = distance (Å). σ2 = respective Debye-Waller factor (10-3×Å2). Scale factor S02 
= 0.9. 
1: k range = 2 – 15 Å-1, resolution ~ 0.12 Å, back transform range ~ 0.85 – 3.4, n  = 131, nidp = 20.6. 
2: k range = 2 – 14 Å-1, resolution ~ 0.13 Å, back transform range = 0.85 – 3.4 Å, n = 121, nidp = 19.4 
8: k range = 2 – 12.6 Å-1, resolution ~ 0.16 Å, back transform range = 0.85 – 3.7 Å, n = 107, nidp = 19. 
 78
The five N-Et-HPTB complexes can be divided into two subgroups, one includes 
3 and 4 and the other includes 5, 6, and 7, based on the similarities in their FT spectra, as 
well as in their EXAFS spectra in the region beyond 8 Å-1 (Fig. 3.6). Table 3.5 shows the 
progressive fits the N-Et-HPTB complexes. The fitting results for 3 – 5 have been 
published83 and only the best fit parameters are listed here for discussion. The inner shell 
features of the N-Et-HPTB complexes can best be fitted with a total coordination number 
of six with 4 to 5 ligands near 2.0 to 2.2 Å and one ligand near 2.3 Å, corresponding to 
the Fe-Namine bond as observed in the crystal structures of 7130 and the diferrous 
precursors of 3 and 4.83 In 5, 6, and 7, a short Fe-O distance of 1.88 – 1.89 Å can be 
resolved from other Fe-O/N distances and is assigned to the peroxo ligand.107, 109, 130, 131  
The second shell peaks of these complexes correspond to 3 to 5 Fe⋅⋅⋅C paths near 2.95 Å, 
which arise from carbon atoms adjacent to the ligating nitrogen atoms of the 
benzimidazole rings of the N-Et-HPTB ligand.  
Similar to the analysis of hDOHHperoxo and 1, the 3.1 Å feature of 5 – 7 is best 
fitted with an Fe⋅⋅⋅Fe path at 3.46 – 3.47 Å. Replacing this Fe⋅⋅⋅Fe path by either one 
Fe⋅⋅⋅P path or five Fe⋅⋅⋅C paths results in significantly lower fit quality. Thus, the r' = 3.1 
Å feature is attributed to an Fe⋅⋅⋅Fe path at 3.46 – 3.47 Å.  This distance is consistent with 
that in the crystal structure of 7,130 which is significantly longer than the 3.21 – 3.26 Å 
Fe⋅⋅⋅Fe distance found in 3 and 4.  An Fe⋅⋅⋅P path is not required for the best fits to the 
data of 5 and 7, suggesting that in the terminal binding mode of O2PPh2 and OPPh3 
ligands, the outer atoms are too disordered relative to the iron centers.  
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Table 3.5. EXAFS fitting result for N-Et-HPTB model complexes 
 
Fe-O/N Fe-N.O Fe---C Fe---Fe/C   Fit 
# N R σ2 N R σ2 N R σ2 N R σ2 F F’ 
Complex 3 
1 6 1.97 24.6          319 0.1608
2 5 1.95 19.4         314 0.1583
Complex 4 
1 3 1.97 3.5 2 2.14 3.9 3 2.96 2.8 1Fe 3.27 1.3 13 0.0135
    1 2.31 6.3       
2 3 1.96 3.8 2 2.13 4.3 3 2.94 5.5 1As 3.21 2.2 12 0.0130
    1 2.30 5.9       
Complex 5 
1 1 1.89 0.2 3 2.04 3.1 4 2.97 2.7 1Fe 3.47 4.5 14 0.0141
    1 2.36 3.2 2 3.23 7.0      
Complex 6 
1 6 1.98 13.1          228 0.1253
2 5 1.99 10.3          205 0.1128
3 1 1.84 1.11 4 2.01 4.4       165 0.1039
4 1 1.88 1.1 3 2.03 2.3       135 0.0992
    1 2.40 3.5         
5 1 1.88 0.3 3 2.03 1.7 4 2.96 1.1    62 0.0696
    1 2.43 8.4 4 3.17 2.9      
6 1 1.88 0.4 3 2.03 2.0 4 2.95 2.4 1Fe 3.47 3.0 19 0.0280
    1 2.42 6.5 2 3.18 4.0      
7 1 1.88 0.5 3 2.03 2.0 4 2.95 2.1 4C 3.51 0.34 28 0.0426
    1 2.41 6.0 2 3.17 1.1      
Complex 7 
1 6 1.97 13.2          268 0.1130
2 5 1.98 10.8          248 0.1046
3 1 1.86 1.4 4 2.01 5.2       222 0.1053
4 1 1.89 0.8 3 2.03 2.8       179 0.0969
    1 2.40 1.6         
5 1 1.90 1.4 3 2.04 3.3 4 2.98 1.1    191 0.1444
    1 2.40 1.2 4 3.19 1.6      
6 1 1.89 0.7 3 2.03 2.8 4 2.96 2.2 1Fe 3.46 1.7 18 0.0170
    1 2.41 1.6 2 3.18 5.1      
7 1 1.89 1.0 3 2.03 3.0 4 2.97 1.9 4C 3.49 -0.2 34 0.0320
    1 2.41 1.5 2 3.17 0.2      
N = coordination number. R = distance (Å). σ2 = respective Debye-Waller factor (10-3×Å2). Scale factor S02 
= 0.9. 
3: k range = 2 – 15 Å-1, resolution ~ 0.12 Å, back transform range = 0.85 – 3.1 Å, n = 131, nidp = 18.3 
4: k range = 2 – 13 Å-1, resolution ~ 0.14 Å, back transform range = 0.85 – 3.4 Å, n = 117, nidp = 18.3 
5: k range = 2 – 15 Å-1, resolution ~ 0.12 Å, back transform range = 0.85 – 3.4 Å, n = 129, nidp = 20.7 
6: k range = 2 – 13.5 Å-1, resolution ~ 0.14 Å, back transform range = 0.85 – 3.1 Å, n = 116, nidp = 18.7 
7: k range = 2 – 15 Å-1, resolution ~ 0.12 Å, back transform range = 0.85 – 3.4 Å, n = 131, nidp = 21.1 
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Figure 3.6.  Fourier transforms (left) of the Fourier-filtered Fe K-edge k3-weighted 
EXAFS data (right) of hDOHHperoxo and model complexes. Data and fit parameters are 
shown bold in Tables 3.3 – 3.5. The red lines indicate the peaks corresponding to Fe---Fe 
paths in the Fourier transform spectra. 
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3.3.4. EPR analysis of cryo-reduced hDOHHperoxo (pH 8.2) and oxyhemerythrin 
 
 
Figure 3.7.  EPR spectra of hDOHHperoxo (left) and oxyHr (right) after cryo-radiolysis 
with 60Co γ source. The spectra were collected in perpendicular mode, at ~ 12 K, and 10 
mW power, 5G modulation amplitude. The cryo-reduced hDOHHperoxo samples were 
annealed at ~ 150 – 170 K for 10 mins. The cryo-reduced oxyHr samples were 
photoannealed at 77 K. The estimated g values for the cryo-reduced 16O2-hDOHHperoxo 
sample are 1.909 and 1.947. The estimated g values for the 16O2-oxyHr are 1.924 and 
1.943 
 
 
 Fig. 3.7 shows the EPR spectra of hDOHHperoxo and oxyHr after cryo-radiolysis 
with 60Co γ rays. The as-isolated hDOHHperoxo and oxyHr samples are EPR silent in 
perpendicular mode. The annealing profiles of the samples are provided in Supporting 
Information. Prior to annealing, the EPR spectrum of this sample exhibits a strong g = 2 
signal that arises from solvated electrons and free radicals generated during radiolysis. 
Upon photoannealing at 77 K for ~ 2 hours (for oxyHr samples) or thermal annealing at ~ 
150 – 170 K for ~ 10 minutes (for hDOHHperoxo samples), these signals decayed 
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significantly, allowing the observation of g < 2.0 axial signals. The 16O2-hDOHHperoxo 
sample cryo-reduced with an X-ray beam exhibits weak free radical signal at g = 2, 
allowing the observation of the g < 2 signal without annealing (see Supporting 
Information). The similarity of the g < 2 signals of hDOHHperoxo before and after 
annealing indicates that thermal annealing at 150 – 170 K does not affect the species 
giving rise to this signal. 
 In the spectrum of cryo-reduced 57Fe-hDOHHperoxo, the g < 2 signal is 
significantly broadened. This line broadening is attributed to the hyperfine coupling of 
the electron to the 57Fe nuclei  (I = 1/2) (56Fe has nuclear spin I  = 0 and does not exhibit 
hyperfine coupling), indicating that this signal is associated with the iron center(s) of 
hDOHH. More importantly, this signal is also broadened in the spectrum of cryo-reduced 
17O2-hDOHHperoxo. Since the nuclear spins of 16O and 17O are 0 and 5/2, respectively, 
this broadening is attributed to the (super)hyperfine coupling of the electron to 17O nuclei. 
This result clearly shows that at least one of the oxygen atoms of the peroxo moiety 
remains bound to the diiron cluster upon cryo-reduction. Similar 17O line broadening is 
also observed in the spectra of cryo-reduced oxyHr (Fig. 3.7). 
 
3.4. Discussion 
EXAFS analysis unequivocally derives an Fe---Fe distance of 3.43 Å for 
hDOHHperoxo. Such a clear observation of the Fe---Fe distance has not been obtained 
for any other peroxo intermediates of diiron enzymes. This distance provides valuable 
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information about the bridging structure of the diiron cluster in hDOHHperoxo when 
compared to model complexes with well characterized core structures (Table 3.6).  
8 contains two μ-1,3 carboxylate ligands in addition to the μ-1,2-peroxo moiety 
and has an Fe---Fe distance of 3.61 Å. This result is consistent with previous 
spectroscopic and computational studies that predicted a bis(μ-1,3-carboxylato)(μ-1,2-
peroxo)diiron(III) structure for 8 and W48F/D84E-R2perox with the Fe---Fe distances at 
~ 3.6 – 3.7 Å.87, 162 This distance is shorter than that observed in the crystal structure of 9 
(4.00 Å). 8 only differs from 9 in that 8 has two O2CPh ligands instead of O2CCH2Ph 
ligand. This difference in the Fe---Fe distances suggests that the bis(μ-1,3-
carboxylato)(μ-1,2-peroxo)diiron(III) core arranges in solution differently from that in 
the crystal. For example, the gauche cis-1,2-peroxo geometry observed in the crystal 
structure of 9 could change to a planar cis-1,2-peroxo geometry in solution for 8, which 
would significantly reduce the Fe---Fe distance. Regardless this difference, it is clear that 
without any single atom bridging ligand, the Fe---Fe distance of 8 and 9 is longer than the 
distance of 3.43 Å found for hDOHHperoxo. 
 
Table 3.6. Correlation of the bridging structure of (μ-1,2-peroxo)diiron(III) with its Fe---
Fe distance 
 
Complex hDOHH 8 and 9 2 1 5 – 7 3, 4, and 11 
Additional 
Bridge(s) 
μ-OH ? bis(μ-1,3-O2CR)
R = Ph or CH2Ph
μ-O μ-OH μ-OR 
 
μ-OR and 
 μ-1,3-O2XR’2, 
X = C, P, As;  
R’ = Ph or Me 
r(Fe---Fe) (Å) 
by EXAFS 
3.43 3.61 3.17 3.42 3.46 – 3.47 3.26 – 3.27 
r(Fe---Fe) (Å) 
by XRD 
 4.000(4)a 3.171(1)b  3.396(1)b 3.462(3)c 3.327(2)d 
a Complex 9, ref. 107; b Complexes 1 and 2, ref. 131; c Complex 7, ref. 130; d Complex 11, ref. 82.  
 84
In contrast to 8 and 9, 2 with only a μ-oxo ligand in addition to the μ-1,2-peroxo 
moiety has an Fe---Fe distance of 3.17 Å, which is significantly shorter than that in 
hDOHHperoxo. Protonation of the μ-oxo ligand of 2 lengthens the Fe---Fe distance to ~ 
3.4 Å, a value similar to that of hDOHHperoxo. Likewise, complexes 5 – 7 with an μ-
alkoxo ligand in the place of the μ-hydroxo ligand have similar Fe---Fe distances at 3.46 
– 3.47 Å. Introduction of an additional μ-1,3 ligand to the five membered-ring (μ-OR)(μ-
1,2-peroxo)diiron(III) core in 3, 4, and 11 shortens its diiron distance to ~ 3.3 Å. This 
comparison demonstrates that hDOHHperoxo contains one and only a μ-OR ligand in 
addition to its μ-1,2-peroxo ligand.  
The presence of a single atom bridging ligand in hDOHHperoxo is further 
supported by the EPR and XAS data of the 1-electron reduced hDOHHperoxo in frozen 
state. The EPR signal observed of cryo-reduced hDOHHperoxo at g < 2.0 is typical of a 
(μ-O(H))diiron(III/II) clusters in both model and enzymatic systems, prepared by 
chemical reduction or cryo-radiolysis.105, 167-169 From extensive studies of many model 
complexes, a general trend has been observed that (μ-hydroxo)diiron(II/III) clusters 
exhibit rhombic EPR signals at gave = 1.43–1.87 with relatively large rhrombicity (Δg ~ 
0.14 – 0.55), while (μ-oxo)diiron(II/III) clusters exhibit axial EPR signals at gave = 1.90–
1.98 with smaller rhrombicity (Δg < 0.07). The small rhrombicity of the (μ-
oxo)diiron(II/III) cluster very likely arise from the ability of the μ-oxo ligand to strongly 
mediate the exchange coupling between the two iron centers.167, 168  
The gave = 1.94 and Δg = 0.05 values for cryo-reduced hDOHHperoxo are more 
consistent with the presence of a (μ-oxo)diiron(II/III) cluster rather than a (μ-
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hydroxo)diiron(II/III) cluster. While hDOHHperoxo does not contain a μ-oxo ligand as 
clearly demonstrated by Mössbauer and XAS study, the presence of the μ-oxo ligand in 
cryo-reduced  hDOHHperoxo can be explained by the proposed mechanism in Scheme 
3.1. The EPR signal of cryo-reduced hDOHHperoxo is distinct from the isotropic g = 2 
signal of intermediate X in RNR R2 and its model complexes.63, 67, 170, 171 In addition, 
during XAS measurement, the Fe K-edge of hDOHHperoxo gradually red shifted, 
indicating that the overall oxidation state of the diiron cluster decreased upon cryo-
reduction. Thus, we propose that the 1-electron reduction of hDOHHperoxo likely leads 
to the dissociation of the peroxo ligand from one iron center as opposed to O-O bond 
cleavage observed for RNR R2. The resulting terminal anionic peroxo ligand then 
deprotonates the hydroxo ligand to form a FeII-O-FeIII-OOH species. As a precedent for 
the proton transfer to a terminal peroxo anion at 20 K and 77 K in this proposed 
mechanism, the same process was observed for heme oxygenase even at 4 K.168 This 
mechanism is supported by the pre-edge quantification results. Upon photoreduction of 
hDOHHperoxo, the pre-edge intensity increases from ~ 6.8 units to 8.7 units and pre-
edge peak ratio increases from 1:1 to 1:5, consistent with a geometrical change from a 
more symmetric octahedral field to a distorted field.165 In the mechanism in Scheme 3.1, 
one 6-coordinate iron center converts to a 5-coordinate center while a μ-oxo ligand is 
formed, which both contribute to the increases in pre-edge intensity and peak ratio. 
The presence of a hydroperoxo ligand bound to a (μ-oxo)diiron(II/III) cluster is 
precedented by the study on oxyhemerythrin and its model complexes.105 [Fe2(μ-OH)(μ-
Ph4DBA)(TMEDA)2(OTf)] (12) and [Fe2(μ-OH)(μ-Ph4DBA)(DPE)2(OTf)] (13), where 
Ph4DBA2- is the dinucleating bis(carboxylate) ligand dibenzofuran-4,6-
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bis(diphenylacetate), are two model complexes that closely resemble the active site of 
deoxyhemerithrin with an asymmetric FeII-OH-FeII core. The reaction of 
deoxyhemerythrin, as well as of 12 and 13, with O2 results in the formation of a FeIII-O-
FeIII-OOH species, in which the proton is transferred from the μ-OH ligand to the 
terminal peroxo ligand. The EPR spectra of cryoreduced oxyHr and 13-O2 exhibit axial 
signals typical of (μ-oxo)diiron(II/III) species. Importantly, 1H-ENDOR spectra of 
cryoreduced oxyHr and 13-O2 show weak doublets with A ~ 11.5 MHz  and A ~ 9.5 
MHz, respectively, which arise from the proton of a hydroperoxo terminally bound to a 
mixed valent (μ-oxo)diiron(II/III) cluster.105 Given the ligand sets of oxyhemerythrin and 
13-O2, their cryo-reduction likely results in a FeII-O-FeIII-OOH species similar to what 
we propose for cryoreduced hDOHHperoxo in Scheme 3.1. Our EPR study of cryo-
reduced 17O2-oxyHr provides further evidence that upon cryo-reduction, the peroxo 
moiety remains bound to the diiron cluster in Hr. 
 
Scheme 3.1. Proposed cryo-reduction of hDOHHperoxo. 
 
 
  
 Together, our XAS and EPR study provide compelling evidence for the (μ-
hydroxo)(μ-peroxo)diiron(III) structure of hDOHHperoxo. A μ-hydroxo has thus far not 
been observed in any other peroxo intermediates of diiron enzymes. This additional 
bridging ligand may lead to the difference in the Mössbauer parameters of 
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hDOHHperoxo compared to those of other diiron enzyme peroxo intermediates. More 
importantly, this μ-hydroxo ligand may contribute significantly to the stability of 
hDOHHperoxo and affect its reactivity. XAS data of hDOHHperoxo at pH 6.5 and 9.5 
are almost identical, indicating that this ligand, as well as the core of hDOHHperoxo 
active site is not affected by pH in this range. Great attention should be paid to this ligand 
in further structural and mechanistic studies of hDOHH. 
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3.5. Supporting Information 
 
 
 
Figure S.3.1. Resonance Raman spectrum of holo hDOHHperoxo prepared with 70 % 
enriched 17O2 (647.1 nm excitation, 200 mW, 0 oC) 
 
 
 
 
Figure S.3.2. Resonance Raman spectra of oxyHr prepared with 60 % enriched 17O2 
 (−−) and decayed Hr after exposed to 488 nm excitation laser (300 mW at ~ 0 oC). 
 89
 
Figure S.3.3. Annealing profile for cryo-reduced 16O2-hDOHHperoxo 
 
 
 
 
Figure S.3.4. Annealing profile for cryo-reduced 17O2-hDOHHperoxo 
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Figure S.3.5. Annealing profile for cryo-reduced 57Fe-hDOHHperoxo 
 
 
 
Figure S.3.6. EPR spectra of hDOHHperoxo before and after cryo-reduction with X-ray 
beam at the XAS beamline X3B of the National Synchrotron Light Source. The cryo-
reduced sample was not annealed. 
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Figure S.3.7. Annealing profile for cryo-reduced 16O2-oxyHr 
 
 
 
Figure S.3.8. Annealing profile for cryo-reduced 17O2-oxyHr 
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Chapter 4                                                                            
Formation and reaction of hDOHHperoxo 
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4.1. Introduction 
 The binding of O2 to the reduced diiron cluster and how the resulting peroxo 
intermediate undergoes O-O bond cleavage are the most important aspects in oxygen 
activation by diiron enzymes. Extensive studies on MMO reveals that each of these two 
steps requires the transfer of one proton.88, 89 The oxygen binding and activation steps of 
MMO and RNR R2 happen on the millisecond time scale.2, 88, 89 For MMO and R2 
reaction cycle, the rate determining step happens after O-O bond cleavage steps.2 
We have shown in previous chapters that the hDOHHperoxo contains a (μ-1,2-
peroxo)diiron(III) cluster with a possible additional μ-hydroxo ligand (Scheme 4.1). This 
μ-hydroxo ligand is a unique feature of hDOHHperoxo, which possibly contributes to its 
unusual stability. Because hDOHH is different from the canonical diiron enzymes in 
overall protein fold and structure of the peroxo intermediate, it is intriguing to compare 
the formation and activation of hDOHHperoxo to those of the well characterized 
enzymes. These insights are required to augment our understanding of oxygen activation 
by diiron enzymes. Moreover, such insights are important to understand how mature 
eIF5A, a growth regulation factor, is synthesized. 
 In this work, various kinetic, spectroscopic, and biochemical techniques are 
utilized to study the formation and reaction of hDOHHperoxo. The results obtained 
herein indicate that hDOHHperoxo activation also requires a proton transfer step as found 
for MMOHperoxo. However, the formation and reaction of hDOHHperoxo differs from 
those of MMOHperoxo in many aspects, presumably due to the additional μ-hydroxo 
ligand and a flexible overall structure of hDOHH. 
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Scheme 4.1. Reaction of deoxyhypusine synthase (DHS) (left) and deoxyhypusine 
hydroxylase (DOHH) (right). 
 
 
 
 
4.2. Experimental 
4.2.1. hDOHH purification 
 A published protocol was used to purify hDOHH with slight modifications. Cell 
paste (~15 g) was mixed with ~ 80 mL anaerobic buffer A (50 mM Tris, 100 mM NaCl, 
pH 7.7) and stirred on an ice bath for ~ 15 min or until an even suspension was obtained. 
The suspension was then lyzed with sonication, which was subsequently centrifuged for 
~ 30 minutes at ~ 30000xg. The clear supernatant (~ 80 mL) was divided into two 50-mL 
centrifuge tubes. 6 mL bed volume of GSH-sepharose (GE Healthcare) was added to each 
tube, which was then capped and rotated at 4 oC overnight.  The content in each 
centrifuge tube was then split evenly into two empty PD-10 columns (4 columns in total). 
Columns 1 and 2 were washed thoroughly with air-saturated buffer. Columns 3 and 4 
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were first washed with anaerobic buffer (~ 100 mL), which was followed with air-
saturated buffer. hDOHH was then cleaved from the GSH-Sepharose resin using 
thrombin as previously described.58 Separation of holo hDOHHperoxo with preparative 
size-exclusion  chromatography (SEC) was carried out as described in Chapter 3.  
4.2.2. Stopped-flow experiments 
 2.5 mL of anaerobic 0.2 mM holo hDOHHperoxo (A630 ~ 0.5) in SEC buffer 
(pH 8.2, 25 mM Tris, 125 mM NaCl) containing 0.1 equivalent of methylviologen was 
prepared by equilibrating with Ar for ~ 2 hours while being stirred in an ice-bath. To this 
solution ~ 10 equivalents of sodium dithionite were added to obtain a solution with the 
characteristic bright blue color of reduced methylviologen. The reaction mixture was 
applied to a PD-10 desalting column (G-25, GE Healthcare) in a glove box maintained at 
0 ppm oxygen. Reduced hDOHH was eluted with 3.5 mL anaerobic 50 mM MOPS pH 
7.5 buffer while excess dithionite, methylviologen, and other salt remained bound to the 
column. The colorless reduced hDOHH sample was then mixed rapidly with O2-saturated 
50 mM MOPS pH 7.5 buffer solution using an Applied Photophysics  SX.18MV model 
stopped-flow device at 4 oC. The concentration of hDOHH and O2 after mixing were 0.1 
and 1.0  mM, respectively. The formation of hDOHHperoxo was monitored at 620 nm.  
4.2.3. pH-dependent reaction of hDOHHperoxo 
 MES, BisTRRIS, MOPS, TRIS, and CHES were used to prepare 50 mM buffer 
solutions at desired pH. The pH’s of the solutions were measured at both room 
temperature and 37 oC. 10 μL of holo hDOHHperoxo was mixed with ~ 200 μL buffer to 
obtain a final concentration of ~ 35 - 40 μM (A630 ~ 0.1). The reaction was monitored at 
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37 oC using a diode-array UV/Vis spectrometer. The self decay rate of hDOHHperoxo 
was estimated by following A630.  
4.2.4. Analytical size exclusion chromatography 
 Analytical SEC analysis was performed using a GF-250 column (4.6 mm ID, 250 
mm length) on an HP Agilent 1100 HPLC system equipped with an autosampler. The 
mobile phase contains 50 mM Tris and 125 mM NaCl pH 7.5. Column temperature was 
maintained at 25 oC.  GST-Apo protein was provided by Dr. Park Myung Hee. The GST 
tag was removed using thrombin as described elsewhere.58 Reduced hDOHH was 
obtained by treating holo hDOHHperoxo with excess dithionite. For SEC analysis of the 
reduced sample, the mobile phase was degassed thoroughly with Ar and the system was 
purged and equilibrated with degassed buffer for prior to sample injection. holo 
hDOHHperoxo in with 200 mM buffer at pH 6.5 (MES) or 9.5 (CHES) was kept at room 
temperature (22 oC) and automatically injected. The time interval between runs of each 
sample was 15 minutes. 4 mM phthalic acid was added to each sample and used as an 
internal standard. The injection volume of each sample was 10 μL. 
4.2.5. Reaction of hDOHHperoxo with eIF5A(Dhp) substrate and its analogues 
eIF5A(Dhp) was synthesized in vivo using a polycistronic plasmid coding for 
both eIF5A(Lys) and DHS.187 eIF5A(Dhp) and eIF5A(Lys) were expressed and purified 
using ion-exchange chromatography as reported recently.172 eIF5A(Dhp) can also be 
synthesized in vitro  analogues were prepared in vitro  using DHS reaction (Scheme 4.1) 
following a protocol described elsewhere.173 By substituting spermidine (Spd) with its 
derivatives, several eIF5A(Dhp) analogues can also be synthesized. Spermidine 
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derivatives were provided by Dr. Myung Hee Park and Dr. Jack E. Folk at NIH. 
Typically, 1 mg eIF5A(Lys) was mixed with 1 mM NAD, 1 mM DTT, 100 ug His-
hDHS, and 0.5 mM Spd or Spd analogues in 0.2 M Gly buffer NaOH (pH 9.5). The 
reaction mixtures were incubated at 37 oC for 3 h. The solutions were then buffer-
exchanged to 50 mM MOPS buffer at pH 7.5.  His6-DHS was purified using Ni-NTA 
superflow resin (Qiagen) following a standard procedure provided with the product by 
Qiagen.  
eIF5A(Dhp) and its analogues (1 equivalent) were reacted with ~ 40-50 μM 
hDOHHperoxo in 50 mM MOPS solution at pH 7.5 and 22 oC. eIF5A(Dhp) was also 
reacted with hDOHHperoxo at pH 6.0 (50 mM MES). The UV/Vis spectrum of the 
reaction solution was monitored using an diode-array spectrometer. The decay rate of 
hDOHHperoxo was reported based on A630. 
eIF5A(Dhp), its analogues, and their DOHH-oxidized products were precipitated 
with 10% trichloroacetic acid and hydrolyzed with 6 N HCl at 110 oC overnight. The 
hydrolysates were dried using a SpeedVac system. The remaining dried solids were 
redisolved in HPLC water for further analysis. Ion-exchange chromatography using o-
phthaldialdehyde derivatization was carried out by Dr. Myung Hee Park as described 
elsewhere.137 Hydrophilic interaction liquid chromatography (HILIC) coupled with ESI 
mass spectrometric detection was carried out using a Bruker microOTOF-Q by Dr. 
Joseph Dalluge in the Mass Spectrometry Laboratory, Department of Chemistry, 
University of Minnesota.   
 Intact protein solutions were also analyzed with reverse phase HPLC by Dr. 
Dalluge using a Water Acquity UPLC/TQD system equipped with triple quadrupole mass 
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spectrometric detection. A standard C18 columns was used with acetonitrile mobile phase 
containing 0.1% HCOOH.  5 μL aliquots of ~ 1 mg/mL protein solutions were injected. 
4.2.6. Mössbauer spectroscopy 
 Holo 57Fe-hDOHHperoxo was prepared as previously described,16  and exchanged 
into buffer solutions at pH 6.5, 7.5, and 9.5. The samples at pH 6.5 and 9.5, ~ 0.1 mM 
each, were incubated at 37 oC until A630 reached a minimum values.  The sample at pH 
7.5 was reacted with ~ 1 equivalent of eIF5A(Dhp) (~ 0.1 mM final concentration) at 37 
oC until A630 reached a minimum value. All samples were then concentrated to ~ 0.5 mM 
protein (~ 1.0 mM in [Fe]), and frozen in Mössbauer cups. Mössbauer spectroscopy was 
performed by Dr. Mrinmoy Chakrabarti in the laboratory of Professor Eckard Münck at 
Carnegie Mellon University, following a procedure described in Chapter 2. 
 
4.3. Results 
4.3.1. Formation of hDOHHperoxo 
Fig. 4.1 illustrates the purification of hDOHH using GSH-Sepharose affinity 
resin. The colorless resin bound GST-tagged hDOHH (or GST-hDOHH) and turned blue 
upon washing with air-saturated buffer (columns 1 and 2). When the protein bound 
columns were washed with anaerobic buffer, they remained colorless and only turned 
blue when washed with aerobic buffer (columns 3 and 4). These results demonstrate that 
hDOHH was expressed in a reduced form in the expression cells and reacted with O2 to 
form hDOHHperoxo during purification. Tag-free hDOHH was then cleaved off the 
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columns using thrombin. hDOHH isolated from affinity columns contains a mixture of 
hDOHHperoxo and other forms of hDOHH as shown by size-exclusion chromatography 
and designated as as-isolated hDOHH. The pure hDOHHperoxo form can be isolated 
from this mixture using either native gel electrophoresis136 or preparative size exclusion 
chromatography as described in previous chapter, which is designated as holo 
hDOHHperoxo. 
               
Figure 4.1. Purification of hDOHH with GSH-Sepharose affinity resin. Columns 1 and 2 
were washed with air-saturated buffer, while column 3 and 4 were first washed with 
anaerobic buffer (left panel) followed by air-saturated buffer (right panel).  
 
  
Fig. 4.2 shows the spectra of hDOHH in various forms. Treatment of holo 
hDOHHperoxo (blue trace, left panel) with ~ 2 equivalents of dithionite resulted in a 
colorless solution (black trace). Exposing this solution to the air without any sample 
workup steps regenerated hDOHHperoxo at 80% yeild (long dashed green trace).  The 
addition of excess ascorbate to the solution increases the absorption at 630 nm to the 
value found for the initial holo hDOHHperoxo sample, but at the same time decreases the 
aborption at ~ 320 nm (short dashed red trace). The same ~ 20 % increase in the 
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absorption at 630 nm was also observed upon the addition of ascorbate to an as-isolated 
hDOHH sample (left panel).  The reaction of a solution containing iron(II) and excess 
ascorbate with O2 results in a purple solution with λmax ~ 520 nm and ε ~ 0.6 mM (Fig. 
4.2, left panel). The addition of excess ascorbate to an iron(III) solution leads to a similar 
result, which is significantly different from the more intense absorption at 630 nm (ε = 
2.8 mM) of hDOHHperoxo. The absorption at 520 nm did not increase when ascorbate 
was added to re-oxidized hDOHH and as-isolated hDOHH solutions. Thus, the increase 
in absorption at 630 nm to the expected value for stoichimetric reaction of reduced 
hDOHH with O2 (Fig. 4.2, left panel inset) upon the addition of ascorbate to oxidized 
hDOHH can be attributed to hDOHHperoxo. 
 
 
  
 
Figure 4.2.  UV/vis spectra of hDOHHperoxo in various forms at pH 8.2. Left panel: ~ 
0.1 mM holo hDOHHperoxo (──)  was reduced with 2 equivalents of dithionite (──), 
which was then completely reacted with O2 (─ ─) before 5 mM ascorbate was added (----
). A solution containing ~0.36 mM Fe(NH4)2(SO4)2 and 5 mM ascorbate was exposed to 
the air ~ 1 minute (─••─). Right panel: ~ as-isolated hDOHH solution containing ~ 0.2 
mM hDOHHperoxo (──) was mixed with 5 mM ascorbate (----). An FeCl3 solution was 
mixed with 5 mM ascorbate 1 minute (─••─). 
 .  
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The above results indicate that the reaction of reduced hDOHH with O2 always 
leads to ~ 20 % side product in addition to the main product hDOHHperoxo. The side 
product is presumably monomeric high spin iron(III) as observed by EPR and Mössbauer 
spectroscopies at similar yields in multiple samples. This side product appears to be 
scavenged by ascorbate to form hDOHHperoxo. Further experiments are required to 
confirm this interpretation as well as to understand why A320 decreases upon the addition 
of ascorbate to re-oxidized hDOHH sample. 
 
   
Figure 4.3. Formation kinetics of hDOHHperoxo from the reaction of reduced hDOHH 
with O2-saturated buffer solution (1:1 mixing) at 4 oC, pH 7.5. Data is displayed with red 
diamonds, fit with blue line, and residual with black line. Fits to the data with two and 
three exponential growth step are shown on the left and right, respectively. 
 
 
As the formation of hDOHHperoxo from the reaction of reduced hDOHH with O2 
occurs within minutes, UV/Vis-detected stopped-flow techniques were utilized to study 
this reaction. Preliminary stopped-flow result is shown in Fig. 4.3.  The absorption at 620 
nm increases faster within the first 20 seconds and more slowly after 20 seconds and does 
not reach the maximum even after 10 minutes. The kinetic curves can be fitted with a 
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triple exponential growth function, with rate constant of ~ 0.226 s-1, 0.0217 s-1, and 
0.0147 s-1. The use of a double exponential growth function fails to simulate the data. The 
formation of hDOHHperoxo is about 100 – 1000 times slower than that found for 
MMOHperoxo and other peroxo intermediates.2 Furthermore, the yield of hDOHHperoxo 
in stopped-flow experiment is only ~ 50% of the expected value. This result, consistent 
with the above observation that only 80% of hDOHHperoxo was regained in re-oxidation 
experiments, suggests that hDOHH does not tightly bind Fe(II) and a fraction of Fe(II) 
was lost during sample work up for the stopped-flow experiments. 
 
4.3.2. pH-Dependent reaction of hDOHHperoxo 
 
 
 
 
Figure 4.4. pH dependent self-decay of hDOHHperoxo at 37 oC. pH was measured at 37 
oC. kobs is displayed with open diamonds (?) and t1/2 with filled red circles (?).  
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Figure 4.5. Self-decay and reaction of hDOHHperoxo with 1 equivalent of eIF5A(Dhp) 
at 22 oC and pH’s 6.0 and 7.5. 
 
Fig. 4.4 shows the pH dependence of self decay of hDOHHperoxo at 37 oC 
monitored by its characteristic absorption at 630 nm. In the pH range of 5.8 – 8.2, the 
self-decay rate of hDOHHperoxo decreases as the pH increases. In contrast, when pH > 
8.2, increasing the pH lowers the self-decay rate of hDOHHperoxo.  This result suggests 
that there are probably two different decay mechanisms for hDOHHperoxo. In addition, 
hDOHHperoxo is most stable at pH ~ 8.2.  
A preliminary study in D2O solution at pD 6.7 (pH 6.3) provides a kinetic solvent 
isotope effect (KSIE) of ~ 1.6. The inverse effect of pH on the decay rate of 
hDOHHperoxo and KSIE indicate that hDOHHperoxo self-decay is proton dependent at 
pH < 8.2. Because the amount of eIF5A(Dhp) substrate was limited, reaction of 
hDOHHperoxo with 1 equivalent of substrate was carried out at pH’s 7.5 and 6.0 (Fig. 
4.5) instead of in the whole possible pH range. The addition of eIF5A(Dph) significantly 
enhances the decay rate of hDOHHperoxo at both pH’s 6.0 and 7.5. eIF5A(Hpu) product 
 104
was previously observed to form to ~ 100% yield at a rate similar to the decay rate of 
hDOHHperoxo at pH 7.5.16 These results clearly demonstrate that the enhancement of 
decay rate by the substrate is associated with substrate oxidation, which is very likely to 
involve O-O bond cleavage to generate a substrate-hydroxylating species. The effect of 
substrate on the decay rate of hDOHHperoxo at pH 6.0 is also expected to happen in the 
same manner as that at pH 7.5. Although more studies are needed, it is clear that the 
activation of hDOHHperoxo requires a proton transfer step as observed previously for 
MMOHperoxo.88, 89  
Mössbauer analysis has been carried out (by Dr. Mrinmoy Chakrabarti in the 
laboratory of Professor Eckard Münck at Carnegie Mellon University) for the decayed 
hDOHH obtained from the reaction of hDOHHperoxo with ~ 1 equivalent of eIF5A(Dhp) 
(Fig. 4.6)). The spectrum in Fig. 4.3 is simulated with 55% of a diamagnetic species (δ = 
0.48 mm/s and ΔEQ = 0.70 mm/s) and ~ 20 % of unreacted hDOHHperoxo. The rest of a 
sample is ~ 15% monomeric high-spin iron(III) as typically found in all hDOHH 
preparations. The Mössbauer parameters of the main species in the decayed 
hDOHHperoxo samples are consistent with high spin iron(III) centers that are 
antiferromagnetically coupled to give a diamagnetic ground state. Preliminary variable 
field variable temperature analysis reveals an exchange coupling constant J ~ 15 cm-1 for 
this species. Mössbauer results indicate that hDOHHperoxo reacts with substrate to yield 
a (μ-hydroxo)diiron(III) species as observed for MMO. This species is designated as 
hDOHHmet.  
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Figure 4.6. Mössbauer spectrum of hDOHHperoxo reacted with ~ 1 equivalent of 
eIF5A(Dhp). 
 
 
Mössbauer analysis also shows that the self-decay of hDOHHperoxo at pH 6.5 
resulted in a sample containing ~ 50 % of a species similar to hDOHHmet and ~ 50% 
monomeric high-spin iron(III). In contrast, decayed hDOHH sample at pH 9.5 contains ~ 
100 % monomeric high-spin iron(III). Consistent with the pH-dependent study, this result 
leads us to propose that there are two different decay pathways for hDOHHperoxo. One 
of the pathways involves O-O bond cleavage and results in the formation of a (μ-
hydroxo)diiron(III) species. This pathway is preferred in the presence of substrate and/or 
at pH lower than 8.2. The other pathway occurs at pH higher than 8.2 and leads to 
uncoupled high spin iron(III) centers, which probably involves peroxo substitution rather 
than O-O bond cleavage.  
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4.3.3. Analytical size-exclusion chromatography 
 It has been shown previously by native gel electrophoresis136 and small angle X-
ray scattering (SAXS)174 that that apo hDOHH is significantly larger and more flexible 
than holo hDOHHperoxo. The formation of monomeric iron(III) species in the self-decay 
of hDOHHperoxo, as well as the unusually slow rate of hDOHHperoxo formation  led us 
to postulate that similar structural change may also occur upon reduction or decay of 
hDOHHperoxo. We thus utilized size-exclusion chromatography (SEC) to study the 
reaction of hDOHHperoxo (Fig. 4.7). The holo hDOHHperoxo chromatogram exhibits a 
sharp peak at tR = 5.11 minutes (FWHM = 0.17 minutes), while the apo hDOHH 
chromatogram show a broader peak at tR = 4.92 minutes (FWHM = 0.36 minutes), 
consistent with previous native gel electrophoresis and SAXS studies.136, 174  
 
 
 
 
Figure 4.7. Size-exclusion chromatographic analysis of hDOHH in various forms. All 
traces are aligned to the peak of the internal standard phthalic acid at tR = 6.56 minutes 
(see Fig. 4.8). 
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Figure 4.8. Size-exclusion chromatographic analysis of the self-decay of hDOHHperoxo 
at pH 9.5 (left) and  pH 6.5 (right). The peak at tR = 6.56 minutes correspond to the 
phthalate standard. 
 
 
At pH 9.5, the sharp peak corresponding to holo hDOHHperoxo decays to a much 
broader peak that is similar to that of apo hDOHH at tR = 4.92 minutes (FWHM = 0.27 
minutes) (Figs. 4.7 and 4.8). This result shows that at pH > 8.2, there is a significant 
conformational change upon hDOHHperoxo decay that separates the iron centers apart to 
form 100 % monomeric high spin (III). At pH 6.5, decayed hDOHHperoxo also exhibits 
a broader peak but at tR = 5.05 minutes (FWHM = 0.28 minutes).  It is likely that at pH < 
8.2 a portion of hDOHH undergoes the same conformational changes to result in 
monomeric high spin iron(III) species, while the rest remains intact to form the putative 
(μ-hydroxo)diiron(III) species. 
The chromatogram of reduced hDOHH exhibits a very broad peak centered near 
tR = 4.98 minutes (FWHM = 0.51 minutes). This retention time and large peak width 
indicates that there are even more conformations adopted by reduced hDOHH than by 
apo hDOHH. One rationale for this observation is that upon reduction of hDOHHperoxo, 
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iron(II) partially dissociate from the protein. The portion of hDOHH that loses iron(II) 
become apo hDOHH, while the rest that binds iron adopts a conformation with smaller 
size. This model is consistent with the studies on the formation of hDOHHperoxo (vide 
supra). Iron dissociation from active site upon reduction may result in lower 
hDOHHperoxo yield upon reoxidation of reduced hDOHH (80%) expected). Sample 
work up resulted in an even greater loss of iron as only ~ 50% of hDOHHperoxo was 
regained. The reaction of O2 with reduced hDOHH solution may involve an equilibrium 
between apo and iron(II)-bound hDOHH, as well as a conformational change, which 
slows down the formation of hDOHHperoxo. 
 
4.3.4. Reaction of hDOHHperoxo with substrate analogues 
Fig. 4.8 shows the substrate analogues that have been successfully synthesized 
and their reaction with ~ 1 equivalent of hDOHHperoxo. The substrate analogues and 
their hDOHH-oxidized products were quantified using ion-exchange HPLC by Dr. 
Myung Hee Park (Table 4.1) and verified with HILIC LC/MS after hydrolysis with 6 N 
HCl. The acronyms for the substrates are provided in the footnote of Table 4.1. The 
relative yields of DOHH products in Table 4.1 are consistent with the kinetics traces in 
Fig. 4.8. eIF5A(d8-Dhp) and eIF5A(trans=Dhp) reacts with hDOHHperoxo at rates 
comparable to that found for the native eIF5A(Dhp) substrate. eIF5A(Lys) and other 
substrate analogues have negligible effects on the decay rate of hDOHHperoxo. 
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Figure 4.9.  Reaction of hDOHHperoxo with ~ 1 equivalent of eI5A(Lys), eIF5A(Dhp), 
and eIF5A(Dhp) analogues (shown on the right). Legends: self-decay (──), reaction with 
eIF5A(Lys) (──), eIF5A(HomoDhp) (----), eIF5A(8Me-Dhp) (──), eIF5A(cis=Dhp) 
(──), eIF5A(trans=Dhp) (?), eIF5A(d8-Dhp) (?), and eIF5A(Dhp) (?). 
 
 
 
Hypusine, Hpu, was detected at m/z = 234.2 (M+H) unit as predicted based on its 
molecular formula. This mass shifted to 236.2 when hDOHHperoxo was labeled with 
18O2, but remained the same when the DOHH reaction was carried out in H218O. 
Deuterated d7-Hpu was detected at m/z 241.2. Consistent with ion exchange HPLC and 
kinetic results, the DOHH product with 8Me-Dhp, HomoDhp, and cis=Dhp were not 
detected with HILIC LC/MS. The oxidation product of trans=Dhp analogues was 
observed at 250.2 m/z, which is consistent with the addition of two OH groups (diol) but 
not an oxide group (epoxide). However, this result does not necessarily reflect the nature 
of the DOHH-oxidized product of eIF5A(trans=Dhp). Because the sample hydrolysis was 
carried out in 6 N HCl solution at 110 oC, if an epoxide product was formed, it would 
have be hydrolyzed to form the corresponding diol product.  
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Table 4.1. Ion exchange HPLC and HILIC LC/MS analysis of DHS and DOHH products 
digested with 6 N HCl at 110 oC 
Spd analogues DHS products 
Relative 
yield 
M+H 
(m/z) 
DOHH 
products 
Relative 
yield 
M+H 
(m/z) 
Spd (3,4) Dhp ++++ 218.2 Hpu ++++ 234.2 
    18O2  
236.2 (85%) 
234.2 (15%) 
    H218O  234.2 (100%) 
d8-Spd (3,4) d8-Dhp  226.2 d7-Hpu  241.2 
Cis=Spd (3,4) cis=Dhp ++ 216.2 Cis=Dhp[O] +- 216.2$ 
Trans=Spd (3,4) trans=Dhp  +++ 216.2 trans=Dhp[O] +++ 250.2 
Caldene (3,3) norDhp ++ * norDhp[O] - * 
8Me-Spd 
(3,Me4) 8Me-Dhp  ++ 232.2 8Me-Dhp[O] +- 
232.2$ 
ApCad (3,5) homoDhp +++ 232.2 homoDhp[O] +- 232.2$ 
*Neither reacted with hDOHH nor analyzed with LC/MS. $Unreacted.  
Spd:  spermidine, NH2(CH2)3NH(CH2)4NH2.  d8-Spd: NH2(CH2)3NH(CD2)4NH2.  
Cis=spd and trans=Spd:  cis/trans-NH2(CH2)3NH-CH2CH=CHCH2NH2. Caldene: 
NH2(CH2)3NH(CH2)3NH2.  
8Me-Spd: NH2(CH2)3NH(CH2)3CH(CH3)NH2. ApCad(3,5): NH2(CH2)3NH(CH2)5NH2.  
Dhp: deoxyhypusine, HC(CO2H)(NH2)(CH2)4NH(CH2)4NH2.  
Cis/trans=Dhp:  cis/trans= HC(CO2H)(NH2)(CH2)4NH CH2CH=CHCH2NH2.  
NorDhp: HC(CO2H)(NH2)(CH2)4NH(CH2)3NH2. 8Me-Dhp: 
HC(CO2H)(NH2)(CH2)4NH(CH2)3CH(CH3)NH2.  
HomoDhp: HC(CO2H)(NH2)(CH2)4NH(CH2)5NH2.  
Hpu: hypusine, HC(CO2H)(NH2)(CH2)4NHCH2CH(OH)CH2)2NH2.  
d7-Hpu:  HC(CO2H)(NH2)(CH2)4NHCD2CD(OH)CD2)2NH2 
trans=Dhp[O]: HC(CO2H)(NH2)(CH2)4NH CH2-(C2H2O)-CH2NH2 or 
HC(CO2H)(NH2)(CH2)4NHCH2(CHOH)2 CH2NH2. Other DOHH-oxidized products were not detected. 
 
 
 
 
 
Figure 4.10. ESI-MS spectra of eIF5A(trans=Dhp) synthesized from the DHS reaction 
and its DOHH-oxidized product. 
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To examine the nature of DOHH-oxidized product of eIF5A(trans=Dhp), we 
analyzed the intact protein with reverse phase LC/MS. Fig. 4.9 shows the mass spectra of 
eIF5A(trans=Dhp) synthesized using the DHS reaction and its DOHH-oxidized product. 
Both spectra exhibit a peak at 16702 m/z that corresponds to unmodified eIF5A(Lys). 
The major peak in the spectrum of eIF5A(trans=Dhp) is at 69 mass units higher than that 
of eIF5A(Lys), confirming the formation this analogue (Fig. 4.8). After the reaction with 
hDOHHperoxo, this M+69 m/z peak disappeared, and a new peak appeared at M + 85 
m/z, which is consistent with the introduction of one oxygen atom to the 
eIF5A(trans=Dhp) substrate. This peak is attributed to an epoxide product, which is 
designated as eIF5A(DhpO). Because eIF5A(trans=Dhp) and eIF5A(DhpO) have the 
same charge, and their mass and overall structures are almost identical are, they are 
expected to fly similarly well in the MS detector. Because the peak intensity ratio of 
M+69:M is similar to that of M+85:M, the conversion of eIF5A(trans=Dhp) to its 
epoxide product is estimated to be quantitative. There are two additional significant peaks 
at M+105 m/z and M+130 m/z in the spectrum of the DOHH reaction sample. The 
M+105 m/z peak is close to the expected mass for a diol product (M+103 m/z) 
(resolution ~ 2 m/z). Because the DOHH reaction was carried out in slightly basic 
solution (pH 7.5) and the LC/MS method was run with ~ 0.1% HCOOH solution, a part 
of the epoxide product could potentially be hydrolyzed to form a the diol product. More 
studies are required to identify this M+105 m/z peak, as well as the M+130 m/z. 
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4.4. Discussion 
  
Scheme 4.2. Proposed working model for hDOHH. 
 
 
 
The results obtained from this study have allowed us to propose a mechanism of 
hDOHH for the first time, which is shown in Scheme 4.2. Unlike other diiron enzymes, 
the best characterized form of hDOHH is hDOHHperoxo, which serves as a focal point in 
Scheme 4.2.  The reaction of reduced hDOHH with O2 to form hDOHHperoxo occurs in 
multiple steps, which is overall about 100-1000 time slower than that in other diiron 
enzymes. This slow formation of hDOHHperoxo can be attributed to the low iron(II) 
affinity of apo hDOHH as well as a requirement for significant entropy-disfavored 
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conformational changes to assemble hDOHHperoxo. The low iron affinity results in ~ 
20% of side product in the reaction of reduced hDOHH with O2. This side product can be 
scavenged to the peroxo form by ascorbate, a physiologically relevant reductant.  
The reaction of hDOHHperoxo depends on pH. At pH > 8.2, hDOHH decays, 
presumably via peroxo displacement, to form monomeric iron(III) species. Proton 
transfer occurs at pH < 8.2 to assist O-O bond cleavage, generating substrate-oxidizing 
species. At pH < 8.2, hDOHHperoxo decays or reacts with its substrate to form a (μ-
hydroxo)diiron(III) species as observed for MMO and other diiron enzymes. A negligible 
substrate H/D kinetic isotope effect is observed, indicating that C-H bond cleavage is not 
the rate determining step. It has been shown previously that holo hDOHH binds 
eIF5A(Dhp) tightly so that their complex can be pulled out of the solution using an 
affinity resin.175 Thus, given the unusual stability of hDOHHperoxo, O-O bond cleavage 
is probably the rate determining step. 
Several substrate analogues with very slightly different sizes and shapes were 
reacted with hDOHHperoxo. eIF5A(HomoDhp) contains one more CH2 group on the side 
chain, while eIF5A(8Me-Dhp) is branched at the terminal position (Fig. 4.8). Both of 
these two analogues fail to enhance the decay rate of hDOHHperoxo. Surprising is the 
inability to promote hDOHHperoxo decay by eIF5A(cis=Dhp), which has the same 
length as that of the native substrate but with a double bond at the oxidation site (Fig. 
4.8), while its trans counterpart reacts at the same rate as the native substrate does. This 
result suggests that the active site of hDOHHperoxo, once assembled, is very well 
constructed in a way that only linear substrates with a specific length can fit in (Scheme 
4.2), which contributes to the strict stereospecificity of hDOHH.  
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 LC/MS on intact protein shows that hDOHHperoxo is involved in the epoxidation 
C=C double bond, which has also been observed for MMOHperoxo and model 
complexes. More importantly, as hDOHH stereospecifically hydroxylates eIF5A(Dhp)  
(Scheme 4.1 and Scheme 4.3), it is also expected to produce only one isomer of 
eIF5A(DhpO) (Scheme 4.3). The hydroxyl group on the Dhp moiety of eIF5A(Dhp) has 
been proposed to properly position tRNA and ribosome in their complex via a hydrogen 
bonding network, which is required for the formation of first peptide bond,134 as well as 
for translation elongation.135 Similar studies on the epoxide analogue of eIF5A(Dhp) 
could provide valuable information on the role of hypusination of eIF5A on translation. 
 
 
Scheme 4.3. Proposed mechanism that leads to the stereospecificity of hDOHH. 
 
 
 
 
 
Dedication note: I would like to dedicate this work to Dr. Jack E. Folk (NIH), who 
passed away in December 2010. I deeply thank him for generously providing us with the 
spermidine derivatives, which were crucial for this study.  
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Chapter 5                                                                            
Characterization of a novel peroxodiiron(III) intermediate of an amine 
N-oxygenase in the biosynthesis pathway of chloramphenicol 
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5.1. Introduction 
 The core geometry of the peroxo intermediate very likely governs its activation, 
i.e. O-O bond cleavage, as well as its reactivity. Most of the peroxo intermediates of 
diiron enzymes and model complexes exhibit cis-μ-1,2-peroxo geometry.16, 77, 78, 81, 83, 108, 
109 This geometry is proposed to be the most stable form of a peroxo-bridged diiron(III) 
cluster, and isomerization to a more activated geometry is necessary for O-O bond 
cleavage.87, 162 Studies of hDOHHperoxo and model complexes proposed that introducing 
a single atom bridging ligand would further stabilize the cis-μ-1,2-peroxo core.16  
While the terminal η2-peroxo binding mode has been observed for monoiron 
species,108, 176-179 the μ-η1:η2 and μ-η2:η2 geometries have not been observed for any (μ-
peroxo)diiron(III) intermediate. In contrast, the μ-η2:η2 geometry, which was once 
overlooked, is not uncommon in both dicopper enzymes and model complexes.180, 181 In 
iron-heme copper model complexes, several iron(III)-peroxo-copper(II) intermediates 
have been characterized spectroscopically, and even crystallographically.133 In these 
intermediates, the peroxo binds η2 to the iron(III) center and either η1 or η2 to the 
copper(II) center. This suggest that a (μ-η1:η2-peroxo)diiron(III) cluster or (μ-η2:η2-
peroxo)diiron(III) cluster may be feasible. 
In both diiron enzymes and model systems, the cis-μ-1,2-peroxo intermediates 
contain high-spin iron(III) centers and exhibit a broad UV/Vis absorption feature with 
λmax > 600 nm and ε > 1,000 M-1cm-1.16, 77, 78, 81, 83, 108, 109 This feature is attributed to the 
peroxo-to-iron(III) charge transfer transition as evidenced by extensive resonance Raman 
studies. Recently, two new peroxodiiron(III) species have been observed, which are 
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spectroscopically different from the usual (μ-1,2-peroxo)diiron(III) species.90, 103 The first 
species is the colorless ToMOperoxo with a Mössbauer isomer shift δ of 0.55 mm/s and a 
quadupole splitting ΔEQ = 0.67 mm/s ,90 which are smaller than the corresponding values 
(δ > 0.63 mm/s and ΔEQ > 1.00 mm/s) of the colored (μ-1,2-peroxo)diiron(III) 
intermediates of other diiron enzymes.16, 77, 78, 81, 83, 108, 109 The other species is 
AurFperoxo that also has small an isomer shifts and quadrupole splittings but exhibits a 
weak broad UV/Vis feature at 500 nm (ε = 500 M-1cm-1).98 The spectroscopic properties 
of ToMOperoxo and AurF peroxo suggest that these two species may differ structurally 
from the more common (μ-1,2-peroxo)diiron(III) intermediate. However, as vibrational 
data for the Fe2O2 cores in these two intermediates have not been obtained, the definitive 
proof for the nature and the geometry of these putative peroxo species is still missing.  
 
Scheme 5.1. The biosynthesis pathway of chloramphenicol 
 
 
 
Here, in collaboration with Dr. Thomas M. Makris and Professor John D. 
Lipscomb at the University of Minnesota, we report the resonance Raman study of a 
putative peroxo intermediate of CmlI, a homolog of AurF that is involved in the 
biosynthesis of chloramphenicol (Scheme 5.1).104 CmlIperoxo forms in the reaction of 
reduced CmlI with O2 and exhibits a similar UV/Vis feature as that of AurFperoxo. 
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Compared to AurFperoxo, CmlIperoxo is relatively stable at room temperature (t1/2 ~30 
mins) and decays to the diferric resting state with different UV/Vis features.104 The 
stability of the CmlIperoxo chromophore enabled us to obtain its resonance Raman 
spectrum in solution, which clearly shows a peroxo binding geometry significantly 
different from the cis-1,2-peroxo geometry commonly found for the peroxo intermediates 
of canonical diiron enzymes with 2-His-4-carboxylate ligand sets. The difference may 
arise from an additional His ligand in CmlI, deduced from EXAFS and sequence 
homology analyses,104 which may cause the shift in peroxo binding geometry of 
CmlIperoxo. 
 
5.2. Experimental 
5.2.1. X-ray absorption spectroscopy of oxidized CmlI at pH 7.0 
CmlI was originally cloned and purified by Dr. Thomas M. Makris in the 
laboratory of Prof. John D. Lipscomb at the University of Minnesota. 2 mM CmlI (4 mM 
in [Fe]) in 200 mM HEPES pH 7.0 solution containing 10% glycerol was frozen in 
tandem Mossbauer/XAS cups. XAS data (8 scans, one on each sample spot) were 
collected on beamline 9-3 at Stanford Synchrotron Radiation Lightsource (SSRL) of the 
SLAC National Accelerator Laboratory. Further details on data collection and analysis 
are provided in Supporting Information. 
5.2.2. Resonance Raman spectroscopy 
CmlIperoxo was prepared by Dr. Thomas M. Makris.104 In resonance Raman 
experiments, as isolated CmlI (2 mM (4 mM in [Fe]) in 50 mM Bicine at pH 9.0) was 
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reduced under anaerobic conditions with an excess amount of dithionite in the presence 
of 0.1 equivalent of methylviologen. Excess reductant and methylviologen were removed 
using a PD-10 desalting column (G-25, GE Healthcare) in an anaerobic chamber. (Note: 
It is important to remove methylviologen because it can be photoreduced by the 
excitation laser as previously reported,182 which inturn reduces CmlIperoxo). Aliquots of 
reduced CmlI from the same batch were exposed to either 16O2, 18O2, or a mixture 
containing 25 % 16O2, 50 % 16O18O, and 25 % 18O2 at ~ 4 oC for several minutes. The 
samples were then snap-frozen with liquid nitrogen and kept at 77 K for future 
experiments. 16O2 and 18O2 samples were repeated three times while the mixed lable 
sample was repeated twice. Multiple measurements were carried out for each sample. For 
each measurement, a ~ 70 μL aliquot of  samples was thawed and transferred to flat-
bottomed NMR quartz tubes and maintained at a temperature range of -10oC to 10oC. The 
isotopically labeled samples were transferred into septum-sealed tubes that were 
evacuated and equilibrated with argon. 
Resonance Raman experiments were performed on an Acton AM-506 
spectrophotometer (1,200-groove grating) with a Princeton Instruments LN_CCD-1100-
PB_UVAR detector cooled to -120oC with liquid nitrogen. The 488 nm excitation line at 
100 – 600 mW power was provided by a Spectra-Physics BeamLok 2060-KR-RS Argon 
ion laser, which is filtered out by a Kaiser Optical holographic super notch filter. Spectra 
were collected in 90o scattering geometry at resolution of 4 cm-1, and referenced to 
indene. Spectra were continuously collected with each spectrum obtained from 80 or 40 
accumulations of 15-second exposures (20 or 10 minutes/spectrum). Spectra within 
desired time range were added to improve the signal-to-noise ratio. Multiple 
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measurements were performed for each CmlIperoxo sample. GRAMS/AI (Thermo 
Galactic, Salem, NH) was utilized data processing. 
5.3. Results and Discussion 
 
 
Figure 5.1. Fourier filtered k3-weighted EXAFS spectrum of CmlI at pH 7.0 and its 
Fourier transform. k range = 2 – 12 Å-1, back transform range = 0.85 – 4.00 Å, resolution 
= 0.16 Å. Best fit parameters :1 Fe-O at 1.89 Å, 4 Fe-N/O at 2.06 Å, 2 Fe---C at 3.01 Å, 
0.5 Fe at 3.34 Å, 0.5 Fe at 3.59 Å, and 3.5 Fe---His multiple scattering paths at ~ 4.3 Å. 
See Table S.5.2 for more details.  
 
 
The pre-edge feature of an oxidized CmlI at pH 7.0 is a doublet with a peak ratio 
of 1:1.2 and a total intensity of 8.6(4) units (Table S.5.1 and Fig. S.5.1). The observed 
intensity and peak ratio are consistent with a high-spin iron(III) center with slightly 
distorted octahedral geometry.174 Details on EXAFS fitting procedures are provided in 
Supporting Information.  The Fourier-filtered data and best fit results are shown in Table 
5.3. The outer shell features at ~ 3.0 and 3.5 Å are simulated with 0.5 Fe---Fe path at 3.34 
Å and 0.5 Fe---Fe path at 3.59 Å. The XANES and EXAFS analysis results are consistent 
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with UV/Vis and Mössbauer analysis that suggests that CmlI exists in a mixture of (μ-
oxo)diiron(III) and (μ-hydroxo)diiron(III) forms,104 which was previously found for 
Δ9D.158 Furthermore, multiple scattering analysis reveals that the diiron cluster of CmlI 
contains about 3 His ligands, consistent with sequence analysis and models to the 
crystallographically solved AurF homolog.104 
Fig. 5.2 shows the resonance Raman spectra of CmlIperoxo prepared with 
different dioxygen isotopes and the spectrum of decayed CmlIperoxo. The 16O2 spectrum 
exhibits a peak at 791 cm-1 that slowly decays over time in ~ 6 – 7 hours at ~ 0 oC. The 
spectra of samples incubated overnight at 4 oC are similar to that of the decay trace in 
Fig. 5.2. In the 18O2 spectrum, the 791 cm-1 peak has a much weaker intensity and a new 
peak appears at 747 cm-1. The 791 cm-1 and 748 cm-1 peaks in the 18O2 sample also decay 
over time and give rise to the spectrum of the decay trace in Fig. 5.2. The 43 cm-1 
downshift of the 791 cm-1 peak is consistent with the value calculated by Hooke’s law for 
an O-O oscillator, indicating that this peak arises from a peroxo moiety. Notably, this is 
the lowest ν(O-O) frequency observed to date for a peroxodiiron(III) intermediate. In the 
spectra of samples prepared with this gas mixture (Figs. 5.2 and A.5.5), a new peak 
appears at 768 cm-1, halfway between the ν(16O-16O) and ν(18O-18O) peaks, which is 
assigned to the 16O18O isotopomer. This ν(16O-18O) peak (FWHM = ~ 14 cm-1) is 
somewhat broader than the ν(16O-16O) and ν(18O-18O) peaks (FWHM ~ 10 – 11 cm-1) 
(Table 5.1), suggesting that the two oxygen atoms of the O-O moiety are bound 
unsymmetrically and are thus inequivalent. There is no other oxygen isotope-sensitive 
peak observed in the spectral window of 230 – 1360 cm-1 (see Supporting Information). 
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Figure 5.2. Resonance Raman spectra of CmlIperoxo samples prepared with 16O2, 18O2, 
1:2:1 mixture of 16O2, 16O18O, and 18O2, respectively, as well as a peroxo decay sample. 
Spectra were obtained with ~ 200 – 300 mW laser power and subjected to two-point 
baseline subtraction. No smoothing or zapping was required. Spectra were aligned and 
normalized based on the sharp peak at 1005 cm-1 that arises from phenylalanine residues 
of the protein. Peak fitting results are provided in Table 5.1. 
 
 
Table 5.1. Gaussian peak fitting results for CmlIperoxo 
Sample Peak 1 (cm-1)  
(FWHM (cm-1))  
Peak 2 (cm-1)  
(FWHM (cm-1)) 
Peak 3 (cm-1)  
(FWHM (cm-1)) 
Peak ratio 
16O2 791 (9.8)   1:0:0 
Mixed label 1* 791 (10.5) 769 (13.6) 747 (10.6) 1.6.:1.5:1 
Mixed label 2* 791 (10.1) 768 (14.6) 747 (10.4) 1:1:1.1 
18O2 791 (8.7)  748 (11.6) 1:0: 2 
Decay - - - - 
* 1:2:1 mixture of 16O2, 16O-18O, and 18O2. FWHM = Full width at half maximum. Spectra were aligned and 
normalized to the phenylalanine signal at 1005 cm-1, which are shown in Fig. 5.2 and Fig S.5.5 (mixed 
label 2). The parameters of the background peak at 758 cm-1 were kept the same for all samples (FWHM = 
12.5 cm-1, intensity ratio of 1005 cm-1 peak: 758 cm-1 peak ~ 1.05 – 1.10). 
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Figure 5.3.  ν(O-O) values reported for various mononuclear iron, binuclear copper or 
iron, and heterobinuclear copper(II)/iron(III) peroxo complexes.16, 77, 78, 81, 83, 108, 109 133, 177, 
179, 181, 184, 185  
 
 
Information about the binding geometry of the O-O ligand of CmlIperoxo can be 
deduced by comparing its vibrational properties and other spectroscopic parameters to 
those of well characterized systems. Fig. 5.3 shows the ν(O-O) frequencies reported for 
various binding geometries in iron(III) and copper(II) peroxo clusters. As CmlIperoxo 
contains high spin iron(III) centers,104 complexes with low spin iron(III) centers are not 
considered here. The μ-1,1-OOH geometry can be ruled out for CmlIperoxo because: 1) 
the ν(O-O), as found for one dicopper complex at 892 cm-1, is much higher than the 791 
cm-1 ν(O-O) of CmlIperoxo; and 2) this geometry is computationally predicted to be very 
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reactive.87, 162 The terminal η1-O-O-, a possible example of which is tentatively proposed 
for a dicopper complex in aprotic solvent,183 is also not feasible for CmlIperoxo in 
aqueous solution. 
The η1 or μ-η1:η1 geometries have the highest ν(O-O) values (830 – 910 cm-1) for 
peroxo iron complexes. This frequency decreases to 807 – 827 cm-1 in (η2-
peroxo)iron(III) complexes. When the η2 peroxo ligand binds to another metal center, its 
ν(O-O) further decreases to 788 – 813 cm-1 and 713 – 767 cm-1 in μ-η1:η2 and μ-η2: η2 
geometries, respectively. The fact that the 791 cm-1 ν(O-O) observed for CmlIperoxo is 
remarkably smaller than those found for η1 or μ-η1:η1 indicates clearly that CmlIperoxo 
does not possess either of these two geometries for peroxo iron(III) species.   
Instead, the ν(O-O) of CmlIperoxo falls in the range found for the μ-η1:η2 
binding mode. Because the frequency ranges of terminal η2 and μ-η1:η2 peroxo 
complexes overlap and neither μ-η1:η2 nor μ-η2:η2 peroxo diiron(III) species have been 
characterized (Fig. 5.3), we are not able to unequivocally rule out the terminal η2 and μ-
η2:η2 modes on the basis of ν(O-O) comparisons. While the ν(Fe-O2) mode has been 
observed by resonance Raman spectroscopy for all (η2-peroxo)iron(III) complexes 
studied thus far, with intensity equivalent to or much higher than that of the 
corresponding ν(O-O),108, 177, 179 ν(Fe-O2) and ν(Cu-O2) features are usually not observed 
for μ-η1:η2 and μ-η2:η2 peroxo dicopper and copper/iron complexes.133, 180, 181, 186 It is 
likely that in these binding modes the excitation into the LMCT band only enhances the 
O-O bond vibration by removing the electron density from the π* orbital of the peroxo 
moiety, while the M-O2 bonds are not sizably affected.186 This results in the observation 
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of the ν(O-O) but not the ν(M-O2) by resonance Raman spectroscopy. The η2-peroxo 
assignment is less preferred for CmlIperoxo because of the absence of a peak 
corresponding to ν(Fe-O2) in the resonance Raman spectrum of CmlIperoxo and the fact 
that the ν(O-O) of CmlIperoxo is more than 20 cm-1 lower than the range found for 
nonheme (η2-peroxo)iron(III) species (Fig. 5.3).  
 
 
                      
 
 
Figure 5.4. Proposed structure of CmlIperoxo (right) built based on the crystal structure 
of oxidized AurF–4-nitrobenzoate complex (3CHT) (left). Fe, O, C, N, and H atoms are 
shown in orange, red, dark grey, blue, and light grey, respectively. The green lines and 
numbers indicate the distances (in Å). Based on these distances, as well as to balance the 
charges on each iron center, the peroxo moiety is expected to bind η2 to the Fe center on 
the left. In this proposed structure, the peroxo moiety is cis to both His ligands, a feature 
previously found in the crystal structure of the ternary enzyme–substrate–O2 complex of 
naphthalene dioxygenase.196 
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As the ν(O-O) frequency of CmlIperoxo is over 20 cm-1 higher than the range 
currently available for the μ-η2:η2 mode (Fig. 5.3), we favor a μ-η1:η2 structure for 
CmlIperoxo as shown in Fig. 5.4.  This structure was modeled based on the crystal 
structure of AurF-product complex (3CHT). While cis-μ-1,2-peroxo geometry is the sole 
binding mode observed for the canonical diiron enzymes with 2-His-4-carboxylate ligand 
set, it is possible that the extra His ligand, which is deduced by EXAFS and sequence 
analysis for CmlI, could contribute to the shift in peroxo binding geometry of 
CmlIperoxo. The terminal η2 mode has been observed crystallographically for the ternary 
enzyme–substrate–O2 complex of naphthalene dioxygenase176 that contains the 2-His-1-
carboxylate facial triad motif. In this structure, the η2-peroxo moiety is cis to both His 
ligands. This proposed structure is further supported by observation that the two oxygen 
atoms of the O-O moiety of CmlIperoxo are inequivalent as suggested by the moderate 
broadening of the ν(16O-18O) peak (Table 5.1, and Figs. 5.2 and S.5.5). 
Such ν(16O-18O) peak broadening or splitting has not been observed for any µ-
η1:η2-peroxo model complexes. There are two heme(FeIII)–peroxo–CuII model complexes 
with ν(O-O) = 808 cm-1 and 803 cm-1 (both with a FWHM ~ 10 cm-1) that were initially 
thought to contain a µ-η2:η2-peroxo moiety because of the lack of the splitting or 
broadening of the ν(16O-18O) peak.187, 188 However, later crystallographic characterization 
of a closely related system with ν(O-O) = 790 cm-1 clearly revealed a µ-η1:η2-peroxo 
geometry.189 In this structure the distance from the copper(II) center to the non-bridging 
oxygen atom of the peroxo moiety is  2.65 Å, which is similar to that in the structure we 
proposed for CmlIperoxo (Fig. 5.4). It is possible that in the µ-η1:η2 mode, the difference 
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between the two oxygen atoms of the O-O moiety may be difficult to probe by resonance 
Raman spectroscopy. Therefore the moderate ν(16O-18O) peak broadening observed for 
CmlIperoxo is indeed relatively significant for a µ-η1:η2-peroxo species. 
 
 
Scheme 5.2. Two possible mechanisms involving the putative (μ-η1:η2-peroxo)diiron(III) 
intermediate of CmlI. 
 
 
 
 
If CmlIperoxo exhibits either μ-η1:η2 or μ-η2:η2 peroxo geometry, then oxygen 
activation by CmlI can be related to that of dicopper systems, in which (μ-η2:η2-
peroxo)dicopper(II) species can reversibly convert to substrate-oxidizing bis(μ-
oxo)dicopper(III) species.190 Substrate binding could facilitate the O-O bond cleavage in 
CmlIperoxo to form a putative (μ-oxo)diiron(IV) or bis(μ-oxo)diiron(IV) species 
(Scheme 5.2, left pathway) capable of cleaving N-H bonds (BDE ~ 95 kcal/mol). 
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Alternatively, a nucleophilic attack mechanism (Scheme 5.2, right pathway), which was 
previously proposed for AurF,103 is also possible given the electron-rich nature of the 
aromatic amine substrates. 
 We note that there is a significant residual 16O2 signal in the resonance Raman 
spectra of all samples CmlIperoxo prepared with 18O2. Moreover, the spectra of mixed 
labeled samples do not exhibit the expected 1:2:1 ν(16O-16O): ν(16O-18O):ν(18O-18O) peak 
intensity ratio (Figs 5.2 and A.5.5, and Table 5.1). Using the same sample preparation 
technique and labeled oxygen sources for hDOHHperoxo, we did not observe sizable 
16O2 signals in the spectra of 18O2-hDOHHperoxo, while the ν(16O-16O): ν(16O-
18O):ν(18O-18O) peak intensity ratio in the spectrum of mixed labeled hDOHHperoxo was 
close to 1:2:1 (Chapter 2). Thus, the adventitious introduction of atmospheric oxygen 
during sample preparation step can be ruled out. Scheme 5.3 describes two possible 
mechanisms leading to the exchange of the peroxo moiety of CmlIperoxo. The top 
pathway involves the reversible binding of oxygen to reduced CmlI, in which the peroxo 
moiety is replaced by contaminant atmospheric oxygen introduced during the resonance 
Raman experiment. An alternative pathway (bottom) involves reversible O-O bond 
cleavage and the exchange of oxygen atoms of the peroxo moiety by solvent. 
 Further experiments are required to understand the spectroscopic properties, 
reactivity, and mechanism of CmlIperoxo reaction. Activity assay and resonance Raman 
studies in H218O water, as well as a Hammett analysis will help to discriminate the 
proposed mechanisms in Schemes 5.2 and 5.3. This work also poses a difficult but 
attractive challenge for biomimetic chemists to obtain relevant nonheme diiron model 
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complexes that may provide a better understanding of the structure and reactivity of 
CmlIperoxo.  
 
 
Scheme 5.3. Two possible peroxo-exchange mechanisms for CmlIperoxo 
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5.5. Supporting Information 
X-ray absorption spectroscopy. The synchrotron ring SPEAR was operated at 3.0eV 
and 50-100 mA beam current. Energy resolution of the focused incoming X-rays was 
achieved using a Si(220) double crystal monochromator.  All spectra were referenced 
against an iron foil, the first inflection point in the spectrum of which was set at 7112 eV. 
 
Figure S.5.1. FEFF model and important scattering paths that were considered in the 
fitting procedure. The single scattering path from A2 is associated with double and triple 
scattering paths involving A1. Two double scattering paths are indistinguishable. A1 = N 
at ~ 2.0 – 2.2 Å , A2 = C or N at ~ 4.1 – 4.4 Å for imidazole moiety. 
 
Standard procedures were used to reduce, average and process the raw data using 
the EXAFSPAK package,149 which was also used for pre-edge quantification following a 
standard method165 and EXAFS fitting. The XAS data was normalized using the 
MBACK method166 prior to pre-edge quantification. Theoretical EXAFS amplitude and 
phase functions were calculated using the FEFF package (version 8.4). The FEFF input 
model is shown in Fig. S.5.1. The parameters r and σ2 were floated, while N was kept 
fixed for each fit and systematically varied in integer steps between fits. Scale factor was 
fixed at 0.9 and threshold energy (E0) was varied but maintained at a common value for 
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all paths. All fits with E0 outside of the  ± 10 eV range are not considered. The goodness of 
fit is calculated as 26 )( calexp χχkF −= ∑ . To judge the effect of the addition of a shell to the fit, 
a normalized goodness of fit, F', is used. F' = F2/n.ν, where ν = nidp – nvar, n is the number of data 
point, nidp is the number of independent points, and nvar is the number of variables used in each 
optimization step. 
  
 
 
 
Figure S.5.2. Pre-edge feature of CmlI at pH 7.0. Peak parameters are provided in Table 
S.5.1. 
 
 
Table S.5.1. Pre-edge parameters for CmlI at pH 7.0 
 
Peak 1 (eV) Int. 1 Peak 2 (eV) Int. 2 Total Int. Int. ratio FWHM 
7113.7(0) 3.9(1) 7115.2(0) 4.6(2) 8.6(4) 1:1.2 1.69(4) 
 Int. = intensity. FWHM = Full width at half maximum. 
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Figure S.5.3. Fourier filtered k5-weighted EXAFS spectrum of CmlI at pH 7.0 and its 
Fourier transform. See Table S.5.2 footnote for other data parameters. Best fit parameter 
are provided in Table S.5.2 (Fit 14). 
 
 
 
Fig. 5.1 shows Fourier filtered k3-weighted EXAFS spectrum of CmlI at pH 7.0 
and its Fourier transform. The inner shell feature at r’ ~ 1.7 Å can be fitted with one shell 
of Fe-O/N paths, but could be split into two subshells with more reasonable σ2 values (Fit 
3, Table S.5.2). The outer shell features between 2 – 4 Å may arise from C/N/O scatterers 
on the ligands or a near by iron scatterer.  As the photoelectrons at higher energy interact 
better with heavy atoms than with light atoms, the amplitude of the Fe---Fe path in 
comparison with Fe-C/N/O paths would be much more enhanced in k5-weighted data than 
in k3-weighted data. In the k5-weighted data of CmlI (Fig. S.5.3), the outer shell feature at 
r’ ~ 3.0 – 3.5 Å are remarkably enhanced compared to other features, indicating that this 
feature arises from a heavy scatterer, which is most likely to be an iron atom. Indeed, the 
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r’ ~ 3.0 – 3.5 Å feature cannot be simulated with only Fe---C/N/O paths (Fits 4 – 8). 
However, adding an Fe---Fe path does not improve the fit either (Fits 9 and 10). This r’ ~ 
3.0 – 3.5 Å feature could only be well modeled with two Fe---Fe paths at ~ 3.3 and 3.6 Å, 
both with a coordination number of 0.5 (Fit 11). This result clearly shows that at pH 7.0 
CmlI exists in two populations, which is consistent with the pre-edge analysis, as well as 
with UV/Vis and Mössbauer data.104 The 3.3 Å Fe---Fe distance likely arises from the (μ-
oxo)diiron(III) form and the 3.6 Å Fe---Fe distance from the (μ-hydroxo)diiron(III) form 
as observed for Δ9-desaturase;78 however, further evidence is required.  
The outermost feature at r’ ~ 4.0 Å (Figs. S.5.3 and 5.4) can be well simulated 
with single scattering paths and important multiple scattering paths involving the 
coordinating N atom and the outer C/N atoms of an imidazole moiety (Fig. S.5.1). When 
the coordination numbers of these paths are varied, the optimized values required 3 – 4 
set of these paths per iron center (Fits 12 and 13). As each imidazole moiety contains two 
set of such scattering paths, the best fits require about 1.5 – 2 imidazole per iron center. 
This result indicates that the diiron active site of CmlI may contain at least 3 His ligand, 
consistent with its sequence analysis.104 
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Table S.5.2. EXAFS fitting results for CmlI at pH 7.0 
 
Fe-O/N Fe-N.O Fe---C Fe---Fe/C   Fit 
# N R σ2 N R σ2 N R σ2 N R σ2 F F’ 
1 6 2.05 16.0          70 0.0400
2 5 2.05 13.1          61 0.0352
3 1 1.90 5.6          57 0.0367
 4 2.07 7.9            
4 1 1.89 8.5 2 3.01 3.1       48 0.0360
 4 2.06 8.5            
5 1 1.89 7.8 2 3.01 -0.3 4C 3.66 1.8    38 0.0334
 4 2.06 8.5            
6 1 1.89 7.9 2 3.03 1.0 4C 3.33 3.7    45 0.0397
 4 2.06 8.3            
7 1 1.89 7.8 2 3.04 0.4 1 3.29 6.4    32 0.0279
 4 2.06 8.3            
8 1 1.89 7.1 2 3.01 0.2 1 3.63 4.3    29 0.0254
 4 2.06 8.2            
9 1 1.88 6.5 2 3.02 2.8 1Fe 3.33 6.4    26 0.0277
 4 2.06 8.0    4C 3.62 2.8      
10 1 1.89 6.3 2 3.01 1.6 4C 3.38 6.7    32 0.0339
 4 2.06 7.9    1Fe 3.61 4.1      
11 1 1.89 5.8 2 3.00 4.4 #0.5 3.34 2.5    19 0.0225
 4 2.06 7.7    #0.5 3.59 1.5      
12 1 1.89 5.7 2 3.01 4.4 #0.5 3.34 2.6 *3.5 4.31 2.0 11 0.0204
 4 2.06 7.7    #0.5 3.59 2.0 |7.0 |4.35 |4.0   
          |3.5 |4.39 |2.0   
13$ 1 1.89 5.9 2 3.00 2.6 #0.5 3.35 5.1 *3.3 4.30 2.04   
 4 2.06 8.0    #0.5 3.61 0.3 |6.6 |4.34 |4.08   
          |3.3 |4.38 |2.04   
k range = 2 – 12 Å-1. Back transform range = 0.85 – 4.00 Å. Resolution = 0.16 Å. n = 100; nidp = 20.4.  N = 
coordination number. R = distance. σ2 = respective Debye-Waller factor in unit of 10-3 Å2. $ Fit to k5-
weighted EXAFS data.& Multiple scattering paths from an imidazole moiety (Fig. S.5.1). *N floated during 
the fit. | Parameters linked with the corresponding floated parametters. #Two N’s varied in the fit but their 
sum maintained at 1.0.  
 
 
 
 
 
 
 
 135
Resonance Raman spectroscopy 
 
 
 
Figure S.5.4. Resonance Raman spectra of CmlIperoxo. From top to bottom: 16O2, 1:2:1 
16O2, 16O18O (mixed label), 18O2; 18O2, and mixed label decay. Two-point baseline 
subtraction was applied. No smoothing or zapping was required. 
 
 
 
 
 
Figure S.5.5. Gaussian peak fitting result to the mixed label 2 sample (Table 5.1). 
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Chapter 6                                                                            
Active site structure of a β-hydroxylase in antibiotic biosynthesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reproduced with permission from [Vu, V. V.; Makris, T. M.; Lipscomb, J. D.; Que, L., 
Active-Site Structure of a β-Hydroxylase in Antibiotic Biosynthesis. J. Am. Chem. Soc. 
2011, 133, 6938-6941.] Copyright [2011] American Chemical Society. 
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6.1. Introduction 
Amino acid β-hydroxylation occurs during the biosynthesis of  many natural 
products in nonribosomal peptide synthetase (NRPS)-based pathways.141 The products 
include many pharmaceutically important antibiotic and chemotherapeutic drugs.138-140 
The newly introduced hydroxyl groups serve as sites for further modifications including 
glycosylation, oxidation, and macrocycle formation.141 These tailoring reactions are 
usually required for pharmacological activity. 
 
Scheme 6.1. The biosynthetic pathway of chloramphenicol 
 
 
 
 
While β-hydroxylation in NRPS biosynthetic pathways is typically catalyzed by 
cytochrome P450s191 and alpha-ketoglutarate-dependent nonheme iron-containing 
enzymes,192, 193 a large new family of tailoring enzymes that contain a nonheme oxo-
bridged diiron active site has been recently characterized.18  The first member of this 
family to be isolated was CmlA from the chloramphenicol biosynthetic pathway. CmlA 
catalyzes β-hydroxylation of p-amino phenylalanine linked by a thioester bond to the 
thiolation domain of the NRPS CmlP (Scheme 6.1).18 Other enzymes from this family 
catalyze β-hydroxylation in the biosynthesis of a wide range of antibiotic and cytostatic 
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agents, including bleomycin and the planin family of antibiotics. Unlike bacterial 
multicomponent monooxygenases (BMMs), which utilize a canonical four helix bundle 
(α4) protein fold to provide the carboxylate and imidazole ligands to the diiron center,2, 3, 
9 members of the CmlA family of monooxygenases employ a metallo β-lactamase (αββα) 
fold to bind the cluster. While a few other diiron enzymes have been shown to utilize a 
lactamase fold,10 CmlA is the first example shown to catalyze substrate hydroxylation.18 
As such, a detailed description of the CmlA active-site is warranted in order to 
understand how this unique enzyme class catalyzes hydroxylation at the dinuclear center. 
To date, no X-ray crystal structure of an enzyme from this family has been reported. In 
this communication, we utilize resonance Raman and X-ray absorption spectroscopies to 
structurally characterize the CmlA active site, including the bridging structure of the 
diiron center and elucidation of the ligand environment. 
 
6.2. Experimental 
6.2.1. Resonance Raman spectroscopy 
CmlA was prepared as described previously.18 To prepare the 18O-labeled CmlA, 
500 µL of 50 mM MOPS buffer at pH 7.75 was first dried using a SpeedVac system. To 
the dried solid, 500 µL H218O (98%) was added to obtain the H218O buffer solution. A 
similar buffer solution was prepared with H216O and a pH measurement confirmed that 
the pH remained at 7.75. Typically, 150 µL CmlA was mixed with 150 µL of H218O 
buffer and concentrated to less than 100 µL. To this concentrated sample, 200 µL H218O 
buffer was added to give a final solution containing >85 % H218O and ~ 0.4 mM protein. 
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Three samples were prepared and incubated at 4 °C for two days before their spectra 
were collected. Samples in H216O and D2O buffer were prepared in the same manner. 
Resonance Raman experiments were performed on an Acton AM-506 
spectrophotometer (1,200-groove grating) with a Princeton Instruments LN_CCD-1100-
PB_UVAR detector cooled to -120 °C with liquid nitrogen. The 413.1 nm excitation line 
was provided by a Spectra-Physics BeamLok 2060-KR-RS krypton ion laser, which was 
filtered out by a Kaiser Optical holographic super notch filter. Samples were contained in 
flat-bottomed NMR quartz tubes (A407 ~ 0.5, 4 mm path length) and maintained at a 
temperature range of -5 – 5 °C. Spectra were collected in a 90° scattering geometry at a 
resolution of 4 cm-1 and referenced to indene. 20 spectra of 20 15 s accumulations were 
collected for each sample at different sample positions at 50 – 100 mW of laser power. 
The spectra were then summed. Alternatively, one spectrum of ~250 15 s accumulations 
at 50 – 100 mW gave similar data quality. GRAMS/AI software (Thermo Galactic, 
Salem, NH) was utilized for baseline correction and smoothing. All spectra were 
subjected to polynomial baseline correction in the spectral region of interest (300 – 1200 
cm-1) and 2-point binomial smoothing. The sharp signal at 1005 cm-1 from the protein 
phenylalanine was used to align the spectra collected on different days. 
6.2.2. X-ray absorption spectroscopy  
XAS experiments were performed at beamline 7-3 of the Stanford Synchrotron 
Radiation Lightsource with the storage ring operating at 3 GeV and 80-100 mA. Fe-K 
edge XAS spectra were collected in fluorescence mode over an energy range of 6900 – 
7820 eV using a Si(220) monochromator and a solid state 30-element Ge detector 
(Canberra). Samples were oriented at 45° relative to the incident beam and maintained at 
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10 – 15 K using an Oxford Instruments CF1208 continuous-flow liquid helium cryostat. 
For internal energy calibration, an iron foil spectrum was collected concomitantly and its 
first inflection point was set to 7112.0 eV.      
The CmlA solution (4 mM [Fe]T, 20% glycerol, 50 mM HEPES, pH 7.5) was 
frozen in 6 XAS solution cells. Each cell has two or three sample spots of ~ 0.8 mm x 8 
mm. Two scans were collected on each spot to obtain a total of 14 first scans and 14 
second scans. To obtain data on a photoreduced sample, 13 scans were collected on one 
sample spot. A similar sample was then prepared in a tandem Mössbauer/XAS cup with a 
larger sample window that allowed irradiation 12 spots of ~ 8 mm × 0.8 mm. 12 first 
scans were collected.  The first scans on every spot superimposed well and were averaged 
and designated as the non-photoreduced data (CmlA). The second scans on several spots 
also overlaid well on each other and were averaged and designated CmlA2nd data. The 
edge shift was observed from scan to scan in the photoreduced data scans, so only the last 
scan was assigned as the CmlAphr data. A photoreduction yield of 11% was estimated 
when the first scans were collected to 13 Å-1 based on the comparision of the XANES 
spectra of CmlA, CmlA2nd, and CmlAphr (Fig. 6.1) using a previously reported method.16 
Data reduction and processing were performed using EXAFSPAK.149 XAS data 
were normalized using the Athena program152 or to tabulated mass absorption 
coefficients using the MBACK program.166 The Athena program was also used to 
perform XANES linear combination for determination of the photoreduction yield. Pre-
edge quantification was carried out using Edg_Fit of EXAFSPAK following a standard 
procedure.165 EXAFS analysis was carried out using the Opt program of EXAFSPAK. 
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Theoretical scattering paths were calculated using FEFF8.4150 using the model shown in 
Fig. 6.2.  
 
 
 
Figure 6.1. Comparison of the edges of normalized first scan, second scan, and 
photoreduced data.  
 
 
 
Figure 6.2. FEFF model and important scattering paths that were considered in the fitting 
procedure. The single scattering path from A2 is associated with double and triple 
scattering paths involving A1. Two double scattering paths are indistinguishable. A1 = C 
at ~ 2.5 Å , A2 = C at ~ 4.0 Å for bidentate carboxylate moiety. A1 = N at ~ 2.0 – 2.2 Å , 
A2 = C or N at ~ 4.1 – 4.4 Å for imidazole moiety. 
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6.3. Results 
6.3.1. Resonance Raman spectroscopy 
 
Figure 6.3.  Resonance Raman spectra of CmlA in H216O, > 85 % H218O, and > 85 % 
D2O buffer solutions. All spectra were subjected to polynomial baseline correction and 2 
points binomial smoothing. The sharp phenylalanine signal at 1005 cm-1 was used to 
align the data.  Asterisks indicate the laser plasma lines.   
 
Oxidized CmlA has a chromophore at ~340 nm, which typically originates from 
an oxo-to-iron(III) charge transfer band associated with the bridging oxygen of the diiron 
cluster.18 Resonance Raman (rR) spectroscopy provides a direct probe for the nature of 
this chromophore, including the precise bridging structure of the CmlA diiron center.  
Fig. 6.3 shows the rR spectrum of as isolated, diferric CmlA in H216O, H218O, and D2O.  
The spectrum of the sample in H216O has a peak at 481 cm-1 (top trace), which downshifts 
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to 464 cm-1 in H218O buffer (middle trace) but is unaffected in D2O buffer (bottom trace). 
The oxygen-isotopic sensitivity of this band clearly indicates that the 481 cm-1 peak 
arises from an oxygen-linked vibration. Indeed, the 481 cm-1 peak and its 17 cm-1 isotopic 
downshift values are consistent with a (µ-oxo)diiron cluster, as found in other diiron 
enzymes and model systems,194, 195 but not with a µ-hydroxo or bis(µ-oxo) cluster. 
Previous results have demonstrated a strong correlation between the observed  ν(Fe-O-
Fe) and ∠Fe-O-Fe values;194, 195 from this correlation, an Fe-μ-O-Fe angle of ~130° can 
be deduced for CmlA.  
6.3.2. XANES analysis 
The XAS spectrum of CmlA exhibits a relatively intense pre-edge feature which 
can be fit with a single peak (Fit 1, Table 6.1) or two peaks (Fit 2, Table 6.1) (Fig. 6.4). 
Fit with two peaks has better goodness of fit. The total pre-edge areas obtained in these 
fits are ~ 13 – 14 units, which is significantly larger than those found for octahedral 
diiron(III) cluster without a μ-oxo ligand. The pre-edge area of CmlA is much smaller 
than those found for (µ-oxo)diiron(III) clusters with 5- or 4-coordinate iron centers but 
falls in the range found for those with 6-coordinate iron centers.62, 157, 159, 165 Furthermore, 
the peak pattern and their ratio in Fit 2 is consistent with a high-spin d5 metal center in 
compressed octahedral ligand field.165 
  
Table 6.1. Pre-edge parameters for CmlA obtained with EDG_FIT 
 
Fit Position 
(eV) 
Area Position 
(eV) 
Area Width  
(eV) 
Total  
area 
Peak  
ratio 
GOF 
1   7114.9(0) 13.4(4) 2.70(2) 13.4(4)  3.54×10-6 
2 7113.5(1) 3.2(1) 7115.2(0) 10.5(5) 2.08(3) 13.7(6) 1: 3.2 1.90×10-6 
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Figure 6.4.  Pre-edge quantification for first scan data with one peak (left) and two peaks 
(right). Parameters are provided in Table 5.1. Legend: Data (o), fit (―), background (–·–
·), peaks (─ ─), and residual (·····). 
 
 
 
6.3.3. EXAFS analysis 
Fig. 6.5 shows unfiltered EXAFS data for CmlA and its Fourier transform. The 
observed signal-to-noise ratio allowed a useable k range up to 13.0 Å-1, and a negligible 
photoreduction yield of ~ 11 % was estimated using a method described elsewhere.16  
The Fourier transform (FT) consists of a prominent first-shell feature in the range of r’ = 
1 – 2.5 Å, a second shell around 3.0 Å, and a third shell from ~3.2 – 4.0 Å. This third 
shell is associated with the double-humped feature at 4 Å-1 in the EXAFS data. Removal 
of the third shell by Fourier back transformation only to r’ = 3.2 Å results in the loss of 
the double-humped feature in the EXAFS data (Fig. 6.5, green EXAFS trace). EXAFS 
analysis of FT-back-transformed data was carried out for the first shell and then the 
second shell, consecutively. Because the third shell possibly arises from multiple 
scattering paths, and no clear FT peaks were observed beyond 4.5 Å, EXAFS analysis of 
the third shell was carried out with the unfiltered data. The FEFF model and important 
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scattering paths are shown in Fig. 6.2. The fitting procedure was similar to that reported 
elsewhere.16, 196 
 
 
 
Figure 6.5. Left: Unfiltered (black) and filtered (green) EXAFS data for CmlA. Right: 
Fourier transform of unfiltered data with k range = 2 – 13 Å-1. 
 
 
6.3.3.1. Single scattering analysis of the first and second shells 
Table 6.2 shows EXAFS fits for the first shell features.  The first shell feature 
cannot be simulated well with a single shell of O/N atoms (Fits 1-6). Splitting this shell 
into two subshells results in a significant improvement in fit quality, with fit 11 
representing the best two-shell fit consisting of one short 1.8 Å Fe-O path and five ~ 2.1 
Å Fe-O/N paths. The short Fe-O distance is indicative of a µ-oxo bridge as observed for 
many oxo-bridged diiron complexes and enzymes. Decreasing the coordination number 
to lower than 6 gives a poorer fit (Fit 12), indicating that the Fe centers are 6-coordinate.  
 
 146
    
Figure 6.6. Fits to the first shell filtered data. Fit parameters are provided in Table 6.2. 
 
 
Table 6.2. Results of EXAFS fitting to the first shell for CmlA 
 
Fit Fe-O Fe-O/N Fe-N/O Fe⋅⋅⋅C/N/O   
# N R σ2 N R σ2 N R σ2 N R σ2 F F’ 
1    6 2.09 9.85       182 0.1504
2    5 2.09 7.24     126 0.1041
3    4 2.09 5.04     81 0.0669
4     6 2.11 7.15    130 0.1074
5     5 2.11 5.38    89 0.0736
6     4 2.11 3.72    63 0.0521
7    5 2.05 30.4 1 2.10 -2.20    108 0.1093
8    4 1.96 52.2 2 2.10 0.15    72 0.0728
9 3 1.86 45.7  3 2.10 1.85    54 0.0547
10 2 1.81 20.1  4 2.10 3.08    47 0.0476
11 1 1.79 4.23  5 2.10 5.20    32 0.0324
12 1 1.80 6.56    4 2.10 3.48   38 0.0384
13 1 1.77 2.24 1 1.97 0.25 4 2.12 2.12    35 0.0457
14 1 1.78 1.71 2 1.99 3.07 3 2.13 1.26    30 0.0392
15 1 1.76 2.55 3 2.03 6.88 2 2.13 1.35    40 0.0522
16 1 1.77 1.15 4 2.03 6.73 1 2.15 -1.80    34 0.0443
17 1 1.80 4.33  5 2.10 5.15 1 2.53 1.73 21 0.0275
18 1 1.80 6.57  4 2.10 3.23 1 2.52 1.15 31 0.0405
k range = 2 – 13 Å-1, resolution ~ 0.14 Å, back transform range 0.5-2.5 Å. N = coordination number. R = 
distance. σ2 = respective Debye-Waller factor in unit of 10-3 Å2. Scale factor S02 = 0.9. GOF = goodness of 
fit calculated as 26 )( calexp χχkF −= ∑ . F' = F2/n.ν, where ν = nidp – nvar, n = 111 is the number of data 
point, nidp = 13.9 is the number of independent points, and nvar is the number of variables used in each 
optimization step. F' is used to indicate the improvement of fit upon the addition of a shell.  
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Any combination of 1 short Fe-O path and two shells of O/N atoms near 2.0 Å 
(Fits 13-16) gives a poorer fit compared to Fit 11. Addition of a low-Z atom at 2.5 Å 
significantly enhances the fit quality (Fit 17). However, this scatterer cannot arise from a 
loosely bound ligand with a long Fe-ligand distance, as a poorer fit is obtained compared 
to both fit 11 and fit 17 when the number of scatterers in the 2.10-Å shell is decreased by 
1 (Fit 18) (Fig. 6.6). We assign the 2.5-Å scatterer to the carbon atom of a symmetric 
bidentate carboxylate ligand, as observed by EXAFS for iron enzymes and complexes.106, 
196 
 
Table 6.3. Results of EXAFS fitting to first and second shells for CmlA 
 
Fit Fe-O Fe-O/N Fe-N/O Fe⋅⋅⋅C/N/O   
# N R σ2 N R σ2 N R σ2 N R σ2 F F’ 
19 1 1.79 3.95 1 2.52 0.00 2 3.37 -0.09    31 0.0288
 5 2.10 5.32           
20 1 1.79 4.00 1 2.52 0.10 3 3.37 1.02    36 0.0335
 5 2.10 4.29           
21 1 1.79 4.07 1 2.53 0.20 4 3.37 2.77    43 0.0399
 5 2.10 5.24           
22 1 1.80 4.07 1 2.53 0.38    1 3.35 5.16 26 0.0241
 5 2.10 5.21           
23 1 1.80 4.13 1 2.53 0.55 2 3.09 5.32 1 3.34 5.71 23 0.0269
 5 2.10 5.19            
Back transform range 0.5-3.2 Å. nidp = 18.7. See footnote of Table 6.2 for information on other parameters. 
 
 
 
Table 6.3 shows the fitting results to the filtered data up to the second shell. The 
second shell feature is well simulated with an Fe···Fe scattering path at ~ 3.3 Å (Fit 22 
and Fig. 6.7). This value falls in the range of Fe···Fe distances found for other diiron 
enzymes and their model complexes.62, 95-97, 105, 109, 159, 164, 197-200 Replacing the Fe···Fe path 
by several Fe···C paths gives poorer fits (Fits 19-21). Thus, EXAFS fitting clearly shows 
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that CmlA has a diiron cluster with an Fe-Fe distance of ~3.3 Å bridged by a µ-oxo 
ligand. The addition of several Fe···C paths at ~ 3.1 Å slightly improves the fit (Fit 23 and 
Fig. 6.7). However, as the F’ factor of Fit 23 is higher than that of Fit 22 the inclusion of 
the ~ 3.1 Å Fe···C paths may not be required at this point.  
 
 
    
 
Figure 6.7. Fits to the first and second shell filtered data. Fit parameters are provided in 
Table 6.3. 
 
 
 
6.3.3.2. Multiple scattering analysis of the unfiltered data 
Multiple scattering contributions are important to consider for the fitting of the 
CmlA EXAFS data. Significant multiple scattering paths from His and bidentate 
carboxylate ligands are shown in Fig. 6.2. The double-humped feature can not be 
simulated with the parameters of the best fit to the second shell filtered data (Fits 24 and 
25, Table 6.4). Addition of single-scattering paths in the range of 4.0 – 4.5 Å or single- 
and multiple scattering paths from the symmetric bidentate carboxylato moiety also fails 
to simulate this feature (Fits 26 and 27). However, when the single-scattering paths and 
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the important multiple-scattering paths from the imidazole ring are included, the third 
shell feature is well simulated (Fit 28) (Fig. 6.8). Including important paths from both 
imidazole and symmetric bidentate carboxylato moieties noticeably enhances the fit 
quality (Fig. 6.9). The numbers of paths from the imidazole moiety were varied during 
the fit. The optimized values of ~4 C single, ~8 double, and ~4 triple scattering paths 
require the presence of ~2 imidazole moieties per iron center. 
 
 
 
Table 6.4. EXAFS fitting results to unfiltered data for CmlA 
 
Fe-O/N Fe⋅⋅⋅C Fe⋅⋅⋅C/N Fe⋅⋅⋅Fe Fit 
# N R σ2 N R σ2 N R σ2 N R σ2 F’ 
24 1 1.80 4.28 1 2.53 0.66    1 3.34 4.20 0.4163
 5 2.10 5.00           
25 1 1.80 4.39 1 2.53 1.11 2 3.09 1.55 1 3.32 5.04 0.4041
 5 2.10 4.98          
26 1 1.80 4.45 1 2.53 1.22 2 3.09 1.17 1 3.32 4.86 0.3812
 5 2.10 4.91    3 4.47 1.45     
27 1 1.80 4.44 1 2.53 1.32 2 3.09 0.98 1 3.32 5.43 0.3970
 5 2.10 4.98 1 3.93 3.63    
    2 |3.98 |7.26       
    1 |3.94 |3.63       
28 1 1.80 4.31 1 2.53 1.14 2 3.09 1.75 1 3.31 4.97 0.3643
 5 2.10 4.92    *3.6 4.35 3.12     
       |7.2 |4.35 |6.31     
       |3.6 |4.35 |3.12     
29 1 1.80 4.41 1 2.53 1.09 2 3.09 1.19 1 3.32 5.36 0.3496
 5 2.10 4.97 1 3.94 5.13 *3.9 4.36 3.80     
    2 |3.94 |10.3 |7.8 |4.36 |7.78     
    1 |3.94 |5.13 |3.9 |4.36 |3.80     
F-factor calculated as 2626 /)(       kχk'F expcalexp χχ ∑∑ −= . See footnote of Table 6.2 for information 
about other parameters. Gray- and black-shaded cells indicate single scattering paths (top) associated with 
double (middle) and triple (bottom) scattering paths from the symmetric bidendate carboxylato and 
imidazole moieties, respectively (Fig. 6.2). | = parameters of multiple scattering paths linked with that of 
the corresponding single scattering paths. * = varied coordination numbers.  
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Figure 6.8. Fits to the unfiltered EXAFS data for CmlA. Both Fits 27 and 28 are lower in 
quality compared to Fit 29. 
 
 
 
Figure 6.9. Best fit to unfiltered EXAFS data for CmlA (Fit 29). Fit parameters are 
provided in Table 6.4. 
  
6.4. Discussion 
The structure of the diferric CmlA active site was probed by resonance Raman 
spectroscopy and X-ray absorption spectroscopy (XAS). The XAS data analysis shows 
that CmlA contains a (µ-oxo)diiron(III) cluster with Fe-µ-O and Fe⋅⋅⋅Fe distances of ca. 
1.80 and 3.32 Å, respectively, the latter clearly associated with the peak at r’ = 3 Å (Fig. 
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6.9). The Fe-µ-O and Fe⋅⋅⋅Fe distances together require an ∠Fe-O-Fe angle of ca. 134°, 
which agrees with the Raman results in Fig. 6.3. Based on comparisons with synthetic 
diiron(III) complexes,194, 195 the spectroscopic data for CmlA indicate the presence of a 
(µ-oxo)(µ-1,3-carboxylato)diiron core, as also found in the β subunit of Class Ia 
ribonucleotide reductases (R2).201, 202  
EXAFS analysis provides further insight into the nature of the iron ligands of 
CmlA. The average Fe-O/N bond distance (excluding the oxo bridge) for CmlA is 2.10 
Å, which reflects the relative number of histidines and oxyanion ligands. This distance is 
shorter than those for various forms of metHr (2.13-2.17 Å),95, 96 which has a total of five 
histidines and two carboxylate ligands for the diiron cluster,1 but longer than those for 
other diiron enzymes with four carboxylates and one or two His ligands (1.99-2.06).62, 96, 
156, 197-199, 201 The average Fe-O/N distance found for CmlA suggests that its diiron active 
site should have more than 2 but less than 5 His ligands.  
Support for this notion comes from an analysis of the outer shell features found in 
the 3.2 – 4.0 Å region of the FT data of CmlA (see green box in Fig. 6.9). These features 
can be attributed to the more distant atoms of imidazole-like ligands, the intensities of 
which are enhanced by multiple scattering pathways,203 and correspond to the double-
humped feature at 4 Å-1 in the unfiltered k-space data (Fig. 6.9 inset). Similarly well 
defined double-humped features near 4.0 Å-1 can be found in unfiltered EXAFS data of 
metHr and model complexes that have 4–6 imidazole-like ligands per cluster.95, 96, 164 In 
contrast, such features are less well defined in the spectra of other diiron enzymes with 
only 1 – 2 His ligands per cluster.62, 96, 156, 197-199, 201 Diiron complexes without imidazole-
like ligands do not exhibit this feature.105, 109 Thus, the clearly defined double-humped 
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feature in the EXAFS spectrum of CmlA suggests that there are more than 2 His ligands 
bound to its diiron active site. 
To obtain a more quantitative analysis of the data, we have applied a multiple 
scattering approach to simulate the double-humped feature (Table 6.4 and Figs. 6.8 and 
6.9). The best fit is shown in Fig. 6.9 and Table 6.4. The optimized numbers of scattering 
paths associated with the imidazole moiety require the presence of ~2 His ligands per 
iron, or ~4(±1) His ligands per cluster, given the ~25% uncertainty in the number of 
scatterers for a given shell determined from EXAFS analysis.204 However, the presence 
of 5 His ligands is highly unlikely on the basis of the average Fe-O/N distance of 2.10 Å 
found for CmlA, as discussed above. 
The best fit of the EXAFS data also requires the inclusion of one low-Z scatterer 
per iron at 2.53 Å (Table 6.2). The small σ2 value associated with the scatterer excludes 
the possibility that it arises from the ligating atom of a weakly bound ligand and leads us 
to assign it to the carboxylate C atom (Ccar) of a symmetrically bidentate carboxylate 
ligand. Scatterers at similar distance have also been found in the EXAFS spectra of the 
terephthalate complex of protocatechuate 3,4-dioxygenase205 and the ternary complex of 
tyrosine hydroxylase with substrate and cofactor196 and are associated with the carbon 
atom of a bidentate carboxylate. The tyrosine hydroxylase result is corroborated by the 
crystal structure of the corresponding complex of the homologous phenylalanine 
hydroxylase.206 For CmlA, the Cα atom of the bidentate carboxylate can also be included 
in the best fit because of the collinearity of the Fe center and the carboxylate Ccar and Cα 
atoms; including the multiple scattering paths involving these atoms noticeably enhances 
the fit (Table 6.4). Taken together, the rR and XAS analyses described above show that 
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CmlA contains a (µ-oxo)(µ-1,3-carboxylato)diiron(III) cluster with 6-coordinate iron 
centers, 2 symmetrically bidentate carboxylate ligands, and 3 – 4 His ligands (Fig. 
6.10A). 
 
 
Figure 6.10. Comparison of the diiron(III) clusters of CmlA and related diiron proteins. 
 
 
This structure is similar to that proposed in our previous study18 which was based 
on alignment of the sequences of CmlA and its homologs with the consensus sequence 
for metallo-β-lactamases. Sequence alignment predicted only 3 His ligands for CmlA,18 
but the presence of an additional His ligand is also possible. Both the CmlA and metallo-
β-lactamase sequences share the signature HxHxDH motif that provides one carboxylate 
and 3 His ligands for the metal cluster. Downstream of this sequence in CmlA, one Asp 
and two Glu residues are conserved and found at approximately the same positions as the 
other amino acid ligands of the dizinc cluster of the metallo-β-lactamases (2 His and 1 
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Cys/Ser). There is only one conserved His residue downstream of the signature sequence 
for CmlA (His378), and this could be the fourth His predicted in the current study. 
However, this His is adjacent to one of the postulated Glu ligands, and based on metallo-
β-lactamases structures, replacement of this Glu by His would place three His ligands on 
one iron and one on the other.  This would be expected to yield two quite different iron 
environments, which is not apparent in the Mössbauer spectrum of CmlA.18  It is possible 
that CmlA adopts a slightly different fold than a metallo-β-lactamase, changing the iron 
to which the additional His coordinates.  
Several new insights derive from the proposed structure of the diiron cluster of 
CmlA.  First, it is clear from the current studies that the diiron cluster of CmlA differs 
from those of the flavo-diiron protein (FDP) family10 in which it was first shown that a 
diiron cluster can be supported in the metallo-β-lactamase αββα fold. FDPs are 
widespread among bacteria and archaea and function as reductases for O2 and NO rather 
than oxygenases. All crystal structures of FDPs reported thus far show that their diiron 
clusters are bridged by a water-derived ligand with an Fe-O distance of ~2.0 Å (Fig. 
6.10B).10 This distance and the other spectroscopic features of the cluster indicate that 
this bridge is not a µ-oxo ligand as found here for CmlA, but rather a protonated form 
such as a hydroxo or an aqua ligand. Furthermore, the bridging atom appears to be 
hydrogen bonded to one of the terminal monodentate carboxylates. These structural 
differences between CmlA and FDPs may account for the contrasting reactivities, but 
additional structural and kinetic studies of both the FDPs and CmlA will be required to 
identify the molecular origin of these differences. 
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Second, despite having monooxygenase reactivity, the diiron core structure of 
CmlA differs from those of the clusters of all canonical oxygen-activating nonheme 
diiron enzymes characterized thus far.2, 3, 9 BMMs, desaturases, and R2 have a conserved 
2-His-4-carboyxlate ligand set with 1 His per iron center (Fig. 6.10C). This ligand set 
promotes a generally accepted oxygen activation mechanism involving a (µ-1,2-
peroxo)diiron(III) intermediate that converts to high-spin higher-valent diiron species 
responsible for substrate oxidation.2, 3, 9  
Distinct oxygen activation mechanisms are postulated for some enzymes that have 
more than two His ligands bound to the diiron active site, including myo-inositol 
oxygenase (MIOX) with a total of 4 His ligands11 and AurF with a total of 3 His ligands15 
(Fig. 6.10D). MIOX is unique in that it activates O2 with a mixed-valent diiron(II/III) 
cluster to form a C-H bond-cleaving (superoxo)diiron(III) intermediate that initiates the 
4e-oxidation of substrate.13 AurF effects the conversion of aromatic amines to nitro 
groups via a diiron(III)-peroxo intermediate that differs from the canonical (µ-1,2-
peroxo)diiron(III) intermediate discussed above.103 
Like MIOX and AurF, CmlA has an additional His ligand on at least one and 
possibly both irons of its diiron cluster, but its molecular mechanism is unlikely to be 
similar to those of MIOX or AurF. In contrast to MIOX, we have shown that it is the 
diiron(II) state of CmlA that reacts with O2 to initiate catalysis.18 With respect to AurF, a 
similar peroxo intermediate may also be formed by CmlA, but this species is unlikely to 
be sufficiently reactive to attack the C-H bond on the substrate (BDE ~ 85 kcal/mol, 
Scheme 6.1). Accordingly, the peroxo intermediate of AurF has not been observed to 
attack C-H bonds of any substrate.   
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This analysis suggests that CmlA may generate some type of high valent diiron 
oxygen species in which the O-O bond of O2 has been broken as found for the canonical 
diiron monooxygenases such as methane monooxygenase (MMO). However, the 
additional His ligand(s) may alter the nature of this reactive species. There are many 
options for the species that could be formed as alternatives to the FeIV2O2 diamond core 
of MMO intermediate Q.61, 207, 208 For example, our recent work has identified synthetic 
diiron(IV) complexes with nitrogen-rich ligand environments that are quite reactive 
towards C-H bonds.233, 249 Although experimental evidence is needed to support the 
hypothesis for an alternative reactive species in CmlA, it is clear that variations to the 
canonical MMO reactive intermediate are emerging and may be relevant to catalysis by 
CmlA.200, 209 
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